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Abstract 
Background  
Epidemiologic evidence is sparse on the role of dietary patterns that may be important 
drivers of high blood pressure (BP) and body mass index (BMI) levels. Additionally, 
dietary fibre intake in association with BP and BMI yielded inconsistent results.  
Objective 
Investigate the relationships of eating frequency, dietary energy density, diet quality, 
evening energy intake, GI, GL, and dietary fibre to BP, BMI using cross>sectional data 
from the INTERnational study on MAcro/micronutrients and blood Pressure 
(INTERMAP) of 4680 men and women aged 40–59 y from Japan, China, the United 
Kingdom, and the United States of America. 
Methods 
During 4 visits, eight BP, four weight and height measures, four 24>hour dietary recalls, 
and two 24>hour urine samples were collected. Consumption of all solid foods was 
aggregated into eating occasions. Nutrient density is expressed using the Nutrient Rich 
Food index. Multivariable adjusted linear regression models were used to estimate BP 
and BMI differences per 2SD higher intakes of eating occasions, dietary energy 
density, Nutrient Rich Food index, evening energy intake, GI, GL, and dietary fibre. 
Results 
Compared to participants with <4 eating occasions/24>hours, those with ≥6 eating 
occasions/24>hours had lower average: systolic BP: 116.4 vs. 121.4 mm Hg; BMI: 27.3 
vs. 29.0 kg/m
2
; total energy: 2127 vs. 2521 kcal/24>hours; dietary energy density: 1.5 
vs. 2.2 kcal/g; and higher Nutrient Rich Food index score: 35.1 vs. 26.8. Additionally, 
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insoluble fibre higher by 4 g/1000 was inversely associated with systolic BP (p<0.05), 
while soluble fibre and GI, GL showed no associations with BP and BMI. 
Conclusions 
Results suggest that higher meal frequency may be associated with improved diet 
quality and lower BP and BMI. Higher intakes of insoluble fibre may contribute to 
lower BP and BMI. This may have implications for behavioural approaches to 
controlling high BP levels and the obesity epidemic. 
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CHAPTER I 
Background
  17
1. BACKGROUND 
1.1. Definition and prevalence of high blood pressure 
High Blood Pressure (BP) is defined as systolic BP of ≥140 mm Hg and diastolic BP of 
≥ 90 mm Hg, or the use of anti>hypertensive medication 
1
. The Seventh Report of the 
Joint National Committee on prevention, detection, evaluation, and treatment of high 
blood pressure (JNC 7) classified hypertension into: Stage 1 (systolic and diastolic BP: 
140>159 and 90>99 mm Hg) and Stage 2 (systolic and diastolic BP: 160>179 and 100>
109 mm Hg and systolic and diastolic BP: ≥180 and ≥110 mm Hg) 
2
. The JNC 7 
introduced the term “pre>hypertension” to include those with systolic BP of 120–139 
mm Hg and/or diastolic BP of 80–89 mm Hg. This new classification aims to identify 
those who can benefit from early lifestyle intervention for BP reduction (Table 1.1) 
3
. 
The relationship between BP and cardiovascular disease (CVD), including coronary 
heart disease (CHD) and stroke, is graded and continuous 
4
. This positive correlation is 
stronger for systolic BP than it is for diastolic BP 
5
. According to a meta>analysis of 
over one million adults from the Prospective Study Collaboration (2002), the risk of 
CVD doubled for increases in systolic and diastolic BP of 20 and 10 mm Hg, 
respectively 
4
. Their analyses were based on 286,000 repeated BP measurements over 
several years of follow up 
4
. In 2004, the INTERHEART study, a global case>control 
study of risk factors contributing to acute myocardial infarction, reported that nearly 
22% of heart attacks in Western Europe, and 25% of heart attacks in Central and 
Eastern Europe could be attributed to raised BP 
6
.  
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Table  1.1. Blood pressure classification 
JNC 7 Category Systolic and diastolic BP, mm Hg 
Normal <120 and 80 
Pre-hypertension 120>129 and 80>84 
 130–139 and 85>89 
Hypertension  
Stage 1  140–159 and 90–99 
Stage 2  160–179 and 100–109 
 ≥180 and 110 
JNC, Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. 
Source: The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment 
of High Blood Pressure. JAMA 2003; 289:2560–71. 
 
In the United States of America (USA), the age adjusted prevalence of hypertension in 
2009>2010 was 28.6%, similar to the 2007>2008 reports (29.7%) 
7
. The prevalence, 
however, was higher in women, older adults, and non>Hispanic blacks 
8
. The National 
Health and Nutrition Examination Survey (NHANES) data showed increased rates of 
hypertension from 24% in 1988>1994 to 29% in 1999>2000, which remained 
unchanged in the 2007>2008 report 
8
. Although efforts have been focused on 
hypertension awareness, treatment, and control, more than 50% of individuals had 
uncontrolled BP levels in 2007>2008 
9
. Prediction models demonstrated that 14,000 
deaths per year could be prevented in adults with every 10% increase in hypertension 
treatment and control 
10
.  
In England, the 2011 Health Survey for England (HSE) reported the prevalence of 
hypertension remained unchanged since the 2003 report (31.7% of men and 29.5% of 
women were hypertensive). More than 50% of men and women with hypertension 
remained untreated. The report also stated that two fifths of men and women who are 
on treatment for hypertension failed to reduce their BP levels to <140/90 mm Hg 
11
.  
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1.1.1. Pathophysiology  
Environmental factors like age and diet, as well as genetic factors, were found to affect 
the BP regulation process 
12
. Studies on families with similar trends in BP provide 
evidence that genetic mutations may be linked to high BP levels 
13,14
. Arterial pressure 
is determined by cardiac output and peripheral resistance. Heart rate and stroke volume 
are two determinants of cardiac output, while peripheral resistance is associated with 
changes in small arteries and arterioles 
15
. The autonomic nervous system regulates the 
functions of the kidneys, which in turn play a role in the regulation of cardiac output, 
fluid retention, and vascular resistance, thus in the onset of hypertension 
16
. When 
kidneys require elevated BP to sustain extracellular fluid volume in the normal range, 
BP starts to escalate 
17
. Therefore, any degree of impairment in renal function (fluid 
balance) causes hypertension. This mechanism is supported by animal 
18
 and human 
studies 
19
, showing an improvement in BP levels following a kidney transplant. 
Peripheral resistance and extracellular fluid volume are also regulated by the renin>
angiotensin>aldosterone system. Arterial vasoconstriction and extracellular volume are 
affected by the level of circulating enzyme Renin. Renin breaks down angiotensinogen 
into angiotensin I, playing a major role in BP regulation. Angiotensin I is further 
hydrolysed into angiotensin II, which enhances the production of the hormone 
Aldosterone, which in turns stimulates reabsorption of salt and water 
20
.  
1.1.2. Risk factors for high blood pressure 
Observational studies and clinical trial data indicate that causes of elevated BP are 
mainly environmental. This includes dietary and lifestyle factors such as: sodium, 
potassium, alcohol consumption, body mass index (BMI) level, physical activity, 
socioeconomic status, and genetic factors > all discussed briefly below.  
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Dietary sodium  
Dietary sodium intake has been directly associated with elevated BP in several 
observational and clinical trial studies 
21>24
. The most widely known trial is the Dietary 
Approaches to Stop Hypertension > Sodium Trial (DASH) 
21
. The crossover trial 
included 412 participants with slightly increased BP levels (systolic BP of 120 to 159 
mm Hg, diastolic BP of 80 to 95 mm Hg). The participants were randomised to receive 
either a DASH diet (rich in fruits, vegetables, and low>fat dairy foods; includes whole 
grains, poultry, fish, and nuts; with less amounts of red meat, sweets, and sugar>
sweetened beverages compared to a typical diet) or a common, typical western diet for 
3 months. Different levels of sodium were provided to trial and control groups; high, 
intermediate, and low: 144, 107 and 67 mmol/24>hours otherwise, all diets were similar 
in nutritional content. The reduction of sodium intake from the high to the intermediate 
level resulted in a reduction in systolic BP by 2.1 (p<0.001) and 1.3 mm Hg (p=0.03) 
in the control and DASH diet periods, respectively. In addition, the reduction in sodium 
intake from the intermediate to the low level further reduced systolic BP by 4.6 mm Hg 
in the control diet period (p<0.001) and by 1.7 mm Hg in the DASH diet period 
(p<0.01). The DASH diet was associated with a significantly lower systolic BP at each 
sodium level 
21
. Evidence from large epidemiologic studies, like the International Co>
operative Study of Electrolyte Excretion and Blood Pressure (INTERSALT), supports 
the direct association between sodium intake and BP 
25
. In 1996, a reanalyses of the 
INTERSALT study confirmed a direct and consistent association between urinary 
sodium and systolic BP in multivariate analyses with and without adjustment for BMI. 
The INTERSALT study included 10074 men and women 20 to 59 years of age from 52 
samples in 32 countries. Higher urinary sodium excretion by 100 mmol was associated 
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with systolic BP higher by 5>7 mm Hg. These findings provide evidence that the 
reduction of sodium intake protects against adverse BP levels 
25
.  
Dietary potassium 
The INTERSALT study provides evidence that dietary potassium is inversely 
associated with BP 
26
. In 1997, Whelton et al. conducted a meta>analyses of 32 
randomised controlled trials (RCT) and concluded that supplementation with an 
average of 75 mmol/24>hours of potassium chloride was associated with average 
reductions in systolic and diastolic BP of 3.1 and 1.9 mm Hg, respectively 
27
. These 
results support the hypothesis that raising potassium intake will help in the prevention 
of high BP level. Potassium affects cell uptake of norepinephrine, increasing blood 
flow and relaxing vascular smooth muscle 
28
. Infusion of an iso>osmotic solution of 
potassium chloride into the brachial artery of dogs lead to a rise in blood flow, making 
it a vasodilator 
29
, while reducing potassium to 1 meq/L causes vasoconstriction 
30
.  
Alcohol  
Consumption of alcohol (ethanol), especially in excessive drinking, has been 
consistently associated with hypertension and elevated BP level in prospective cohort 
31
 
and cross>sectional 
32
 studies. Intervention studies have also reported favourable effects 
on BP level through the reduction of alcohol consumption 
33,34
. A meta>analysis of 15 
trials assessed the effects of reduced alcohol consumption on BP level, showing 
significant reductions in systolic and diastolic BP of (−3.3, 95% confidence interval 
(CI): −2.5, −4.1 mm Hg) and (−2.0, 95% CI: −1.5, −2.6 mm Hg) with reduced alcohol 
intake 
35
. In Japan, a 7>year follow up study including metal workers was conducted to 
investigate the association between ethanol consumption and BP 
36
. In comparison to 
non>drinkers, consumption of 300 g or above of ethanol per week was found to increase 
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systolic BP by 0.44 mm Hg per year 
36
. The proposed mechanism by which ethanol 
raises BP is complex. The sympathetic nervous system plays a key role in elevating BP 
after alcohol consumption 
37
. It has been proposed that ethanol consumption inhibits 
nitric oxide (atheroprotective), alters calcium–magnesium balance, affects renin>
angiotensin>aldosterone system, and causes insulin resistance, all of which are 
contributory factors in raising BP level 
38
.  
Body weight  
Obesity and CVD are interlinked. This is illustrated by the unfavourable cardiovascular 
risk profile in obese individuals including hypertension, hyperlipidaemia, and type 2 
diabetes mellitus (DM) 
39>41
. There are several proposed mechanisms by which obesity 
may cause hypertension. One is attributed to the activation of the sympathetic nervous 
system in those who are obese 
42
. The sympathetic nervous system is stimulated by 
high caloric intake, especially of dietary carbohydrate and fat, particularly free>fatty 
acids 
43
, which stimulate adrenergic receptors. This eventually increases norepinephrine 
in peripheral tissues and plasma, increasing vascular tone 
44
. Elevated BP associated 
with obesity may be also be related to the rise in angiotensinogen, a precursor of 
angiotensin, which is released from adipocytes. In addition, larger body mass is 
accompanied by increased blood volume, along with a rise in blood thickness 
45
. Obese 
individuals typically manifest increased arterial thickness, especially excessive 
adiposity over an extended period, which eventually raises BP level. Obesity has also 
been consistently linked to insulin resistance 
46>48
. Experimental trials and cohort 
studies showed that both hyperglycaemia and hyperinsulinemia were linked to elevated 
BP levels 
49>52
. This link occurs through the stimulation of the rennin>angiotensin 
system, promotion of vascular smooth muscle cell proliferation and release of 
prothrombotic factors. Both the kidneys and the arterial wall are damaged due to 
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increased blood sugar levels which causes the deposition of advanced glycation end 
products; reduction in nitric oxide and the production of oxygen radicals 
53>55
.   
Physical activity 
Physical activity has been shown to be protective against CVD 
56
. Regular physical 
activity was also associated with lower risk of hypertension 
57
. Longitudinal 
intervention studies have supported the inverse association between physical activity 
and BP level 
58,59
. A meta>analysis in the year 2007, including 72 trials and 105 study 
groups, on the effect of different exercise methods on BP control showed overall net 
reductions in systolic and diastolic BP of 3.0 and 2.4 mm Hg associated with training 
59
. There were also significant reductions in systemic vascular resistance, plasma renin 
activity, and plasma norepinephrine, all of which were shown to be favourable to BP 
level. Other measurements were also reduced: body weight, waist circumference, body 
fat percent, and insulin resistance, all of which affect BP level 
59
. An RCT comparing 
the DASH diet alone or in combination with exercise and body weight management 
was conducted for 4 months in 144 overweight and obese adults with elevated BP 
60
. 
Results showed that those following the DASH diet had a BP reduction of 11.2/7.5 mm 
Hg, while those on the DASH diet plus exercise had a reduction of 16.1/9.9 mm Hg. 
The control group (following a weight reduction diet) had a BP reduction of 3.4/3.8 
mm Hg (p< 0.001) 
60
. It has been proposed that exercise decreases the production of 
catecholamines (epinephrine and norepinephrine) and improves insulin sensitivity, 
therefore decreases BP level 
57
. Decreases in cardiac output and peripheral resistance 
were also documented post exercise treatment, especially in individuals with increased 
peripheral resistance 
61
.  
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Socioeconomic status 
Indicators of socioeconomic status>including education, income, and occupation>were 
inversely associated with BP levels in a number of cross>sectional studies 
62>64
. Also, 
the Women’s Health Study (WHS), a randomised trial on the effects of using aspirin, 
vitamin E, and beta>carotene to prevent CVD and cancer, assessed the association 
between socioeconomic status and hypertension in 39876 female health professionals 
65
. Results showed an independent association of socioeconomic status with incident 
hypertension after 10 years of follow up. Across quintiles of income, those in the 
highest quintile (quintile 5) had an 11>16% lower risk of developing high BP compared 
to those in the lowest income quintile (quintile 1). Across categories of education, the 
relative risk for BP development was lower in those in the highest category of 
education (p for trend <0.0001) 
65
. The relation between low socioeconomic status and 
higher risk of hypertension may be related to several factors, like access to quality 
medical care 
66
, dietary habits 
67,68
, and the condition of residential area 
61
. With limited 
financial and living means, diets may be low in fruits and vegetables and high in fat and 
sodium, leading to an increased risk of developing hypertension 
68
. In addition, 
emotional distress caused by financial limitations and increased job strain may elevate 
neuro>hormonal activity, leading to hypertension 
69
.  
Genetic factors 
Both genetic and environmental factors influence the BP regulation process. With 
advances in genetic approaches, there is a clearer understanding of the biological 
pathways that explain inter>individual variations in BP 
12
. The genome>wide 
association study of systolic and diastolic BP included 200,000 European participants 
in a multi>stage designed study aimed to identify genetic variants that influence BP and 
other outcomes 
70
. A total of 16 loci with genes related to BP were identified, where six 
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of them include genes known to regulate BP (GUCY1A3–GUCY1B3, NPR3–C5orf23, 
ADM, FURIN–FES, GOSR2, GNAS–EDN3). Association of hypertension, left 
ventricular wall thickness, stroke and coronary artery disease with a genetic risk score 
based on 29 genomes was significant. Those in the highest quintile of the genetic risk 
score had higher systolic and diastolic BP levels by 4.6 and 3.0 mm Hg compared to 
those in the lowest quintile 
70
. In the Women's Genome Health Study (WGHS) sample 
of 23294 women, an increase of one standard deviation (SD) in the genetic risk score 
was associated with a 23% increase in odds of hypertension (95% CI: 19, 28%) 
71
. 
Across deciles of the genetic risk score, those in the highest category had a higher 
prevalence of hypertension compared to those in the lowest category (29% vs. 16%; OR 
2.09, 95% CI: 1.9, 2.4) 
71
.  
1.2. Definition and prevalence of overweight and obesity 
Adiposity is commonly approximated by BMI (kg/m
2
): body weight (kg) divided by the 
square of height (m). Adiposity, expressed by an elevated BMI level (≥25 kg/m
2
) 
72
, is 
an established risk factor for mortality and morbidity, primarily of CVD 
73
, liver 
cirrhosis 
74
, cancer 
75
, diabetes 
76
, and adult>onset asthma 
77
.  
Long term analyses of trends in BMI level have shown that adiposity has increased 
globally in both genders between 1980 and 2008 
78
. Male BMI has increased by 1.1 
kg/m
2
 per decade since the early 1980’s; with similar increases observed in the United 
Kingdom (UK) and Australia. Women in the USA had an average increase of 1.2 kg/m
2
 
per decade. The age>standardized prevalence of obesity around the world was 9.8% 
(95% CI: 9.2, 10.4) in men and 13.8% (95% CI: 13.1, 14.7) in women in 2008. These 
values are twice the 1980 levels for men and for women 
78
. The 2007–2008 NHANES 
reported that approximately 34.2% of all adults in the USA were overweight (≥25 
  26
kg/m
2
) 
79
, 33.8% were obese (BMI ≥ 30 kg/m
2
) 
79
, and 5.7% were morbidly obese 
(BMI ≥ 40 kg/m
2
) 
79
 compared to 33.1%, 22.9%, and 2.9%, respectively, in the age 
adjusted data from 1988–1994 
80
. Data from the HSE show that the percentage of adults 
with optimum BMI (between 18.5 to 24.9 kg/m
2
) 
79
 decreased from 41% to 32% 
between 1993 and 2005. The prevalence of obesity increased over the same period from 
13.2% to 23.1% in men, and 16.4% to 24.8% in women 
81
. The 2011 HSE reported an 
increase in the prevalence of obesity in men and women compared to 2006 (24% and 
26% respectively). A higher proportion of men than women were overweight (41% 
compared with 33%); therefore, 65% of men and 58% of women were overweight or 
obese 
82
. 
1.2.1. Risk factors for overweight and obesity  
Obesity generally results from excess energy intake compared to energy expenditure 
83
. 
Obesity is a multifactorial health issue that can be attributed to environmental and 
genetic factors. Due to the rising prevalence of obesity worldwide, it can be argued that 
environmental and behavioural factors are likely to play the major role in its epidemic. 
Some of the most important risk factors associated with obesity are briefly discussed 
below: diet, physical activity, socioeconomic status, and genetic factors. 
Diet 
There is substantial evidence on the impact of increased dietary intake on body weight 
84>86
. Rapid urbanisation and westernization in different parts of the world have changed 
local diets, often coinciding with increased obesity 
87,88
. The Western diet was generally 
described as high in fat and in energy density 
72,89
. With the expansion of food>
manufactures, available diets are now high in energy, protein, and fat and low in fibre. 
A recent systematic review and meta>analyses of 15 RCTs found that both diet and 
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exercise interventions over 6 months resulted in body weight reduction and favourable 
metabolic profile including: high density lipoprotein cholesterol (3.86, 95% CI: 2.70, 
4.63 mg/dL), fasting glucose (>2.16, 95% CI: >3.78, >0.72 mg/dL), and fasting insulin  
(>2.75, 95% CI: >4.50, >1.00 SIU/mL) 
90
. 
Physical activity  
Regular exercise contributes to body weight loss and stability 
45
. Physical inactivity has 
long been associated with body weight gain 
91>93
. Individuals with the lowest activity 
level have the highest risk for CVD 
94
. Data suggest that the decline in physical activity 
correlates to an increase in hours spent watching television, increase in using household 
devices (e.g. dishwasher), decrease in the time spent walking among children, with 
these changes occurring simultaneously with increases in obesity 
95
. Evidence from a 
longitudinal cohort study on school children show that a sedentary lifestyle in 
adolescence strongly predicts obesity (OR 3.9, 95% CI: 1.4, 10.9). It was suggested that 
increasing physical activity during adolescent years may support the prevention of 
obesity, especially in the abdomen 
93
.  
Socioeconomic status 
Evidence suggests that low socioeconomic status is strongly correlated with obesity 
96
. 
Previously, Sobal et al. reviewed published literature on the relation between 
socioeconomic status and obesity between the 1960s and 1980s and concluded that 
socioeconomic status is generally inversely related to obesity in the developed world. 
Women of lower socioeconomic status in developed countries were most likely to be 
obese. In contrast, in developing countries, those in higher socioeconomic status were 
likely to be obese 
97
. Following the Sobal et al. review, this trend was supported in an 
updated review of epidemiologic studies, primarily cross>sectional, including data from 
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1988–2004 
98
. Women of lower socioeconomic status were more overweight in highly 
developed countries, whereas women in developing countries had lower body weight 
98
. The link between socioeconomic status and obesity in developed countries may be 
attributed to the lack of education among individuals of low income who generally do 
not perceive themselves as being overweight compared to those of high income 
99
. In 
addition, limited access to healthy foods, consumption of energy dense foods, and lack 
of motivation to participate in physical activity were all associated with low income 
100
. 
Areas of poor economic status have a higher number of fast>food restaurants 
101
, with 
less activity and sports centres 
102,103
. 
Genetic factors 
It has been hypothesised in the early 1960s that obesity observed in populations 
suffering from starvation could be related to certain genes. It was suggested that this 
relation may explain the tendency of some individuals who possess those genes to gain 
far more body weight than those who do not 
104
. Since then, a large body of research 
aimed to identify predisposing genes that may explain familial general obesity and fat 
distribution 
13,105>108
. The Quebec Family Study, a prospective cohort study 
investigating the role of genetics in the aetiology of obesity, provides evidence that fat 
mass is affected by a recessive major gene responsible for 40>45% of variations and 
distribution of fat 
109
. At this time, more than 250 genes, markers, or chromosomal 
regions associated with obesity have been identified 
110
. The Genetic Investigation of 
ANthropometric Traits (GIANT) consortium is an international collaboration that aims 
to identify genetic loci associated with measures of obesity and other outcomes. Two 
loci (FTO and MC4R) were initially reported to be associated with BMI. Six additional 
loci were recently identified (TMEM18, KCTD15, GNPDA2, SH2B1, MTCH2 and 
NEGR), confirming their role in the predisposition of monogenetic forms of obesity 
107
. 
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1.3. Eating frequency 
Meals and snacking patterns, i.e., eating frequency, have been linked to body weight 
and the development of chronic disease 
111
. However, data are sparse on the association 
between the number of eating occasions per day and BP. Previous cross>sectional and 
prospective cohort studies on associations between eating frequency and body weight 
have yielded inconsistent results, with several reporting that more frequent meal intake 
throughout the day is associated with lower BMI 
112>114
, and others finding no 
association 
115,116
. This gap in knowledge has been identified by the 2010 Dietary 
Guidelines Advisory Report that called for future research in this field 
117
.  
1.3.1. Eating frequency and blood pressure  
The association between eating frequency and BP has not been thoroughly investigated 
in observational and intervention studies 
118,119
. Even on those occasions, BP level was 
seldom the primary outcome in studies of food frequency. For example, Arnold et al. 
examined the metabolic effect of grazing in 19 healthy free>living normo>
cholesterolemic individuals, in a 4>week experimental design 
120
. Participants received 
either 3 or 9 meals per day for 14 days, with a one and seven>day washout period 
between the two diet regimens. Results showed no significant differences were 
observed in either body weight or systolic BP, however, total cholesterol, low density 
lipoprotein (LDL) and high density lipoprotein (HDL) were significantly lower in the 9 
meals per day regimen. The 24>hour insulin and insulin>glucose output was lower in the 
grazing diet than the 3>meal diet, although this difference was not significant. It should 
be noted that a short trial and washout period makes differences in systolic BP and 
other markers difficult to obtain 
120
. 
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Forslund et al. studied the effect of two diet treatments (3 meals and 3 meals plus 3 
snacks per day) in a randomised one>year body weight loss trial including 180 
participants 
121
. Body weight loss was found to be greater in the 3 meals plus 3 snacks 
group, although the difference was not significant. Additionally, BP, glucose, insulin, 
LDL, HDL, and triacylglyceride TAG did not differ between the two groups. It is 
noteworthy that body weight, waist and hip circumference, BP, blood samples were all 
measured once at baseline and after one year 
121
. Poston et al. conducted a similar 
prospective 24>week randomised weight reduction trial in 100 over>weight participants 
122
. Participants were divided into snackers (≥4.5 meals/day) and non>snackers (≤ 5.5 
meals/day), based on data from the USA NHANES database. These groups were 
randomised to receive a meal replacement or a meal replacement plus snack. Although 
body weight and systolic BP declined in all groups, no significant difference was 
observed across all four groups (non>snackers meal replacement only, non>snackers 
meal replacement plus snacks, snackers meal replacement only, snackers meal 
replacement plus snacks) 
122
. 
In contrast, Stote et al. conducted a randomised crossover design for 8 weeks to 
examine the relation between eating frequency and BP level in healthy adults with a 
BMI between 18 and 25 kg/m
2 119
. Participants were given either one or three meals per 
day, consumed under the supervision of a registered dietician, with an 11>week 
washout period. Findings indicated that systolic and diastolic BP were significantly 
lower (6%) among those consuming 3 meals/day in comparison to those consuming one 
meal/day. The long washout period (11 weeks) ensured the effects of one diet regimen 
did not last up to the alternative regimen. In this study, meal frequency was the only 
change between the two diets, and no caloric restriction was applied 
119
.  
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1.3.2. Eating frequency and body weight 
The association between the number of eating occasions per day and body weight has 
been the focus of a number of prospective cohort, cross>sectional, and intervention 
studies 
113,123>128
. However, the findings of this literature reveal inconsistencies despite 
similar study designs, all of which include different levels of adjustments for key 
confounding variables, such as under>reporting, physical activity, energy intake, 
dieting, and smoking 
126,127
. A number of cross>sectional and longitudinal studies have 
found that more frequent meal intake throughout the day was associated with lower 
BMI 
112>114,127,129>132
, while others reported no significant findings 
115,116,128,133>137
. 
One of the earliest trials exploring the association between eating frequency and body 
weight found an inverse association between the number of meals consumed in a day 
and body weight 
126
. A total of 379 male participants were divided into: those having 
≤3, 3>4 meals, 3>4 meals with snacks, 3>4 meals with one bedtime snack, and ≥5 meals. 
In comparisons of the five groups, the percentages of overweight and mean skin fold 
thickness were significantly higher in those consuming three or less meals per day 
126
.  
A cross>sectional analysis of the Tecumseh Community Health Study, a prospective 
epidemiologic study of a community's health and disease status in Michigan, USA, 
included 2000 men and women 
131
. A single 24>hour dietary recall and an adiposity 
index computed from body weight and skin>fold thickness measures were used. In 
order to quantify meal frequency, Metzner et al. combined meals if they were less than 
30 minutes apart and were consumed within an hour; the combined intake was counted 
as a meal when it provided 40 calories or more. After adjustment for energy intake, the 
mean adiposity index was inversely and significantly associated with the number of 
meals consumed. This study, however, did not address confounding factors like under 
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reporters or physical activity level 
131
. Similar results were reported using data from 
The Seasonal Variation of Blood Cholesterol Study (SEASONS), a prospective study 
where 499 USA men and women were followed up for one year 
113
. The risk of obesity, 
adjusted for known confounders, was found to be 45% lower (95% CI: 0.33, 0.91) in 
those consuming ≥4 meals per day, in comparison to those consuming ≤3 meals per 
day. In this study, data were gathered from 5 body weight measurements and 15 24>
hour dietary recalls. A meal was defined as that providing 50 kcal or more, with a 15 
minute time interval or more between each meal 
113
. Another study supporting the 
inverse association between eating frequency and BMI is a longitudinal study by 
Franko et al., where a sample of 1209 black and 1166 white adolescent girls (9>19 y) 
were followed up over a period of 10 years 
112
. The study used data from a 3>day food 
record obtained during annual visits, in conjunction with height and body weight 
measurements and self>reported levels of physical activity. Results indicate that meal 
frequency was inversely and consistently associated with BMI, adjusted for 
demographic and energy expenditure variables 
112
. 
The aforementioned studies found an inverse association between eating frequency and 
body weight, however a likely source of error may be under>reporting. Ruidavets et al. 
addressed this issue in their cross>sectional study in 330 free living middle>aged men 
132
. A 3 day food record was used, as in the work of Franko et al. 
112
. These records 
were then validated by home visits of certified dieticians. Ruidavets et al. adopted the 
same definition by Metzner et al. of an interval of 30 min used to separate meals from 
one another 
131
. After under reporters and dieters had been excluded, waist>hip ratio 
(WHR) and BMI were found to be significantly and inversely associated with the 
number of meals. These results remained consistent after adjustment for confounders, 
such as total caloric intake, age, physical activity, and smoking. Based on these 
  33
findings, it was suggested that the observed inverse association between BMI and 
eating frequency may be attributable to the reduction in insulin production and 
lipogenesis which can be associated with higher eating frequency 
132
. A similar study 
design was conducted by Drummond et al., in which under>reporters were excluded in 
a cross>sectional study of a sample of 48 men and 47 women with a wide BMI range of 
18 and 30 kg/m
2
 
127
. A seven>day food record was used to determine eating frequency. 
This was supplemented by the measurement of skin>fold thickness and physical activity 
level. The definition of eating occasions was based upon that offered by De Castro, in 
which eating occasions are combined when they occur within 15 minutes of each other 
138
. This approach attempts to avoid misconceptions in describing eating occasions as 
meals or snacks, or discriminating against those with high daily eating frequencies. The 
relationship between eating frequency and body weight was found to be significantly 
inverse in men. An inverse association was also observed between eating frequency and 
BMI 
127
. 
A prospective cohort study by Ritchie examined the relation between frequency of 
eating and adiposity in 2372 adolescent black and white girls (9–10 to 19–20 years) 
from 3 USA centres. The study sample was derived from the 10 years National Heart, 
Lung, and Blood Institute Growth and Health Study (NGHS). Dietary data were 
obtained from a 3>day food record; where annual information on dietary patterns was 
provided and records were examined in association with BMI and waist circumference 
changes over 10 years. Results show that eating frequency was higher in white girls 
(p<0.0001). Black girls had lower eating frequencies and higher increases in BMI 
(p=0.02) and waist circumference (p=0.01). In addition, lower snacking and eating 
frequency, adjusted for known confounders, was associated with a higher increase in 
BMI (p=0.01) and waist circumference (p=0.03) over the 10 year period 
114
.  
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A cross>sectional analysis of the Malmo Diet and Cancer (MDC) study, a prospective 
population study in Sweden, included a sub>sample of 3009 adults aged 47 to 68 years. 
Using a 7>day diet record, self>reported daily eating occasions were inversely 
associated with BMI and waist circumference (p<0.05) in normal weight men, adjusted 
for potential confounders. In addition, those having higher eating occasions per day had 
higher intake of total dietary fibre (p<0.0001), smoked less, and were more active 
(p<0.01) compared to those having lower eating occasions per day 
130
.  
In contrast to the above findings, a number of studies did not support the hypothesis 
that greater daily eating frequency is associated with lower BMI. Dreon et al. found no 
significant association between eating frequency and body weight or percent body fat 
133
. While their cross>sectional study of 155 sedentary overweight men used a 7>day 
food record, regression models did not adjust for other possible confounding factors. It 
should also be noted that the sample population was extremely homogeneous in terms 
of body weight, body fat composition, and eating patterns, with minimal deviation in 
either the number of eating occasions or in the amount of calories consumed during 
each eating occasion 
133
. The NHANES I epidemiologic follow up study of the 
association between frequency of eating occasions and body weight also did not 
support the hypothesis that eating frequency is inversely associated with BMI 
128
. Data 
in this study were based upon a single 24>hour dietary recall administered in 1971>
1975, in which interviewers estimated the number of eating occasions based on time of 
food consumption. The frequency of eating occasions and BMI were inversely related 
at baseline in multiple covariate adjusted regression models. At follow up in 1982–
1984, participants were asked to report the number of meals and snacks per day, with 
under>reporters and dieters being excluded from the final analysis. After adjustment for 
multiple confounding factors, no significant association was shown between body 
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weight change and number of eating occasions. Key methodological issues are that 
only a single 24>hour dietary recall was used, and that the method by which eating 
occasions were quantified was different at baseline from follow up 
128
. The larger data 
set of the European Prospective Investigation into Cancer and Nutrition (EPIC) in 
14,666 men and women also found a weak inverse association between eating 
frequency and body weight 
137
. Data, however, were derived from a single food 
frequency questionnaire (FFQ), in which a single question asked participants to 
quantify the number of times they ate in a day, suggesting that the findings are not 
necessarily representative. 
The aforementioned studies have not compared frequency of meal intake in different 
body weight groups (i.e. obese vs. normal) individuals. This type of comparison was 
considered in a few prospective cohort, case>control and cross>sectional studies 
115,134,136
. The longitudinal study, Gustaf study, presented more representative data on 
meal intake by using twelve telephone>administered 24>hour recalls over a period of 
three months 
115
. The study sample included obese and normal men from Sweden. No 
significant differences were observed in meal patterns and trends between the two 
groups, which may be attributed to a high level of under>reporters in the obese sample 
(73%) 
115
.  
The eating behaviour and activity levels of 19 weight>gaining men and women and of 
weight>stable, matched control subjects were compared with the use of a 7>day diet 
diary (weight gain of ≥ 5% in the previous 6 months as reported by participants). 
Results show that weight>gaining individuals consumed more total energy and have 
more food in their stomachs after each meal than the weight stable group. However, 
meal frequency was not significantly different between the 2 groups. Their findings 
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may have been biased by under>reporters of energy intake, especially overweight 
participants 
136
.  
The work of Howarth et al. differed slightly from the previous studies, as it included a 
sample of younger and older adults from the USA Department of Agriculture (USDA) 
Continuing Survey of Food Intake by Individuals 
135
. After adjustment for possible 
confounders, eating frequency was shown to be positively associated with energy 
intake and BMI. However, their investigation was based on the use of self>reported 
body weight and height, plus one 24>hour dietary recall 
135
. It is worth noting that self>
reported body weight and height and a single 24>hour dietary recall were shown to 
reduce the reliability of findings 
139,140
.  
Based on the above findings, it is important to consider methods of dietary         
assessment 
141
, presence of under>reporters of energy 
142
, adjustment for physical 
activity level, and the definition of what constitutes an eating occasion 
141,143
.  
Studies included were based on data from FFQ, 24>hour dietary recall method and food 
diary records. By way of illustration, the work of Metzner et al. used a single 24>hour 
dietary recall and found an inverse association between eating frequency and markers 
of adiposity (using an adiposity index based on 4 skin>fold measures) in their cross>
sectional study 
131
. Cross>sectional studies by Burley et al. and Drummond et al. 
recorded similar results utilising a 4>day food diary, while Yannakoulia et al. found no 
association with the use of a 3>day food diary 
125,127,144
.  
The validity and reliability of dietary assessment methods is important to consider in 
epidemiologic studies that collect data through self>reported dietary intake approaches 
(e.g. food record and FFQ). Under>reporting is the most common problem encountered 
in data collection, especially among overweight individuals 
145,146
 or among older 
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participants 
147
. A review of epidemiologic studies on meal frequency and body weight 
from 1964 to 1997 by Bellisle et al. states that results may be misinterpreted due to the 
presence of under>reporters of energy 
148
. Prospective cohort and cross>sectional studies 
have generally found that respondents with a higher level of education and intrinsic 
motivation tend to provide more reliable data on energy intake and are less likely to 
under>report their intake 
149>151
. Furthermore, female participants generally show a 
higher degree of under>reporting compared to male participants 
150,152>154
. The 
association between under>reporting and BMI may be largely dependent on the method 
of dietary assessment 
154>156
. When comparing dietary assessment methods, De Vries et 
al. found that food records have higher precision in reflecting actual intake compared to 
other methods 
152
. A number of studies have suggested that the use of multiple 24>hour 
dietary recalls tends to be more representative of typical intake than the use of both 
FFQs and 24>hour dietary records, and can minimise the effect of random error caused 
by day to day variability in intake 
157,158
.  
In longitudinal studies investigating the influence of meal frequency on body weight 
there may also be an issue of “reverse causality”, in which people tend to skip meals in 
hopes of losing weight. This could result in a lower meal frequency being associated 
with over>weight, therefore potentially altering the results. It is therefore important to 
consider both the method of dietary assessment and the presence of under>reporters in 
order to minimise the potential of error in interpreting findings 
142,148
. 
Another confounding factor in the association between eating frequency and BMI is 
physical activity 
148,159
. Duval et al. used a 7>day food diary in their prospective cohort 
study to measure dietary intake. Results showed that eating frequency was inversely 
correlated with BMI, waist circumference, and fat mass. However, once adjustments 
had been made for physical activity and oxygen consumption the relationship between 
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eating frequency and adiposity was no longer significant. This suggests that those with 
higher eating frequency also had greater physical activity, and that physical activity is 
therefore potentially a confounder that should be adjusted for in regression models 
examining the association between eating frequency and BMI 
159
. 
Finally, an important major factor to consider in studies of meal frequency is the 
absence of a common definition of what constitutes an eating occasion 
118,148,160
. This 
issue has been addressed in a number of critical reviews 
123,161,162
. These reviews 
explain that as definitions are often notably different, it can be difficult to compare 
results of studies on meal frequency 
123
, and to generalize findings 
143
. This means that 
a common, consistent definition is required in order for the association between eating 
frequency and health to be objectively studied 
141,162
.  
1.4. Dietary energy density 
Dietary energy density is a relatively new concept that can be utilised for BP level 
control and body weight reduction 
163
. Dietary energy density is defined as energy of 
food and/or beverage divided by the weight of food and/or beverage (kcal/gram). This 
value is affected by a number of nutrients, such as fibre, water and the fat content of 
food 
164
. This is because fibre and water provide a considerable amount of weight but 
little or no energy, and so are low in dietary energy density. In contrast, fat has an 
increased amount of energy per gram, and is therefore high in dietary energy density. 
There are several methods for the calculation of dietary energy density, for example; 
excluding all beverages and using food only, excluding energy>containing>beverages 
and using food and non>caloric beverages, and using all foods and beverages 
165
. In 
2010, the Dietary Guidelines Advisory committee published a systematic review 
acknowledging the association between dietary energy density and body weight, and 
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concluded that low dietary energy density is strongly associated with body weight loss 
and maintenance in adults 
166
. The review also concluded that cohort studies including 
children and adolescents support the hypothesis that dietary energy density is positively 
associated with adiposity 
166
. 
The association between dietary energy density and total energy intake in feeding trials 
shows that the consumption of low dietary energy density leads to overall reduction in 
energy intake and increased satiety among adults 
167,168
. With the available evidence 
over the years supporting low dietary energy density intake or low fat intake, the food 
industry responded with the production of low fat meals and foods 
169,170
. Despite this 
approach, the average population energy intake and prevalence of obesity has increased 
in Western population in the last decade 
171
. It may be that some foods that are 
marketed as low in fat are actually high in dietary energy density 
172
. Evidence suggests 
that total energy intake is less when people are provided with low energy density foods 
compared to similar foods with high energy density 
167,173>178
. A few intervention trials 
have compared energy intake between high fat foods that are energy dense and high fat 
foods that are low in energy density 
179,180
. Results show that high fat foods, which are 
energy dense, promote overall energy intake. It was therefore concluded that dietary 
energy density is the major factor in energy intake in Western diets. The extensive 
work of Drewnowski on energy density of food supports the above conclusion, 
focusing on the fact that “Energy density as opposed to the macronutrient content of 
foods, is currently thought to be the key factor in the regulation of food intake” 
181
. This 
suggests that changes in dietary energy density are the main determinants of energy 
intake. 
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1.4.1. Dietary energy density and blood pressure  
Intervention and cohort studies on the relationship between dietary energy density and 
BP are limited 
182
. Ledikwe et al. was the first to assess the influence of dietary energy 
density changes on BP. Data were analysed from the PREMIER study, a multicentre 
randomised trial investigating the effects of 3 interventions to reduce BP in participants 
with pre>hypertension and hypertension in 6 months 
183
. Participants were assigned to 
either: an established group educated on weight loss, sodium reduction, and physical 
activity; an established plus DASH>diet educated group; and the advice group educated 
once on these topics. Participants assigned to the established plus DASH>diet educated 
group had the greatest dietary energy density reduction and the greatest increase in the 
weight of food consumed. Participants in the highest tertile (i.e., largest dietary energy 
density reduction) had greater weight loss (5.9 kg) than those in the middle (4.0 kg) or 
lowest (2.4 kg) tertile.
183
. A cross>sectional study assessed the relationship between 
dietary energy density and the metabolic syndrome in 489 Iranian female teachers using 
a single FFQ 
184
. No significant difference was observed in systolic and diastolic BP 
across quartiles of dietary energy density. Those in the highest quartile of dietary 
energy density showed higher levels of serum TAG, total cholesterol and LDL>C and 
lower levels of serum HDL>C compared to those in the lowest quartile. It is worth 
noting that a single use of FFQ may be considered a limitation, in addition of including 
a sample of highly educated women 
184
. A Japanese cross>sectional study examined the 
association between dietary energy density and the metabolic syndrome 
185
. A total of 
1136 female dietetic students aged 18>22 years were provided with a self>administered 
diet history questionnaire. No significant association between dietary energy density 
and BP was found 
185
. Findings may be biased by sample characteristic (young 
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dietetics) with an average BMI level of 21.3 kg/m
2
, making it difficult to observe 
differences in BP levels.  
1.4.2. Dietary energy density and body weight  
In review of the available literature, RCTs have examined the association between 
dietary energy density and body weight reduction in particular 
186>190
. The majority of 
trials concluded that low dietary energy density contributes to body weight loss 
186,188,190,191
 with the exception of two RCTs reporting no change in body weight loss 
with low dietary energy density 
187,192
.  
A USA trial by Ello>Martin et al. compared two body weight reduction diets, one of 
low fat content and the other of low fat content in addition to low energy density foods, 
such as fruit and vegetables 
190
. After one year, the group assigned to the low fat and 
low energy density diet showed more body weight loss and reported higher satiety level 
than the group assigned to the low fat diet only (−7.9, SD=0.9 kg vs. −6.4, SD=0.9 kg; 
p<0.01) 
190
. A randomised trial by Rolls et al. compared body weight loss among 
participants instructed to consume an energy restricted diet that was supplemented with 
one or two portions of low energy density soup, two portions of high energy density 
snacks, or no particular food group (control). After one year, those consuming two 
portions of soup had greater body weight loss (7.2, SD=0.9 kg) than those consuming 
two portions of high energy density snacks (4.8, SD=0.7 kg, p=0.03) 
188
. 
However, a few trials comparing low and high dietary energy density intake do not 
support the above findings 
187,192
. Lowe et al. reported no significant difference in body 
weight loss during weight maintenance period for those participants following reduced 
dietary energy density intake when compared to intervention groups 
187
. Song et al. also 
reported that comparisons of a group following a low dietary energy density plus 
  42
exercise against a group following a high dietary energy density plus exercise showed 
no significant difference in body weight loss 
192
. 
In cohort studies, the main outcomes on the association between dietary energy density 
and body weight included: changes in body weight or BMI 
193>196
; maintenance of body 
weight 
183,197,198
; or changes in waist circumference 
199,200
. The Nurses’ Health Study 
(NHSII), a prospective cohort study of 116671 female USA nurses, examined the long>
term effect of dietary energy density on body weight gain 
193
. A total of 50026 women 
were followed up for 8 years; dietary energy density was assessed at 3 time points with 
4>year intervals. Results show that in a multivariate adjusted model, those in the highest 
quintile of increases in dietary energy density had significantly higher average body 
weight gain than those in the lowest quintile of dietary energy density (quintile 5, 3.94, 
SE=0.06 kg vs. quintile 1, 2.80, SE=0.06 kg, p<0.001). Overweight and obese 
participants showed a stronger positive association between changes in dietary energy 
density and body weight increase when compared to normal weight participants 
193
. 
Similar results were found in other cohort studies, such as the work of Savage et al. 
including 186 USA women 
195
. Using three telephoned 24>hour recalls, body weight 
gain and increases in BMI over 6 years were positively associated with dietary energy 
density, with no changes in dietary energy density being recorded over time for each 
participant. Body weight gain was highest for those in the highest tertile of dietary 
energy density (6.4, SE=6.5 kg) compared to those in the lowest tertile (2.5, SE=6.8 kg, 
p<0.01). Those consuming low dietary energy density had a generally higher intake of 
vegetables, fruit, and cereal, with less fried vegetables and baked goods 
195
.  
Fewer prospective studies have investigated the association between dietary energy 
density and waist circumference. Analyses of data from the EPIC study (n=89432 men 
and women) showed annual body weight change was not significantly associated with 
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dietary energy density over 6.5 years, however dietary energy density was significantly 
and directly associated with waist circumference change (0.1, 95% CI: 0.01, 0.18 
cm/year) 
199
.  
A cross>sectional analyses (n=7356) of data from the 1994–1996 Continuing Survey of 
Food Intakes by Individuals—a 2>day survey conducted by the USDA investigated the 
association between dietary energy density and total energy intake, weight of food, and 
body weight 
201
. Results show that a diet with low energy density is associated with 
lower total energy intake than with high energy density diets (≈425 and 275 kcal/day 
less, in men and women). Further analyses into food choices showed that those with the 
lowest dietary energy density had the highest fruit and vegetable intake (>9 
servings/day) (p<0.05). The study concluded that the consumption of a diet with low 
energy density is associated with higher food weight (≈400 and 300 g/day more, in men 
and women), thus a more profound feeling of fullness 
201
. This was supported by the 
work of Rolls; low energy density foods such as fruits, vegetables, and grains result in 
the consumption of a greater weight of food relative to total energy, which may lead to 
a feeling of fullness and thereby prevents overeating 
202
. 
The above RCT, prospective, and cross>sectional studies support a strong association 
between dietary energy density and body weight. The mechanism behind this 
association has not been thoroughly investigated; however a leading hypothesis is that 
the enhanced satiety level of low energy density diets leads to lower overall energy 
intake 
167,168
. A recent RCT suggests that lower dietary energy density is related to a 
decrease of the hunger>stimulating hormone, ghrelin, and an increase in peptide YY 
(PYY), a satiety hormone 
203
. Another proposed mechanism is that people tend to 
consume a consistent weight of food 
179,204,205
, therefore low energy density food 
choices may reduce overall energy intake 
168,206
.  
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1.5. Nutrient density  
Obesity has been associated with high fat and sugar intake and low vitamin and mineral 
intake 
207,208
. In previous reports, the 2005 Dietary Guidelines Advisory called attention 
to the low intakes of many nutrients among USA adults. These include fibre, vitamins 
A and C, calcium, magnesium, and potassium 
209
. An updated 2010 Dietary Guidelines 
Advisory report stated that Americans are consuming excess amounts of sodium, fat, 
added sugars, and refined grains. The 2010 report emphasized on encouraging the 
consumption of nutrient>dense foods and limiting the intake of sodium, fat, added 
sugars, and refined grains 
117
.  
 The term “poor diet quality” was often used to describe diets that are high in energy 
density and low in nutrient density, which therefore result in adiposity 
85
. As a result of 
this, the incorporation of nutrient rich foods into the diet is necessary to augment diet 
quality, i.e. improve nutrient density 
210
. Early efforts to define nutrient density 
suggested ranking the nutrient content of food with words like fair, adequate, good, or 
excellent based on the recommended dietary allowance (RDA) 
211
. In 2005, the Dietary 
Guidelines Advisory and the USDA MyPyramid distinguished between energy dense 
and nutrient dense foods in an attempt to help consumers make nutrient>rich food 
choices without surpassing the recommended daily energy intake 
209,212
. The USA Food 
and Drug Administration (FDA) define healthy food as that which contains sufficient 
amounts of protein, fibre, vitamins A and C, calcium, and iron 
213
. Because of different 
forms of interpretation, a unified definition of nutrient density is currently unavailable 
and was not made clear in the 2005 or 2010 Dietary Guidelines Advisory. A nutrient>
rich diet may be described as having “more” of the recommended nutrients as opposed 
to calorie content 
209,214
.  
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The concept of nutrient profiling describes the attempt to compute the percentage of 
suggested intakes of selected nutrients in foods with respect to the energy provided by 
that food 
215
. Scores are appointed to each food item in order to provide an overall 
assessment of its nutrient quality. Ranking of scores according to key nutrients is then 
applied 
215
. Some model algorithms include selected “recommended” nutrients like 
vitamins and minerals, or nutrients to limit like fat and sugar, or both 
216>218
. A positive 
score is appointed to selected nutrients in a food, depending on the percentage of daily 
values available. The sum of nutrients to limit is subtracted from recommended 
nutrients, if the appointed algorithm includes both indexes 
219
. Recently, the Nutrient 
Rich Food index score has been promoted as a comprehensive, simple tool for use by 
the general public to make sound decisions about the food they choose. The Nutrient 
Rich Food approach is unique because of its applicability to individual food items, and 
to the diet as a whole. This means that it can be used as a guide to nutritious food rather 
than a rating or numbering method 
219
. The selection of nutrients included in the 
Nutrient Rich Food index score was based on the 2005 Dietary Guidelines Advisory, 
which reported a low intake of specific nutrients among adults and children 
209
, 
selection of nutrients to be limited is based on the guidelines of the FDA and the 
regulations of the European Union 
213
. The family of Nutrient Rich Food scores has 
evolved gradually. At first, there was the nutrient rich sub>score which included 
desirable nutrients that ranged from 6 to 15 nutrients 
215,220
. The nutrient rich model 
included the 6 nutrients to encourage as per FDA recommendations (protein, fibre, 
vitamins A and C, calcium, and iron). With consideration to the Dietary Guidelines 
Advisory report, the nutrient rich model was revised to include 3 additional nutrients 
(vitamin E, magnesium, and potassium). Next, the nutrient rich model included 2 more 
nutrients (vitamin B12, and zinc). Models for undesirable nutrients or nutrients to limit 
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score include (saturated fat, added sugar and sodium), and (total fat, total sugar, and 
sodium) 
221
. Percent daily values are computed based on the amount of food and are 
then capped at 100% to avoid disproportionate values 
215
. The maximum values for 
daily intake of saturated fat, total sugar, added sugar and sodium are used as reference 
in a 2000 kcal diet (20 g, 125 g, 50 g, and 2400 mg, respectively) 
221
. The Nutrient Rich 
Food score algorithm is based on either 100 g or 100 kcal of food 
221,222
. 
Other indexes for diet quality are available, for example, the Australian Nutritious Food 
Index 
223
, the Ratio of Recommended to Restricted food components 
224
, the Diet 
Quality Index which is based on the percentage of dietary recommendations met 
225
, 
and the Healthy Eating Index. The Healthy Eating Index is a measure of diet quality in 
compliance with the 2005 Dietary Guidelines Advisory and MyPyramid including 
(saturated fat intake, total fat intake, cholesterol intake, sodium intake, grain intake, 
fruit intake, dairy intake, meat intake, vegetable intake, and dietary variety) 
209
. It uses a 
scale of a maximum of 100>points with awards points to classify nutrients and foods as 
being adequately or moderately consumed. Following extensive analyses, the Healthy 
Eating Index score has been validated and established as a measure of diet quality 
226,227
. A limitation of the Healthy Eating Index score method is that it does not 
distinguish between whole and processed grains; it is also mostly useful for 
retrospective analyses of diet quality and identifying changes over time. 
It is essential to objectively consider the validation of the chosen method and the main 
nutrients included in the algorithm 
214
. For the current study, the Nutrient Rich Food 9.3 
index score is used. The Nutrient Rich Food 9.3 index score has been validated against 
the Healthy Eating Index score 
228
. The validity of the Nutrient Rich Food family score 
was tested using data from the NHANES 1999>2002. The Nutrient Rich Food scores 
were significantly related to the Healthy Eating Index score, with the strongest 
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correlation between the Nutrient Rich Food 9.3 index score and the Healthy Eating 
Index score (r=0.5) compared to other Nutrient Rich Food family scores 
228
. 
1.5.1. Nutrient density and blood pressure 
Review of the available literature indicates that observational and experimental studies 
exploring the association between nutrient density and BP are limited 
229
. A 
retrospective case series pilot study explored the effectiveness of a high nutrient density 
diet on glycaemic control and risk factors of CVD, including BP 
230
. The high nutrient 
density diet was rich in micronutrients from fruits, vegetables, nuts, beans, and legumes 
rich in fibre. The small study sample included 13 women with type II DM from the 
USA aged 30>80 years. After 7 months on the high nutrient density diet plan, both 
systolic and diastolic BP dropped significantly by 18% and 15.2%, respectively, 
compared to pre>intervention levels (p=0.0004 and p=0.01). This study, however, did 
not explain method and frequency of BP measurement and did not clarify the amount of 
total energy for the specified diets, all of which are considered limitations 
230
. A recent 
cross>sectional study in Iran on 9568 men and women explored the association between 
the Healthy Eating Index score and CVD risk factors 
231
. Across quintiles of the 
Healthy Eating Index score, women in the highest quintile had lower systolic BP 
compared to the lowest quintile (quintile 1: 112.7, SD=20.2 vs. quintile 5: 110.6, 
SD=19.5 mm Hg; p=0.001). A limitation of this study is using a single FFQ with only 
48 food items 
231
. A cross>sectional analysis of the NHANES 2001–2008 investigated 
the association between the Healthy Eating Index score and CVD risk factors in 18,988 
adults 
232
. A single 24>hour dietary recall was used, and the averages of 3 to 4 BP 
readings were utilized. Across quartiles of the Healthy Eating Index score, average 
adjusted BMI and diastolic BP were significantly lower in the highest quartile 
compared to the lowest (p<0.0001 and p=0.0002), while systolic BP showed no 
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significance (p=0.08). It worth noting that under>reporting may be an issue in this 
sample, especially among obese and overweight participants. Another limitation is that 
a single 24>hour recall was used for dietary analyses 
232
. The Coronary Artery Risk 
Development in Young Adults (CARDIA) study, a multi>centre population based 
cohort of the change in CVD risk factors over 10 years, study examined the relation 
between Diet Quality Index and CVD risk factors prospectively in 5115 black and 
white young adults from the USA. With the use of 3 diet history questionnaires, 
participants in the highest quartile of the Diet Quality Index had less increases in 
systolic and diastolic BP (estimated 13 year change) (p=0.03 and p=0.01) 
233
.  
1.5.2. Nutrient density and body weight 
Studies investigating the association between diet quality and BMI have been generally 
focused on dietary patterns 
234,235
. Currently, only one study has investigated the 
association between the Nutrient Rich Food 9.3 index score and BMI, as well as total 
energy intake 
236
. This was a cross>sectional sample from the Rotterdam study, a cohort 
of 7983 Dutch adults, using a semi>quantitative FFQ. Results show that those in the 
highest quintile of the Nutrient Rich Food 9.3 index score had the lowest total energy 
intake (1631, SE=372 kcal) compared to those in the lowest quintile of the Nutrient 
Rich Food 9.3 index score (2289, SE=550 kcal) 
236
.  
Other studies have examined the relationship between other available measures of diet 
quality, e.g., the Healthy Eating Index score and BMI 
229,237,238
. The work of Tande et 
al. explored the association between the Healthy Eating Index score and obesity using 
data from the third
 
NHANES in 15658 USA adults 
237
. In their analyses of a single 24>
hour dietary recall, each 10 unit increase in total Healthy Eating Index score was 
associated with 8.3% (95% CI: 1.8, 14.9%, p<0.05) lower abdominal obesity waist 
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circumference in women and 14.5% lower in men (95% CI: 6.8, 21.9 %, p<0.001). 
Abdominal obesity waist circumference is defined as ≥ 102 cm for men and ≥ 88 cm 
for women. A higher Healthy Eating Index score was shown to be associated with 
lower risk of abdominal obesity 
237
.  
Studies using dietary pattern analyses explored the association between healthy pattern 
and BMI or waist circumference. For example, the on>going Baltimore longitudinal 
study of aging, a prospective study in 459 adults, used cluster analyses to obtain 5 
dietary patterns 
234
. Participants in the healthy eating cluster (rich in fruit, vegetables, 
reduced>fat dairy, and whole grains and low in red and processed meat, fast food, and 
soda) had less annual increases in BMI (0.05, SE=0.06 kg/m
2
) compared to participants 
in the meat>and>potatoes cluster (0.30, SE=0.06 kg/m
2
, p<0.01). Those in the healthy 
cluster were also found to have smaller annual change in waist circumference (0.43, 
SE=0.27 cm) in comparison to those in the white bread cluster (1.32, SE=0.29 cm, 
p<0.05) 
234
. 
1.6. Time of meals and blood pressure, body weight 
1.6.1. Studies on shift work  
Prospective cohort and cross>sectional studies on shift workers provide evidence that 
time of energy intake may be associated with health 
175,239>242
. Shift work is defined as 
work after the usual 8>hour daytime. It may disrupt the diurnal biological rhythm and 
affect dietary behaviour 
243
. A number of epidemiologic studies found direct 
associations between night shift work and the risk of developing CVD 
240,244
. A meta>
analyses of prospective cohort and cross>sectional studies suggests that shift workers 
are at 1.4 relative risk of developing CVD compared to regular day workers 
239
. A 
cross>sectional study in France divided 2610 white>collar workers into 3 types of shift 
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and day work to examine the relationship between shift work and cardiovascular risk 
factors 
245
. In univariate analyses, systolic BP was higher (132.7, SE=17.4 mm Hg) 
among the 3 categories of shift workers compared to day workers (126.9, SE=15.1 mm 
Hg, p<0.05). Night workers also had higher plasma TG (1.6, SE=0.8 g/L) compared to 
day workers (1.3, SE=0.8 g/L). The adjusted risk of hypertension was also twice the 
number of times higher in night workers compared to day workers (OR: 2.1, 95% CI: 
1.4, 3.2) 
245
. Epidemiologic studies reporting no association between shift work and 
CVD may potentially be attributed to differences in definitions of shift>work 
246,247
. 
Intervention studies found that the adoption of a better shift schedule was associated 
with improved biomarkers of heart disease (LDL, HDL) 
248
, while night shift work was 
typically associated with body weight gain and the worsening of cardiovascular 
parameters 
249
. Morgan et al. studied the effects of time of meal intake and 
carbohydrate quality on glucose control and insulin secretion through the use of four 
different types of diets 
250
. In their cross>over design, participants were randomly 
assigned to: a low glycaemic index (GI) diet with the majority of the energy consumed 
in the morning; a low GI diet with the majority of the energy consumed in the evening; 
a high GI diet with the majority of the energy consumed in the morning; and a high GI 
diet with the majority of the energy consumed in the evening. Results show that when a 
higher GI diet was consumed during the evening, a higher level of glucose response 
and lower insulin sensitivity were observed compared to the other 3 diets (p<0.05) 
250
. 
The association between BMI and shift work was investigated in a cross>sectional study 
of 319 men aged 35>60 years randomly selected from a production company in Italy 
251
. 
Shift workers had a rotating schedule (working 2 nights, 2 afternoons, and 2 mornings 
with 3 days of rest), while day>workers only worked during daytime. Of the total 
sample, 74% of obese were shift workers (p<0.05), in models adjusted for known 
  51
confounders 
251
. The Nurses and Midwives’ e>cohort study (NMeS), a longitudinal 
population>based study, examined factors associated with health outcomes in nurses 
and midwives of Australia, New Zealand, and the UK. A cross>sectional analyses of 
NMeS compared 1259 day and 1235 night workers and showed that night workers had 
a higher prevalence of overweight and obesity (1.15 times) compared to day workers 
(95% CI: 1.03, 1.28, p=0.01; 95% CI: 1.02, 1.30, p=0.02, respectively), using adjusted 
BMI measures 
252
. A cohort study in Japan investigated changes in parameters related 
to metabolic disturbances by dividing 1529 factory workers into 4 categories followed 
up for 10 years: daytime workers (day–day), those who switched from shift work to 
daytime work (shift–day), those who switched from daytime work to shift work (day–
shift), and those doing shift work only (shift–shift) 
253
. For day–shift workers, age 
adjusted average BMI increase was 1.0 kg/m
2
, significantly higher than day>day and 
shift>day workers. For those in the shift>shift and day–shift group, increase in 
cholesterol was higher compared to other groups but not significant 
253
.  
The adverse health effects associated with night work may be attributed to meal intake 
late in the night that may cause changes in glucose tolerance and insulin response, 
including reduction in insulin sensitivity later in the day and increased glucose 
production in night shift workers 
254>256
. An increase in TAG level observed in night 
shift workers suggests insulin resistance 
257
. Night shifts were associated with a 
decrease in non>essential fatty acids (NEFA) levels in plasma, which require a longer 
time to return to basal level compared to day>shifts. Plasma NEFA results from the 
breakdown of TAG in adipose tissue by lipase. Therefore, as lipase is inhibited by 
insulin, low NEFA levels coincide with high postprandial insulin in night shift       
workers 
257
. Elevated TAG level is also an independent risk factor for CVD 
258
. With 
disruption of the circadian rhythm associated with night work, degree of stress is also 
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elevated 
259
. Sleep deprivation associated with shift work may alter the endocrine 
leading to a disruption in carbohydrate metabolism 
260
. Poor dietary habits are also 
associated with night work. A cross>sectional sample of nurses aged 25>63 reported 
their preference for fast food and food high in sugar due to ease of access compared to 
healthy meals 
261
. Spiegel et al. also reported that night shift workers tend to feel 
hungry and consume foods that are energy>dense and rich in carbohydrates compared to 
daytime workers, with adjustment for total energy intake (p<0.05) 
262
. Lack of exercise 
and engagement in physical activity are also common behaviours among night shift 
workers 
263,264
. 
1.7. Glycaemic index, glycaemic load, and dietary fibre  
Introduction 
Given that dietary fibre is a major determinant of dietary energy density 
205
, the role of 
GI, GL and dietary fibre in relation to BP and BMI is explored. 
The World Health Organisation (WHO) and the Food and Agriculture Organization of 
the United Nations (FAO) classified carbohydrates based on the degree of 
polymerization (DP), i.e., the number of linked saccharide units. Sugars 
(monosaccharaides, disaccharides) have a DP of 1>2, while oligosaccharides (Malto>
oligosaccharides [ >glucans]) and polysaccharides (starch and non>starch) have a DP of 
3>9, and 9 or above, respectively 
265
.  
Sugars, in general, can improve the texture and viscosity of food, and are thus used in 
baked goods to improve dough yield and to prevent the finished products from drying 
out. Monosaccharaides including glucose, fructose and galactose are considered a 
single saccharide unit, which is the building block of disaccharides. Both glucose and 
fructose can be found in honey and fruit, especially berries, and can be used for food 
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preservation and as sweeteners, the latter is also found in vegetables 
266
. Galactose, on 
the other hand, is primarily found in cultured dairy products, with minimal amounts 
identified in specific fruits and vegetables (apples, bananas, onions, and tomatoes) 
266
. 
The other class of sugars—disaccharides—includes lactose, maltose, and sucrose, all of 
which contain two saccharide units 
267
. Lactose can be found in dairy products, maltose 
in barley and wheat, and sucrose is the most widely used type of sugar, due to its 
natural presence in most fruits and vegetables and its prevalence in processed foods 
268
. 
Finally, starch, a mixture of amylose and amylopectin, is found in cereals, legumes, and 
root vegetables 
269
. 
In terms of digestion, carbohydrates can be divided into available carbohydrates (e.g., 
glucose, fructose, lactose, etc.) and resistant carbohydrates (e.g., dietary fibre and 
starch). The name “available” or “glycaemic” carbohydrates stems from the fact that 
these are easily absorbed in the small intestine 
270
, whereas resistant carbohydrates, or 
non>glycaemic carbohydrates, are not 
271
. Dietary fibre is most resistant and cannot be 
hydrolysed in the small bowel. Instead, its total or partial fermentation, if present, takes 
place in the colon. Consequently, dietary fibre acts as a bulking agent, both directly and 
through the water it absorbs. If fermentation occurs, it is achieved by micro flora in the 
colon, thus stimulating its growth and contributing to faecal bulk. Following 
fermentation, dietary fibre is metabolized to hydrogen, methane, carbon dioxide, and 
short>chain fatty acids (SCFAs), which are further digested in the colonocytes. The 
energy released by the fermented but non>digestible carbohydrates is estimated at 1.5>2 
kcal/g, while the unfermented and non>digestible carbohydrates have no caloric value 
272
.  
The amount and type of carbohydrate is important to consider in relation to insulin 
response and postprandial glycaemia. Given today’s excessive intake of refined sugar 
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273,274
, combined with the dietary fibre intake at its lowest point since the 1970s 
275
, it is 
essential to develop cost>effective strategies that can be implemented to modify dietary 
choices and behaviours. Such efforts would play a significant role in management and 
prevention of many diseases.  
Glycaemic index and glycaemic load 
The term ‘glycaemic index’ was first introduced by Jenkins et al. 
276
, who classified 
carbohydrates based on the glycaemic response following a meal. In this context, GI 
applies to foods rich in available carbohydrates (e.g., rice, potatoes). Foods that have a 
low glycaemic response and are digested and absorbed slowly have low GI, whereas 
high GI foods have a high glycaemic response and are absorbed more rapidly 
277
. In 
their study involving 16 participants, Crapo et al.
278
 tested the hypothesis that ‘simple’ 
sugars are absorbed more rapidly than ‘complex’ carbohydrates. The authors assessed 
the effects of dextrose, rice, potato, corn, and bread on post>meal glucose and insulin 
responses using a 50 g test load of glucose. Their findings revealed that glucose and 
potato produced higher glucose responses (peaking at 136 and 138 mg/100 ml, 
respectively), compared to rice and bread (with their respective peaks of 119 and 122 
mg/100 ml, p<0.01, 0.05). This was in contrast to the previously reported hypothesis 
that the speed of carbohydrate absorption is solely determined by the degree of 
polymerisation. Jenkins et al. first conducted their trial on a sample of 5>10 healthy 
individuals 
276
. In this study, the participants were given glucose tolerance tests, 
whereby their blood glucose was measured at 15>minute intervals during the first hour, 
and every 30 minutes thereafter. Glucose response was identified as the percentage of 
the incremental area under the blood glucose response curve (AUC) resulting from the 
ingestion of equal amounts of carbohydrates as glucose 
276
.  
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The importance of GI and its relation to various health issues has since been recognised 
by the FAO and WHO 
265
, the European Association for the Study of Diabetes 
279
, and 
Diabetes UK 
280
, among other important organisations supporting the hypothesis that a 
low GI diet contributes to better glycaemic control in diabetics. Evidence suggests that 
the rate of glucose absorption and the length of time blood glucose remains high may 
adversely affect health through stimulation of hormonal and metabolic changes, both of 
which play an important role in the development of these chronic diseases 
277
. 
However, knowledge about the relation of GI to health is still limited, and there is a 
need to standardise the GI values found in various foods as well as recommended daily 
allowances for different populations.  
As previously noted, GI is defined as the incremental AUC after the intake of a specific 
amount of carbohydrate. After consuming 50 g of available carbohydrates, blood 
glucose levels increase and are measured over the period of two hours, after which the 
values are expressed as a percent of the glucose response. More specifically, to obtain 
the GI of the test food, its AUC is divided by the AUC of a standard reference food 
(glucose or bread). According to this classification, high GI foods have a value of 70 or 
above, whereas low GI foods have a value of 55 or less. Wolever et al. expanded this 
classification to include the “GI of meals”, which is helpful for assessing the GI intake 
after consuming a variety of foods with different carbohydrate content. This composite 
GI is calculated by determining the average GI value of all constituent food items, 
weighted by the available carbohydrates provided by each food, using the following 
calculation: 
Meal GI = ∑ GI × CHO ÷ ∑ CHO

   
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Where GI is the GI for the food , CHO is the amount of carbohydrate provided by 
food  (g/day), and n is the number of food items consumed 281. When calculating the 
final GI of the meal, other contributing factors that may influence absorption and affect 
the GI were considered, such as grinding, degree of ripening, heat treatment, added 
acids, etc. 
282
. 
Another term associated with GI and dietary intake is glycaemic load (GL), which is 
calculated by multiplying the GI of a specific food by the amount of available 
carbohydrates in that food. It is differentiated from GI, which only describes the 
quality, but not the quantity of carbohydrates 
277
. Some foods, such as carrots, have a 
high GI but a low GL (GI=35, GL=2), as they contain only a small percentage of 
carbohydrates (6 g per recommended serving of 80 g).  
1.7.1. Glycaemic index, glycaemic load and blood pressure  
A low GI, GL diet has been linked to improved blood lipids and insulin sensitivity, and 
can result in the modification of BP levels 
283,284
. However, research in this field is 
limited, leaving the association between GI, GL and BP insufficiently explored.  
Recently, the relation between GI, GL and CHD was assessed in a meta>analysis of 
eight prospective studies conducted from 2000 to 2011, involving 220,050 patients in 
total 
285,286>293
. The reported findings indicated that the risk of CHD was significantly 
associated with GI; pooled relative risk was 0.99 (95% CI: 0.84, 1.16) in women 
286,287,290,292
 and 1.26 (95% CI: 1.12, 1.43) in men 
287,288,291>293
. For GL, the relative risk 
was 1.69 (95% CI: 1.32, 2.16) in women 
287,290,292
, whereas no association between GL 
and CHD incidence was detected in men (relative risk= 1.08, 95% CI: 0.92, 1.27) 
287,288,291>293
. Similarly, another meta>analysis including prospective studies conducted 
in the period ending in 2011 assessed the relationship between GI, GL and the risk of 
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developing CVD 
294
. In fourteen reviewed studies 
286,288,289,291>293,295>302
, including a 
total of 229,213 participants, risk of CVD in the highest vs. the lowest quintile of GI 
and GL was 1.13 (95% CI: 1.04, 1.22) and 1.23 (95% CI: 1.11, 1.36), respectively. 
Moreover, the findings indicated that women consuming food with higher GI and GL 
were at a greater risk of developing CVD (GI: relative risk=1.19, 95% CI: 1.06, 1.34; 
GL: relative risk=1.35, 95% CI: 1.18, 1.55), than men (GI: relative risk=1.05, 95% CI: 
0.94, 1.17; GL: relative risk=1.10, 95% CI: 0.95, 1.28) 
294
. Thus, these results 
285,294
 
indicate that women whose intake of high GI, GI foods is greater, especially 
overweight and obese women, are potentially at risk of developing CVD.  
Intervention studies on the effect of low GI, GL diets on BP have produced inconsistent 
results, with some showing no effect 
303
 and others showing reductions in systolic and 
diastolic BP 
304,305
. One of the few intervention studies is a pilot study involving 38 
men with at least one CHD risk 
306
. The participants were randomly assigned to two 
groups, receiving healthy diets, one rich in low and the other in high GI foods. After six 
months, the reduction in ambulatory 24>hour systolic BP was greater in the low GI diet 
group (M=13 mm Hg, SD=17) compared to the high GI diet group (M=3 mm Hg, 
SD=18, p<0.05) 
306
. On the other hand, among men and women that took part in the 
PREMIER trial (n=756), the changes in GI and GL were not associated with BP at 6>
month or 18>month follow>up 
307
.  
A few observational and cross>sectional studies have investigated the association 
between GI, GL and BP, showing inconsistent results as well 
308>310
. In the Women’s 
Health Initiative (WHI) study, an observational study of CVD and other chronic 
diseases in postmenopausal women (n=878), average systolic BP from two readings 
was surprisingly lower in the highest quartile of GL in White women (p=0.03), 
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irrespective of their BMI 
310
. On the other hand, a similar study involving 858 
Australian adolescents, the association between GI, GL and the changes in BP level 
(reported as the mean of three readings) was assessed over a 5>year period. In 
multivariate adjusted models, dietary GI higher by 3.5 (SD =1) was associated with 
1.81 mm Hg higher systolic BP (p=0.001) in girls aged 12 years at baseline 
308
. 
However, the National Diet and Nutritional Survey (NDNS) involving 1152 adults 
revealed non>significant associations between GI and BP in a cross>sectional analysis 
using multivariate adjusted models 
309
. 
The mechanism by which high GI diets affect BP level has been linked to elevated 
blood sugar, which can damage arterial walls by decreasing the production of nitric 
oxide, inducing oxidative stress, and enhancing the activity of protein kinase C 
311
. In 
addition, hyperglycaemia may stimulate renal sodium retention, therefore elevating   
BP 
312
.  
1.7.2. Glycaemic index, glycaemic load and body weight 
The GI concept was first introduced to help control the glycaemic response in diabetics, 
and the associated benefit is well established. Because hyperinsulinemia promotes 
lipogenesis, a low GI, GL diet that produces low insulin response may also promote 
body weight loss 
313
. While low GI, GL diets have recently been linked to satiety and 
metabolism in intervention studies, evidence supporting these benefits is         
inconsistent 
314>317
. Thus far, 22 trials have investigated the effect of low GI, GL diets 
on body weight in adults, where body weight loss was the primary outcome 
303,305,318>
337
. The majority of these studies were based on controlled parallel designed trials. In 
six trials 
303,318,319,321,325,335
, significant differences in body weight loss were reported 
when low GI, GL diets were compared to either high GI, GL diets 
318,325
, a low fat diet 
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303
, or an energy restricted diet 
335
. The reported body weight reductions from baseline 
ranged from 1 to 7 kg, p<0.05; with individuals participating in these trials being either 
overweight 
325
 or obese 
303,318,335
. Thus, it cannot be established whether similar effects 
would be produced in normal>weight individuals. In contrast, 12 trials reported non>
significant body weight reductions in the group that followed low GI, GL diets, 
compared to controls 
305,322>324,326>328,330>332,334,336
.  
Other outcomes, including fat mass, body fat percentage, lean muscle, energy intake, 
and satiety, were also investigated. Several trials comparing body fat percentage in 
study participants following a low GI or low GL diet reported non>significant 
reductions compared to controls 
303,305,318,320,323>327,329,331,336,337
. Despite inconsistent 
findings, the prevalent view is that low GI, GL diets can be beneficial in certain 
population samples. In a study on individuals diagnosed with high postprandial insulin 
levels, Ebbeling et al. reported significant body weight and fat percentage reductions 
following a low GI or low GL diet, in comparison to those who were placed on a low 
fat diet (5.8 kg vs. 1.2 kg; p=0.004 and 2.6% vs. 0.9%; p=0.03, respectively) 
326
.  
The above evidence indicates that a low GI, GL diet is as effective in reducing body 
weight as other dietary interventions. Following a meta>analysis of 6 RCTs conducted 
in 2007, the authors concluded that low GI, GL diets were beneficial in reducing body 
weight by an average total body weight loss of 1 kg, fat mass reduction of 1 kg, and 
BMI decrease of 1.3 units compared to other diets (p<0.05) 
317
.  
Several epidemiological studies reported inconsistent results on the association between 
GI, GL and body weight. For example, findings of the EURODIAB IDDM 
Complications Study 
338
—a cross>sectional study including 3250 participants with type 
1 diabetes from 31 European centres—suggest direct associations between GI and waist 
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to hip ratio in men (p=0.005), but not women. The findings of the Insulin Resistance 
Atherosclerosis Study (IRAS), a cross>sectional study, revealed significant direct 
associations between GL and BMI, but not GI, in models adjusted for potential 
confounders. However, these associations were no longer statistically significant after 
adjusting for total energy intake from non>carbohydrate sources 
339
. More recently, 
results from the EPIC study indicate that a diet based on foods with GI higher by 10 
units was associated with a 34 g increase in body weight (95% CI: −47, 115 g) and 0.2 
cm increase in waist circumference per year. The increase in GL by 50 units was 
associated with a 10 g increase in body weight (95% CI: >65, 85 g) and a 0.1 cm 
increase in waist circumference per year 
340
.  
Several limitations should be noted however with the above intervention trials. For 
example, in some of the aforementioned trials, caloric intake was not restricted to 
induce body weight loss 
320,321,325,326
. Moreover, in a number of trials 
322,332,335,336
, GI 
and GL values of the foods included in the participants’ diets were not reported, and 
there was no consensus on the low and/or high GI and GL. More specifically, Aston et 
al.
320
 considered 55.5 a low GI, while in the study by Sloth et al. 
336
 the upper limit was 
set at 79. In addition, short trial duration and difficulties in adhering to treatment diets 
may be considered limitations in intervention studies related to body weight loss. 
Furthermore, the inconsistency between findings of intervention and epidemiological 
studies may be due to the GI values of foods. In cohort studies, the GI distribution is 
mostly centred at the higher level. For example, in the IRAS study 
339
, the median GI 
was 58, while this value was considered a high GI in several intervention trials 
341,342
. 
In addition, the lowest GI value in the IRAS study was 45 
339
, while it ranged between 
48 and 50 in other cohort studies 
343,344
, all of which were significantly higher than 
permitted in low GI intervention diets 
345>347
. 
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Dietary fibre 
The American Association of Cereal Chemists defines dietary fibre as “The edible part 
of plants or analogous carbohydrates that is resistant to digestion and absorption in the 
human small intestine, with complete or partial fermentation in the large intestine. 
Dietary ﬁbre includes polysaccharides, oligosaccharides, lignin and associated plant 
substances. Dietary ﬁbre promotes beneﬁcial physiological effects including laxation, 
and/or blood cholesterol attenuation, and/or blood glucose attenuation” 
348
. More 
recently, the international Codex Alimentarius Commission stated that “Dietary fibre 
means carbohydrate polymers with three or more monomeric units, which are neither 
digested nor absorbed in the human small intestine” 
349
. 
Dietary fibres can be divided into insoluble and soluble fibre depending upon their 
solubility in water. Insoluble fibre (cellulose, lignin) increases faecal bulk, thus 
accelerating its passage through the intestine. Dietary sources of insoluble fibre include 
wheat bran, vegetables, and whole grains 
350
. Soluble fibre (pectin, gum) increases 
viscosity and turns to gel during digestion, and has lowering effects on plasma 
cholesterol and glycaemic response 
351
. Dietary sources of soluble fibre include oat 
bran, barley, nuts, seeds, beans, lentils, peas, and some fruits and vegetables. Insoluble 
resistant starch, oligosaccharides (i.e., cellulose and hemicelluloses) and soluble fibre 
(i.e., pectin, inulin, and b>glucans) have a higher fermentation rate compared to cereal 
fibre 
352
. When all parts of the kernel (i.e., bran, germ, and endosperm) are available in 
a food, it is considered to be whole grain. In the market, whole grain food products 
consist of 12% of total dietary fibre, mainly insoluble cereal, and some bran>rich 
products contain 25% of dietary fibre 
353
. In the USA, the main source of whole grain 
and bran products are from corn and wheat 
354
. The average American consumes about 
15 g of fibre per day, which is about 50% of the fibre intake suggested by the American 
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Heart Association 
350
.  
Meta>analyses of prospective cohort studies showed that higher intake of total fibre is 
associated with a lower risk of incident coronary events 
355
, stroke 
356
 and DM. The 
extensive review of available literature revealed inconclusive epidemiological evidence 
to the contributions of total, insoluble, and soluble fibre to BP and BMI.  
1.7.3. Dietary fibre and blood pressure 
Cross>sectional studies investigating the relationship between dietary total fibre intake 
and BP in vegetarian population samples found significant inverse associations 
357>359
. 
Vegetarians often consume a diet that is relatively low in salt, rich in potassium, 
magnesium, and PUFA; therefore, it was difficult to assess the independent association 
between fibre intake and BP in these populations 
358,359
. A number of cross>sectional 
studies involving the general population reported inverse associations between total 
fibre and BP 
360>365
, with some results significant for diastolic BP only 
366,367
, while 
others found no association 
363,366,368,369
, despite similar study design. It is worth noting 
that regression models used in data analyses of these studies were mainly adjusted for 
lifestyle confounders only 
360>363,366,368
, or a limited number of dietary confounders 
363,366,368
. More recently, a cross>sectional analysis of the Prevención con Dieta 
Mediterránea trial (PREDIMED) —a multicentre, randomised trial including 457 men 
and women, indicated that systolic and diastolic BP were significantly lower in quintile 
5 of total fibre intake (>31 g/day) compared to quintile 1 (<21 g/day), after adjusting 
for age, sex, and sample (p for trend=0.01 and 0.001). These findings were based on 
two BP readings and the use of a single FFQ 
370
. In contrast, a cross>sectional analysis 
of the EPIC>Florence sample of 7601 participants showed no significant association 
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between dietary total fibre and systolic and diastolic BP. Similar to the PREDIMED, 
the average of two BP readings was used, and only one FFQ was analysed 
368
.  
There have been few prospective cohort studies that found inverse relationships 
between total fibre intake and BP change 
346
, or risk of developing hypertension 
364,365
. 
For example, in the CARDIA study, compared to the lowest quintile of fibre intake, 
those in the highest quintile had lower systolic and diastolic BP levels in year ten after 
adjusting for baseline BP and other lifestyle confounders (p=0.01, p<0.001). These 
results, however, were only significant for White men and women. Similar to previous 
cross>sectional studies, the regression models did not adjust for dietary confounders 
346
. 
Additionally, the UK National Health Service (NHS) reported a lower relative risk of 
hypertension (0.76) among women with high total fibre intake (≥ 25 g/day) compared 
to women with low total fibre intake (<10 g/day, p=0.002). However, the association 
was no longer significant after further adjustment for calcium, magnesium, and 
potassium intake 
365
. In contrast, the Health Professional’s Follow>up Study (HPFS), 
including 30,000 male participants, found the relative risk of hypertension was 1.46 
(95% CI: 1.09, 1.96) for those whose total fibre intake was < 12.0 g/day, while relative 
risk was lower (1.11, 95% CI: 0.94, 1.31) when the total fibre intake was greater (20.0>
23.9 g/day), after adjusting for dietary potassium, magnesium, and total energy intake 
364
. It is worth noting that, in both studies 
364,365
, BP was self>reported, and the 
population samples were highly selective.  
With regard to types of fibre, a recent systematic review and meta>analyses of cohort 
studies assessed the association between risk of CVD, CHD and total, insoluble, and 
soluble fibre intakes 
371
. Pooled estimates including 15 studies showed that, for CVD, 
the risk ratio was 0.91 with a 7 g/day increase in total fibre intake (95% CI: 0.87, 0.94), 
with similar findings reported for CHD. For insoluble fibre intake, five studies 
372>376
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showed that a 7>g/day increase in insoluble fibre intake was associated with similar risk 
ratios for CVD and CHD (0.82, 95% CI: 0.70, 0.96). However, for soluble fibre intake, 
six 
372>377
 studies included in the meta>analyses showed non>significant associations 
with CHD 
371
. The French SUpplementation en VItamines et Mineraux AntioXydants 
(SU.VI.MAX) study, an on>going randomized, double>blind, placebo>controlled, 
primary>prevention trial was, to the author’s knowledge, the only study that 
investigated the relation between insoluble and soluble fibre intake and the risk of high 
BP 
378
. Their cross>sectional analysis included 5961 men and women with at least six 
24>hour dietary recalls and two BP measures. The results reported by quintiles of total, 
insoluble, and soluble fibre intakes showed: OR 0.71 (95% CI: 0.54, 0.93; p for 
trend=0.02) for total fibre, and 0.68 (95% CI: 0.52, 0.89; p for trend=0.01) for insoluble 
fibre, while soluble fibre showed no significant association 0.86 (95% CI: 0.68, 1.10; p 
for trend=0.10), adjusted for BMI. It is worth noting that participants were receiving 
daily antioxidant supplementation of vitamin C, vitamin E, β>carotene, selenium, and 
zinc as part of the study 
378
.  
Based on the findings of the aforementioned epidemiologic evidence, inconsistent 
findings may be explained by methodological issues including the validity of dietary 
assessment methods 
363>365,368
, absent or limited adjustment for dietary and lifestyle 
confounders 
363,366,368
, inadequate frequency of BP measurements 
363,368,369
, or by 
differences in study design 
379>383
. 
Most intervention trials investigating the effect of fibre supplementation on BP found 
that it had a non>significant lowering reduction on both systolic and diastolic BP. Based 
on a meta>analysis conducted by Streppel et al. of randomised placebo controlled trials 
from 1966 to 2003, the overall effect of fibre supplementation (average dose of 11.5 
g/day) on systolic and diastolic BP was >1.13 and >1.26 mm Hg 
384
. These findings also 
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suggest that the reduction in BP level was greater in older individuals (> 40 years) 
compared to younger (significant for systolic BP only), and in hypertensive participants 
(significant for systolic and diastolic BP) compared to normotensive 
384
. Based on the 
same meta>analysis 
384
, insoluble fibre supplementation in six trials reduced systolic 
and diastolic BP by an average of >0.2 and >0.6 mm Hg 
379,382,385>388
. Additionally, the 
effect of soluble fibre intake on BP was assessed in 10 trials, revealing a non>
significant reduction in systolic and diastolic BP (by an average of >1.3 and >0.8 mm 
Hg) following soluble fibre supplementation 
380,381,383,385,389>394
.  
Several methodological issues are also present in trials investigating the effect of 
insoluble, soluble fibre on BP, including small sample size, short trial period, BP not 
being the main outcome, inadequate methods and frequency of BP measurement, short 
wash>out periods in cross>over trials, and inclusion of a body weight reduction plan. 
Additionally, BP responses to fibre intake in these trials may also depend on its type 
(insoluble and soluble), dose, and if its form of consumption is as supplement or as a 
part of a fibre>rich diet 
384
. 
1.7.4. Dietary fibre and body weight 
The relationship between total fibre intake and body weight has been investigated in 
several observational studies, some of which have found inverse associations between 
total fibre intake and body weight or BMI 
339,346,395,396
. However, some large>scale 
studies reported no association 
397,398
.  
Howarth et al. used data from the USDA Continuing Survey of Food Intakes by 
Individuals (n=4539) to investigate associations between fibre intake and fat and 
excessive body weight gain 
396
. While inverse associations between total fibre and BMI 
were reported in women (p=0.001), this was not the case for men (p=0.4). Although 
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possible under>reporters of energy intake were excluded from data analyses, the study 
was still subject to several limitations; notably, the use of one or two 24>hour dietary 
recalls and self>reported body weight and height 
396
. Results from IRAS, involving 979 
participants indicate that fibre intake higher by 10 g/day was associated with a 0.80 
kg/m
2
 lower BMI level in cross>sectional analysis, using FFQs. It is worth noting that 
Pearson correlation coefficients between FFQ and 24>hour dietary recalls were low 
(r=0.2), and differed considerably between samples and ethnic groups 
339
.  
More recent studies have attempted to identify the relationship between consumption of 
specific foods high in fibre (e.g., whole grain, cereal) and health outcomes 
397,399>401
. 
Results from the UK NHS reported inverse associations between body weight gain and 
whole grain intake, as well as direct associations with refined grain intakes including 
74091 individuals. In a 12>year follow>up, those who had the greatest increase in total 
fibre intake had gained 1.5 kg less body weight compared to those who had the smallest 
increase in total fibre (p=0.0001), after adjusting for lifestyle and dietary confounders 
402
. In contrast, Cheng et al. reported no association between total fibre or whole grain 
intake and BMI per SD increase in fibre and whole>grain intake (p=0.5). This 
prospective study included 215 adolescents, all of whom were followed>up over a 4>
year period. At each visit, a 3>day food record was analysed. However, it is worth 
noting that, as the dietary method used was not validated against other methods, energy 
intake under>reporting may be a potential confounder 
397
.  
Literature review conducted as a part of this study revealed paucity of epidemiological 
investigations into the link between the types of fibre and BMI. Findings of the French 
SU.VI.MAX cohort indicate that the highest total and insoluble fibre intakes were 
associated with lower risk of being overweight: quintile 5 vs. quintile 1, OR 0.70 (95% 
CI: 0.54, 0.91, p for trend=0.01) was reported for total fibre, and 0.69 (95% CI: 0.53, 
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0.90; p for trend=0.01) for insoluble fibre, while soluble fibre showed no significant 
association 0.96 (95% CI: 0.76, 1.22; p for trend=0.27). Models used in this study were 
adjusted for lifestyle and dietary factors, with the exception of protein intake 
378
.  
Intervention studies have suggested that total dietary fibre is beneficial for body weight 
loss 
379,403,404
. However, it is possible that the form of food, type and dose of fibre 
provided, and dietary energy density may have affected the reported results 
404,405
. The 
effect of type of fibre included in the diet on body weight loss was noted when 
additions of up to 30 g/day of total fibre lead to surprisingly small reductions in body 
weight 
403,404
, which may be attributed to the different effects of types of fibre 
(insoluble and soluble) 
404
. In a randomised crossover trial, lasting 4 weeks, with a 2>
week washout period, Rave et al. examined the effect of a calorie>restricted whole 
grain cereal diet on body weight of their participants, all of whom were obese 
406
. The 
sample was randomly split into two groups, a nutrient>dense meal replacement product 
or a whole>grain based dietary product. Body weight decreased in both treatment 
groups, (22.5, SD=2.0 vs. 23.2, SD=1.6 kg, with no significant difference between the 
two treatments, except for an improvement in insulin sensitivity in the whole grain 
cereal diet. These findings were attributed by the authors to the short trial period. In 
addition, it is likely that the participants may have under>reported their intake of other 
foods eaten at home 
406
. Melanson et al. conducted a controlled trial over a period of 24 
weeks, where participants were randomly assigned to two groups, and received either a 
diet rich in whole>grain cereal, or a conventional low calorie, low cereal diet 
407
. The 
diet prescribed to the first group consisted of two meals of whole>grain cereal for 12 
weeks, which was reduced to one meal during the remaining 12 weeks. Their food 
intake was assessed via 3>day food records. The authors reported no difference in body 
weight loss achieved by the two groups. This may be explained by the fact that, in the 
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second 12>week period, the participants in the treatment group reduced their fibre 
intake to 21 g/day, a value close to that received by the conventional group (17 g/day) 
407
. A similar trial found no difference in body weight reduction when obese adults 
were asked to follow either a diet rich in whole grains, or a diet that excluded whole 
grains for 12 weeks. The whole grain diet group, however, had lower body fat 
percentage (p=0.001) and 38% lower high>sensitivity C>reactive protein compared to 
controls, independent of body weight loss 
401
.  
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Hypotheses and Objectives 
The following hypotheses are tested: 1. There is an inverse association between 
frequency of daily eating occasions and BP and BMI of the UK and the USA 
INTERMAP study participants. 2. Dietary energy density is directly associated with BP 
and BMI, while nutrient density is inversely associated with BP and BMI. 3. Higher 
evening relative to morning energy intake is directly associated with BP and BMI.          
3. Higher GI and GL are directly associated with BP and BMI. 4. Dietary fibre intake, 
including insoluble and soluble fibre, is inversely associated with BP and BMI. 5. A 
diet low in GI, GL and high in dietary fibre is associated with lower BP and BMI. 
The objectives of this thesis are to: 1. Examine the associations of daily eating 
occasions, dietary energy density, and nutrient density with BP and BMI. 2. Explore the 
impact of time of energy intake on BP and BMI. 3. Investigate the associations of GI, 
GL to BP and BMI. 3. Determine relations to BP and BMI of total dietary fibre and its 
individual>components (insoluble and soluble fibre).  
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CHAPTER II 
Methods 
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2. METHODS 
The INTERnational study on MAcro/micronutrients and blood Pressure (INTERMAP) 
is a cross>sectional epidemiologic investigation on associations between dietary factors 
and BP in middle>aged and older adults. There are several publications using the 
INTERMAP data investigating different dietary and non>dietary aspects and BP 
408>414
  
2.1. INTERMAP methods 
2.1.1. Study design 
The INTERMAP study surveyed 4680 men and women ages 40>59 years from 17 
population samples in four countries (Japan, the People's Republic of China, the UK, 
and the USA) 
415
. The study protocol was established in two International Coordinating 
Centres (ICC) led by principal investigators (Jeremiah Stamler, Chicago, USA; Paul 
Elliott, London, UK). The principal investigators developed the study design, data 
collection, and analyses of data. Protocols for nutrition data processing were 
established by two USA centres: the International Nutrition Coordinator and the 
Nutrition Coordinating Centre. The study sample was chosen assuming a power of 90% 
that would detect a correlation of 0.06 between a nutrient and BP with alpha=0.01 
415
.  
2.1.2. Study sample 
Study samples were recruited randomly from community and workforce populations
415
. 
Age and gender stratifications of participants were applied to ensure that equal numbers 
of persons were obtained in each group (four 10 year age and gender categories). 
Recruiting staff was trained in the appropriate data collection and processing protocols, 
as per the Manuals of Operations. All staff was certified in study methods. A total of 
110 participants were excluded: either they did not attend all four clinic visits (5 
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people), their dietary interviews were declared as unreliable by the interviewing 
dietician and site nutritionist (7 people), their total dietary intake was less than 500 
kcal/24>hours or more than 5000 kcal/24>hours (37 people), their two 24>hour urine 
collections were not available (37 people), or missing or incomplete data (24 people). 
For every participant that was excluded, a replacement was made from the same age 
and/or sex group. For this thesis, further exclusion was done of possible under>
reporter’s of energy (explained in section 2.1.5), therefore, a total of 2385 participants 
were included from two population samples in the UK and eight population samples in 
the USA. Country specific metabolic phenotype of the INTERMAP study had been 
investigated using Proton Nuclear Magnetic Resonance (
1
H NMR) spectroscopy 
416
. 
This approach aimed to objectively identify metabonomic profiles that discriminate 
across populations. Hierarchical cluster analysis of NMR spectra showed urinary 
metabolite excretion patterns of e.g., alanine, formate, hippurate and N-
methylnicotinate to be similar for Western samples, suggesting participants from the 
UK and the USA had similar dietary intakes 
416
.  
2.1.3. Clinic visits  
A total of four visits were documented for each participant. Two visits were on 
consecutive days, with the following two visits occurring 2>3 weeks later. Whenever 
possible, the visits were scheduled at the convenience of participants. On each of the 
four visits, BP was measured twice. Twenty>four hour dietary recall was performed 
once on each visit. Collection of 24>hour urine was performed on visit 1 and completed 
on visit 2; the second collection was on visit 3 and completed on visit 4. Height and 
body weight were measured twice (on visits 1 and 3). A health history questionnaire 
was collected on the first visit>gathering information on medical history, medication 
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intake, smoking, and physical activity. On all four visits, participants provided 
information on their vitamin and supplement intake.  
2.1.4. Training of observers  
Blood pressure collection 
For BP measurements, INTERMAP observers were extensively trained in practice and 
then certified in accordance with INTERMAP protocols. Certification required trainees 
to pass a two phase evaluation test: phase one was a film to assess their recognition of 
Korotkoff sounds for systolic and diastolic BP measures within ±4 mm Hg. Phase two 
included assessment of measurement technique by a certified BP observer.  
Measurement of blood pressure  
A total of 8 systolic and diastolic BP readings were available for each participant: BP 
was measured twice on all four visits. A random zero mercury sphygmomanometer was 
used to measure BP by trained personnel, as explained above. Participants were 
instructed to abstain from eating, drinking, smoking, and physical activity for 30 
minutes before BP measures were conducted. After 5 minutes of rest with the 
instrument cuff placed, the device was inflated. Cuff sizes were provided to cater to the 
needs of all participants 
415
. A time interval of 30 seconds was allotted between 
measurements to ensure that participants were comfortable, and to minimise any 
unexpected rise in BP due to BP measurement effect 
417
. In order to minimise 
measuring error, all centres used the Mark II Hawksley random zero 
sphygmomanometer, a replica of the standard mercury sphygmomanometer. Measuring 
error was also minimised through the addition of a random mercury measure to the 
manometer prior to measurement, in order to ‘blind’ the observer to the reading 
418
. 
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Anthropometric measurements and health questionnaire  
On visits 1 and 3, height and body weight were measured twice. Methods of 
measurements were standardised for all sites to ensure proper comparability. A 
stadiometer was used to measure height. A calibrated scale was used to measure body 
weight, without shoes or heavy clothes. Measurements were repeated if consecutive 
readings differed by more than 2 cm or 1 kg. Socioeconomic and lifestyle data were 
collected on visits 1 and 3 including: age, employment (yes/no), on a special diet at the 
time of the study (yes/no), physical activity (hours per day engaged in moderate and 
heavy physical activity during leisure time as reported by participants), dietary 
supplement use (yes/no), years of education (years completed), smoking (yes/no), 
family medical history, and current medication intake. Information about physical 
activity included questions about the intensity of activity (heavy, moderate, light, no 
activity) and frequency. The questions were designed to be simple and 
straightforward
415
. 
Dietary recalls 
The International Nutrition Coordinator ran a 4>day workshop to train interviewers. The 
workshop was designed to introduce trainees to the aims and objectives of 
INTERMAP, and to explain the dietary assessment method through lectures and written 
exercises. Trainees were required to do the following: code four 24>hour dietary recalls 
with <6% line errors, practice dietary collection and coding on 5 tape>recorded 24>hour 
recalls, and tape an evaluation procedure to assess the performance of their peers. 
Extensive training was provided for 24>hour urine collection to ensure an 
understanding of participants’ experience. Training included all aspects of the study: 
administration of medical questionnaire and dietary recall, data input, coding, and the 
handling of urine samples. After the training period, practice was conducted on ten 
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volunteers to ensure study protocol was followed. The country nutritionist and the 
International Nutrition Coordinator continued to monitor and observe the training 
process 
419
. 
2.1.5. Dietary data  
Dietary assessment and coding 
The 24>hour dietary recall method was used to collect data on dietary intake. Interviews 
were conducted by trained and certified dieticians, following a structured format. 
Intakes of all food, drinks, and supplements were recorded. Food and drink models and 
photographs were used to help estimate food portion, and as memory aids. Each study 
site had a nutritionist, and each country had a national nutritionist responsible for 
monitoring data collection and processing. All interviews were taped to enable 
rechecking of details and to ensure that protocol was followed correctly. The dietary 
data collection of the INTERMAP study followed standard methods 
419
. First 
participants were instructed on the importance of accuracy and detailed information on 
all dietary data, followed by how the food models work. Afterwards, individual 
interviews were structured in 3 phases: participants generally explained their energy 
intake in the last 24 hours, along with the time and place of energy intake. Meal 
locations included home, work, school, restaurant, friend’s home, during travel, and 
other. Participants were asked on the first and third visit whether or not they were 
following a specific diet plan (weight reduction, low salt diet, etc.). Second, the open>
question technique was used to obtain details on food items (brand, portion size, 
additions to food and drink). This involved the use of visual aid and food models to 
help provide details on the particular food and/or drink consumed. A list of commonly 
forgotten foods was consulted to ensure that all consumed food and drink had been 
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reported. Finally, the interviewer repeated the contents of the report to give the 
participant an opportunity to edit the recall. Detailed information on alcohol 
consumption over the previous 7 days was recorded on the first and third visits 
415
. 
In the UK, data were first recorded manually, after which they were coded and 
computerized 
409
. In the USA, dietary data were transferred to the software (the 
Nutrition Data System, version 2.9, 1996, University of Minnesota, Minneapolis) for 
on>screen coding during an interview 
419
. The Nutrition Data System allows for 
automatic coding and calculation of nutrient content. Country>specific nutrient 
databases were consulted to estimate nutrient content of all reported foods and 
beverages by the country nutritionist. On the occasions that food and/or drink product 
information was missing or incomplete, the site nutritionist and country nutritionist 
cooperated to complete the data, by contacting food manufacturers or consulting 
product labels. When nutrient values were unusually low or high, recalls were 
consulted for any abnormal intakes. The site nutritionist then decided whether or not 
the intake was valid. Nutrient databases considered different intakes for each         
country 
419
. Tables were then standardized across countries and validated by the 
Nutrition Coordinating Centre 
419,420
. All nutrient data here are exclusive of supplement 
intake. 
Quality control  
The site nutritionist and country nutritionist worked together to ensure the quality of 
data collected and to rate the performance of interviewers. Dietary recalls were 
reviewed by site nutritionists to ensure all information was available and no data were 
missing. A random sample was occasionally withdrawn for revision by site 
nutritionists, to ensure continued accuracy and quality. The country nutritionist then 
selected a sub>sample of these for monitoring. A rating score from 1 to 4 was assigned 
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for interviewers, where 1 indicated “retrain” and 4 “excellent”. Interviewers with low 
scores (1 or 2) were educated and monitored by site and country nutritionists until a 
score of 3 was achieved. In addition, the site nutritionist would randomly select one out 
of ten recalls and code it blindly. If 6% or more of the coded lines appeared inaccurate, 
the recall would be sent back to the person who had coded it for revision, after which 
the site nutritionist would recheck. The site nutritionist would then send off recalls to 
the country nutritionist for a final review, with 3 recalls out of each batch of 30 being 
coded blindly. Again, if 6% or more of the coded lines appeared inaccurate, the recall 
would be sent back to the site nutritionist for revision.  
In order to assess the validity of dietary recalls, sample and gender>controlled 
correlations were calculated between dietary and urinary total protein, sodium, and 
potassium. Correlation coefficients were 0.48, 0.36, 0.51 for the UK and 0.52, 0.46, 
0.58 for the USA, respectively 
419
.  
Under-reporting 
Under>reporting of energy intake was defined by the author as a ratio of energy intake 
to estimated energy expenditure lower than the 95% confidence limit 
421
. Schofield 
equations 
422
 were used to determine the basal metabolic rate of participants, with 
energy expenditure calculated at ‘low’ physical activity level [1.3] for adults 
83
. On this 
basis, 311 participants were excluded as possibly having under>reported their energy 
intake. All analyses in this report are therefore based on data from 2385 UK and USA 
participants (1232 men and 1153 women).  
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2.2. Eating occasions 
An eating occasion is defined by the author as any instance in which participants 
reported the consumption of solid meals and snacks, with a minimum time gap of 15 
minutes between occasions. This time gap was adopted from previous studies on eating 
frequency 
113,141
, as it allows the capture of main meal intakes as well as snacks. All 
beverages, including water, fruit juice, soda, alcoholic beverages, tea and coffee, were 
excluded from the eating occasion counts to avoid over>estimation of the total number 
of eating occasions per day. This was noticeable when the data set was first dealt with, 
where initially beverages were considered as eating occasions. Beverages, especially 
tea and coffee, were consumed a lot during the day, which exaggerated the total number 
of eating occasions per day. Therefore, in this report, the eating occasion number 
analysed was confined to solid intake only. Thus, if a participant had for example a cup 
of tea between meals, that would not be considered an eating occasion. To achieve the 
15>minute time gap specified, it was necessary to convert the time of energy intake to 
minutes of the day, which was conveniently read by the statistical software (SAS). 
Each line of food intake was checked to ensure that the 15>minute rule was applied, and 
to ensure the number of each eating occasion is in order of time of energy intake. 
Missing data on eating occasions were manually recorded; this was observed for 
intakes at exactly 12:00 noon or 12:00 midnight. For the UK data set, manual recording 
of the time of energy intake for each food item was done for a total of 2004 paper>
recalls (4 recalls for 501 UK participants). To ensure accuracy, 100 paper>recalls were 
selected where the time of energy intake was checked against the electronic version. 
After the input of eating occasions was made available for both the UK and USA data 
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sets, the two data sets were combined. Eating occasions were classified into the 
following categories: <4, ≥4 to <5, ≥5 to <6, and ≥6 per 24>hours. 
2.3. Dietary energy density 
Dietary energy density in this report was calculated by the author in two steps. First, 
solid foods and beverages were coded separately for each of the UK and USA data sets 
using food codes and food descriptions, to determine which are solid foods and which 
are beverages. Items that were considered beverages are: tea, coffee, juices, alcohol 
drinks, and milk. After separate codes were generated for solid foods and beverages, 
their weights and energy were calculated. From this, two variables were generated: (1) 
dietary energy density of solid food: calculated by dividing energy of solid food by 
weight of solid food, and (2) dietary energy density of solid food and beverages 
(combined): calculated by dividing energy of solid food and beverages by weight of 
solid food and beverages. The UK and USA data sets were then combined and both 
dietary energy density variables were averaged over four visits.  
Studies have previously concluded that beverages should be excluded when calculating 
dietary energy density, therefore using the dietary energy density of solid food 
165,423
. 
The lower density of liquids compared to solid food may result in disproportionate 
individual dietary energy density values. These values can vary greatly between intake 
assessment methods and may therefore affect the associations of health outcomes with 
the dietary energy density variable. Also, dietary energy density from food only yielded 
intraindividual>to>interindividual coefficient of variation ratios that were relatively 
lower than other methods (e.g., energy density from food and energy>containing 
beverages) 
165,423
. 
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2.4. Nutrient density  
For the purpose of this study, the Nutrient Rich Food 9.3 index score was chosen to 
define nutrient density. This index includes the sum of daily values of nine nutrients to 
encourage: (protein; dietary fibre; vitamins A, C and E; calcium; iron; potassium and 
magnesium) minus the sum daily values of three nutrients to limit based on 100 kcal: 
(saturated fat, added sugar and sodium). For example: Nutrient Rich Food 9.3 index 
score = [(protein g÷50 g + fibre g÷25 g + vitamin A IU÷5000 IU + vitamin C mg÷60 
mg + vitamin E IU÷30 IU + calcium mg÷1000 mg + iron mg÷18 mg + magnesium 
mg÷400 mg + potassium mg÷3500 mg) – (saturated fat g÷20 g + added sugars g÷50 g 
+ sodium mg÷2400 mg)] × 100. 
All components of the Nutrient Rich Food 9.3 index score algorithm were available in 
the INTERMAP data set for both the UK and the USA, except for added sugar. 
Therefore, it was necessary to generate a separate code for added sugar. This included: 
white sugar, brown sugar, caster sugar, and sweeteners of all kinds. The algorithm also 
included either added sodium or total sodium. Because dietary recalls of added sodium 
are generally less accurate than total sodium, thus total sodium was used in the 
algorithm. After the components were coded, the nutrient rich score was firstly 
calculated for each visit and then the average nutrient rich score of 4 visits. The 
nutrients to limit score was then calculated for each visit, and the average computed for 
4 visits. For each visit, the Nutrient Rich Food 9.3 index score was calculated by 
subtracting the nutrients to limit score from the nutrient rich score. The average 
Nutrient Rich Food 9.3 index score over 4 visits was used for the final analyses. 
Participants were classified into gender>specific quintiles of the Nutrient Rich Food 9.3 
index score (quintile 1 to quintile 5). 
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2.5. Time of energy intake 
For the UK data set, electronic coding of the time of food intake was not available. 
Therefore, it was necessary for the author to revisit all the UK dietary recalls and code 
the time of intake for each food item. A total of 2004 recalls were revisited, with a total 
of 67883 lines being coded for the time of food intake. For the USA data set, the time 
of food intake was already available electronically.  
The time of energy intake was expressed as a ratio of evening to morning energy 
intake. Morning intake was defined as the average energy intake from 6:00 am to 11:55 
am, while evening intake was defined as average energy intake from 6:00 pm to 11:55 
pm: 
ℎ							
= 	
evening	energy	intake
24 − hour	energy	intake
÷
morning	energy	intake
24 − hour	energy	intake
 
These times were selected based on when the majority (97%) of the UK and USA 
INTERMAP participants consumed their morning and evening meals. Participants were 
classified into gender>specific quartiles of the ratio of evening to morning energy intake 
(<1.0, ≥1.0 to <1.5, ≥1.5 to <2.0, ≥2.0).  
2.6. Food groups 
Available food descriptions for the INTERMAP UK and USA data were reviewed by 
the author to generate new food groups using the food>group definitions provided by 
the American Dietetic Association as reference. Each food line in the UK and USA 
data sets was therefore assigned to a new food group. Mean food group per day was 
computed in grams, and averaged over four days. The average grams/1000 kcal for 
each food group was used for the final analyses. Food groups generated include: dairy 
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products (whole and low or medium>fat), meat (beef, veal, lamb, poultry, and pork), 
fish (including shellfish), raw vegetables, cooked vegetables, potatoes, cakes and pies, 
raw fruit (excluded were avocado, coconut, sugar cane, plantains, and tamarind, 
because their nutritional value differs substantially from that of most fruit. Fruit nectars, 
fruit drinks, lemonades, and soft drinks were not considered fruit juice, because these 
beverages contain minimal fruit content and are often sweetened). 
2.7. Macro and micro nutrients 
Estimated nutrient intakes were calculated using country>specific, national nutrient 
databases. Databases differed in types and number of foods used and methods for 
deriving values. The Nutrition Coordinating Centre modified available databases to 
make data comparable for the UK and USA by adding new food and preparation 
methods prior to and during fieldwork. Intakes of macro and micronutrients were 
calculated as (g/day), (%) of total kcal intake; or g/1000 kcal, and averaged over 4 
visits.  
2.8. Glycaemic index and glycaemic load 
The GI was calculated using available carbohydrates of each food item. The first step 
was to sum available carbohydrates of all food items, next; the proportion of available 
carbohydrates is calculated: (available carbohydrates of each food item ÷ total available 
carbohydrates of the day). The third step is to calculate proportional GI: (proportion of 
available carbohydrates × GI of the food item). Lastly, we sum the proportional GI 
values to obtain food GI 
277
. For each person, average GI and GL of four values was 
used. Glucose was used as the reference food to assign GI values. 
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For the UK dataset, GI and GL values were not available, and were assigned by 
previous INTERMAP researcher, Ian Brown, and were then validated by the author. 
The steps for assigning GI and GL values were as follows: use of the online reference 
of the University of Sydney (www.glycemicindex.com); when more than one value was 
available, the average value of GI was used. Where GI values were not available in the 
literature for some foods, GI was either estimated from similar foods, or estimated by 
Professor Tom Wolever (University of Toronto). The present researcher validated GI 
values by updating GI values for all food items in the UK dataset.  
For the USA dataset, the Nutrition Coordinating Centre provided values of both GI and 
GL, using the above calculation method. They followed the same process for assigning 
GI values: for foods where measured GI data were unavailable in the literature, GI was 
either estimated from similar foods, calculated from available carbohydrate amounts 
and the GI of ingredients within the food, or given a default GI. 
For GL calculation, the first step is to multiply food available carbohydrates by food 
GI, divided by 100. Next, the values are summed up to obtain food GL 
277
. Lastly, the 
UK and USA datasets were combined for further analyses. Participants were classified 
into gender>specific quintiles of GI, GL (quintile 1 to quintile 5). 
2.9. Statistical methods 
Analyses were performed using SAS (Statistical Analysis System version 9.3; SAS 
Institute Inc., Cary NC, USA). Initially, descriptive analyses were performed, followed 
by correlation and multivariable linear regression analyses. All statistical tests were 
two>sided, with p values (p<0.05) considered significant.  
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2.9.1. Descriptive analysis 
Mean and SD were calculated for all continuous study variables, averaged over four 
visits for each participant, and presented by gender, country, and in total. These 
variables include: BP, BMI, dietary and lifestyle factors, macro and micronutrients. The 
means of macro and micronutrients are described as (% total intake) or (amount/1000 
kcal) where appropriate, to adjust for individual differences in total energy intake. 
Average alcohol intake over 14 days was expressed in g/24>hours. Urinary excretion of 
sodium, potassium, magnesium, and calcium are expressed as mmol/24>hours. Mean 
and SD were calculated for glycaemic index and glycaemic load including UK and 
USA samples, while mean and SD of total, insoluble, and soluble fibre included USA 
samples only; all were averaged over four visits for each participant, and presented by 
gender and in total. Dichotomous variables include: cigarette smoking, adherence to a 
special diet, dietary supplement use, family history of hypertension in any 1st degree 
relative, medical history of CVD or DM, use of antihypertensive and/or CVD 
treatment, employment, marital status.  
Across categories of eating occasions, Chi square tests were used to examine 
differences in the prevalence of normal weight, overweight, and obesity. In addition, 
Chi square tests were used to examine differences in meal location and the use of 
antihypertensive and/or CVD treatment across eating occasion categories.  
2.9.2. Reliability  
Reliability of BP and BMI and eating occasions, dietary energy density, nutrient 
density, and the ratio of evening to morning energy intake were estimated from the 
formula 1 ÷ [1+ (ratio ÷ 4)] x100, where the ratio is intra>individual variance ÷ inter>
individual variance, estimated separately by gender, and for women and men 
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combined; mean across four visits. This was calculated from the means of the first two 
and second two visits in order to account for a higher correlation between values on 
consecutive days. The reliability of eating occasions for example, gives a first 
approximation of the effect of random error (day>to>day variability) on the size of 
eating occasion associations with BP and BMI; the statistic is the estimated size of an 
observed coefficient as a percent of the theoretical coefficient in univariate regression 
analysis. The percentage demonstrates the reduction in regression dilution bias gained 
from the repeated measures 
424,425
.  
2.9.3. Correlations between specific variables 
Strongly correlated explanatory variables were identified (r>0.05), since high 
correlation suggests collinearity. The presence of strongly correlated variables in a 
multivariable linear regression model may potentially lead to misleading results and the 
overestimation of standard errors of the coefficients. Initially, a correlation model was 
used for continuous variables, adjusted for age, gender, and population sample. Model 
outputs were monitored for indications of multicollinearity.  
2.9.4. Multivariable regression analysis  
Regression analyses were performed after combining the UK and USA data sets. 
Generalized linear models and multivariable linear regression models were used. For 
generalized linear models, variables are presented as adjusted means and SE, where 
cross>adjusted sum of squares (SS, or Type III SS in SAS) is used to test the null 
hypothesis that the model does not explain the variance of the response variable.  
To examine the associations between BP, BMI and eating occasions, dietary energy 
density, nutrient density, the ratio of evening to morning energy intake, GI, GL, and 
total, insoluble, and soluble fibre intakes, sequential adjustments for confounders were 
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applied. Each model includes additional variables over the previous model. The 
selection of covariates for inclusion in the model was drawn from published literature 
on potential variables that correlate with BP and BMI. This includes dietary and 
lifestyle factors associated with high BP and BMI levels. The multivariable linear 
regression analyses were used to examine associations between the variable of interest 
(per 2SD of eating occasions, dietary energy density, nutrient density, the ratio of 
evening to morning energy intake, GI, GL, and total, insoluble, and soluble fibre 
intakes) and BP and BMI. Differences in BMI (kg/m
2
) are also presented in text as 
differences in weight (kg), using the average height of INTERMAP UK and USA 
participants (1.7 meter). The following calculation was used:  
/0		1ℎ	23 = 	difference	in	BMI	 × 	2height	in	m3
2 
  
The potential for age and sex interactions were assessed through the inclusion of a 
separate interaction term in each regression model. Where significant interaction was 
detected (p<0.05), age> or sex>specific regression models are reported. The degree of 
multicollinearity present in each regression model was measured from the regressions 
of the variable of interest against all covariates.  
The models for the (eating occasions, dietary energy density, nutrient density, the ratio 
of evening to morning energy intake) and BP associations are as follows (with and 
without BMI): Model 1 adjusted for gender, age and population sample (Table 2.1). 
Model 1a adjusted for variables in Model 1 plus total energy intake (kcal/24>hours). 
Model 2 adjusted for variables in Model 1 plus adherence to a special diet, engagement 
in moderate and heavy physical activity, dietary supplement use, smoking, years of 
education (years completed), DM or CVD diagnosis, and family history of high BP. 
Model 3 adjusted for variables in Model 2 plus 24>hour urinary excretion of sodium 
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and potassium (mmol/24>hours). Model 3a adjusted for variables in Model 3 plus total 
fibre intake (g/1000 kcal). Model 4 adjusted for variables in Model 3 plus alcohol 
intake (g/24>hours). 
The models for the (eating occasions, dietary energy density, nutrient density, the ratio 
of evening to morning energy intake) and BMI associations are as follows: Model 1 
adjusted for gender, age and population sample (Table 2.2). Model 1a adjusted for 
variables in Model 1 plus total energy intake (kcal/24>hours). Model 2 adjusted for 
variables in Model 1 plus adherence to a special diet, engagement in moderate and 
heavy physical activity, dietary supplement use, smoking, and years of education (years 
completed). Model 2a adjusted for variables in Model 2 plus total fibre intake (g/1000 
kcal). Model 3 adjusted for variables in Model 2 plus alcohol intake (g/24>hours). 
Sensitivity analyses were conducted using model 4 where BP was the outcome (Table 
2.3) and model 3 where BMI was the outcome (Table 2.4). These include: gender sub>
cohort analyses, the exclusion of certain sub>cohorts (individuals with high variability 
in their diet, those following a special diet, those diagnosed with CVD or DM). 
Individuals with high variability in their diet were classified by a series of nutrient, BP, 
and BMI coefficient of variation criteria and urinary to dietary ratios. They were 
defined by senior INTERMAP researchers prior to data analyses, so that individuals 
with unreliable dietary recalls or fluctuating BPs or BMIs could be flagged. 
Additionally censored regression analyses was applied for those on antihypertensive 
medication 
426
. The effects on the magnitude and direction of regression coefficients of 
the various sub>cohort and sensitivity analyses were assessed. 
Multivariable models adjusted extensively for lifestyle and dietary factors were used to 
assess relations of GI, GL, total, insoluble, and soluble fibre to BP and BMI (Tables 2.5 
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and 2.6). This method (the nutrient density method) is one of several available 
approaches in epidemiologic analyses to adjust for total energy intake when addressing 
the relations of specific nutrient intakes with total energy intake 
427
. Other methods 
include: energy>adjusted (residual), the standard multivariable, and the energy 
decomposition method. The multivariable nutrient density model used in the present 
report is an isocaloric analysis that allows for interpretation of the relation of the 
nutrient composition of the diet with the outcome, i.e., BP, BMI while controlling for 
total energy intake; thus avoiding statistical problems presented by other nutrient 
density models that do not control for total energy. The coefficient for total energy 
intake will be therefore interpreted as the effect of the “biological value of energy” 
because nutrient densities (nutrient/total energy) are not part of/or highly correlated 
with total energy intake. Example of a multivariable nutrient density model: outcome 
(disease) = (nutrient/total energy) (%) + total calories (kcal/24>hours) 
428
. Therefore, 
nutrient densities were computed as percentages of total energy (total protein, total fat, 
total sugar %) or as g/1000 kcal (total fibre, insoluble and soluble fibre), then both the 
densities and total energy intake were used in multivariable regression models.  
The multivariable nutrient density models for the GI, GL, fibre (total, insoluble, 
soluble) and BP associations are as follows (with and without BMI): Model 1 adjusted 
for age, gender, total energy intake (kcal/24>hours), total protein (%kcal), total fat 
(%kcal), and population sample (Table 2.5). Model 2 adjusted for variables in Model 1 
plus adherence to a special diet, engagement in moderate and heavy physical activity, 
dietary supplement use, smoking, years of education (years completed), alcohol intake 
(g/24>hours), DM or CVD diagnosis, family history of high BP, and 24>hour urinary 
excretion of sodium (mmol/24>hours). Additional models for total, insoluble, soluble 
fibre and BP associations were used to adjust for nutrients known to be high in fibre>
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rich foods: Model 3 was adjusted for variables in model 2 plus 24>hour urinary 
excretion of magnesium (mmol/24>hours). Model 4 was adjusted for variables in model 
2 plus 24>hour urinary excretion of potassium (mmol/24>hours). Model 5 was adjusted 
for variables in model 2 plus 24>hour urinary excretion of calcium (mmol/24>hours). 
The multivariable nutrient density models for the GI, GL, fibre (total, insoluble, 
soluble) and BMI associations are as follows: Model 1 adjusted for age, gender, total 
energy intake (kcal/24>hours), total protein (%kcal), total fat (%kcal), and population 
sample (Table 2.6). Model 2 adjusted for variables in Model 1 plus adherence to a 
special diet, engagement in moderate and heavy physical activity, dietary supplement 
use, smoking, years of education (years completed), and alcohol intake (g/24>hours). 
Additional models for total, insoluble, soluble fibre and BMI associations were used to 
adjust for nutrients known to be high in fibre>rich foods: Model 3 was adjusted for 
variables in model 2 plus 24>hour urinary excretion of magnesium (mmol/24>hours). 
Model 4 was adjusted for variables in model 2 plus 24>hour urinary excretion of 
potassium (mmol/24>hours). Model 5 was adjusted for variables in model 2 plus 24>
hour urinary excretion of calcium (mmol/24>hours).  
For the combined effect of GI and fibre intake on BP, BMI, UK and USA participants 
were cross>classified by GI and total fibre intake using model 1 to examine the relation.  
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Table  2.1. Model variables in multivariable linear regression of blood pressure against eating 
occasions, dietary energy density, nutrient density, and the ratio of evening to morning 
energy intake 
Model 
number 
Description  
Model 1 Adjusted for gender, age and population sample. 
Model 1a Adjusted for variables in Model 1 plus total energy intake (kcal/24-hours). 
Model 2 Adjusted for variables in Model 1 plus adherence to a special diet, engagement in moderate and 
heavy physical activity (h/24-hours), dietary supplement use 
1
, smoking, years of education (years 
completed), DM or CVD diagnosis 
2
, and family history of high BP. 
Model 3 Adjusted for variables in Model 2 plus 24-hour urinary excretion of sodium and potassium (mmol/24-
hours). 
Model 3a Adjusted for variables in Model 3 plus total fibre intake (g/1000 kcal) 
3
. 
Model 4 Adjusted for variables in Model 3 plus alcohol intake (g/24-hours)
 4
. 
1 
Taking dietary supplements at time of study. 
2 
Medical history of diabetes mellitus or cardiovascular disease (heart attack, other heart disease, stroke).
 
3 
For eating occasions and blood pressure associations. 
4 
Alcohol intake over the previous 7 days was recorded on the first and third visits; average alcohol intake over 14 days is used. 
 
 
Table  2.2. Model variables in multivariable linear regression of body mass index against 
eating occasions, dietary energy density, nutrient density, and the ratio of evening to 
morning energy intake 
Model 
number 
Description  
Model 1 Adjusted for gender, age and population sample. 
Model 1a Adjusted for variables in Model 1 plus total energy intake (kcal/24-hours). 
Model 2 Adjusted for variables in Model 1 plus adherence to a special diet, engagement in moderate and 
heavy physical activity (h/24-hours), dietary supplement use 
1
, smoking, and years of education (years 
completed). 
Model 2a Adjusted for variables in Model 2 plus total fibre intake (g/1000 kcal) 
2
. 
Model 3 Adjusted for variables in Model 2 plus alcohol intake (g/24-hours)
 3
. 
1 
Taking dietary supplements at time of study. 
2 
For eating occasions and body mass index associations only. 
3 
Alcohol intake over the previous 7 days was recorded on the first and third visits; average alcohol intake over 14 days is used. 
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Table  2.3. Sub-cohort, exclusions and other sensitivity analyses where blood pressure is the 
outcome. 
Sex: men and women separately 
Censored regression for antihypertensive medication use 
Excluding participants with a highly variable diet  
Excluding those following a special diet 
Excluding individuals with a medical history of CVD or DM 
 
 
 
Table  2.4. Sub-cohort, exclusions and other sensitivity analyses where body mass index is 
the outcome 
Sex: men and women separately 
Excluding participants with a highly variable diet  
Excluding those following a special diet 
Excluding individuals with a medical history of CVD or DM 
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Table  2.5. Model variables in multivariable nutrient density models of blood pressure 
against glycaemic index, glycaemic load, dietary fibre and its components 
Model 
number 
Description 
Model 1 Adjusted for age, gender, total energy intake (kcal/24-hours), total protein (%kcal), total fat (%kcal), 
and population sample. 
Model 2 Adjusted for variables in Model 2 plus adherence to a special diet, engagement in moderate and 
heavy physical activity (h/24-hours), dietary supplement use 
1
, smoking, years of education (years 
completed), alcohol intake (g/24-hours)
 2
, DM or CVD diagnosis 
3
, family history of high BP, 24-hour 
urinary excretion of sodium (mmol/24-hours). 
 Model 3 Adjusted for variables in Model 2 plus 24-hour urinary excretion of magnesium (mmol/24-hours). 
Model 4 Adjusted for variables in Model 2 plus 24-hour urinary excretion of potassium (mmol/24-hours). 
Model 5 Adjusted for variables in Model 2 plus 24-hour urinary excretion of calcium (mmol/24-hours).  
 
1 
Taking dietary supplements at time of study. 
2 
Alcohol intake over the previous 7 days was recorded on the first and third visits; average alcohol intake over 14 days is used. 
3 
Medical history of diabetes mellitus or cardiovascular disease (heart attack, other heart disease, stroke).
 
 
 
Table  2.6. Model variables in multivariable nutrient density models of body mass index 
against glycaemic index, glycaemic load, dietary fibre and its components 
Model 
number 
Description  
Model 1 Adjusted for age, gender, total energy intake (kcal/24-hours), total protein (%kcal), total fat (%kcal), 
and population sample. 
Model 2 Adjusted for variables in Model 1 plus adherence to a special diet, engagement in moderate and 
heavy physical activity (h/24-hours), dietary supplement use 
1
, smoking, years of education (years 
completed), and alcohol intake (g/24-hours) 
2
. 
Model 3 Adjusted for variables in Model 2 plus 24-hour urinary excretion of magnesium (mmol/24-hours). 
Model 4 Adjusted for variables in Model 2 plus 24-hour urinary excretion of potassium (mmol/24-hours). 
Model 5 Adjusted for variables in Model 2 plus 24-hour urinary excretion of calcium (mmol/24-hours).  
 
1 
Taking dietary supplements at time of study. 
2 
Alcohol intake over the previous 7 days was recorded on the first and third visits; average alcohol intake over 14 days is used. 
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3. RESULTS PART I 
The first part of the results presents associations of eating occasions, dietary energy density, 
nutrient density, and the ratio of evening to morning energy intake to BP and BMI.  
3.1. Descriptive statistics  
The following analyses are based on data from 2385 UK and USA INTERMAP participants 
(1232 men and 1153 women). Gender and country specific dietary and lifestyle 
characteristics are presented in (Table 3.1).  
Average systolic BP was higher in the UK (120.2 mm Hg) than in the USA (118.4 mm Hg), 
with a similar trend for diastolic BP (77.3 mm Hg in the UK and 73.3 mm Hg in the USA). 
Average systolic and diastolic BP were higher in men than in women in both countries. 
Average BMI was lower in the UK (27.1 kg/m
2
) than in the USA (28.6 kg/m
2
). Men in the 
UK and the USA had higher average BMI compared to women (27.4 vs. 26.8 kg/m
2
; 28.8 
kg.m
2 
vs. 28.3 kg/m
2
). The percentage of participants receiving drug treatment for high BP or 
CVD was higher in the USA (21.8%) than in the UK (14.2%). In the UK, men were more 
likely to be receiving drug treatment for high BP or CVD than women (15.7% vs. 12.4%), 
while the proportion of men and women receiving treatment in the USA was similar (21.8%). 
Average eating occasions/24>hours were higher in the UK compared to the USA (5.4 vs. 4.6). 
Men in both countries had slightly lower average eating occasions/24>hours compared to 
women. Average dietary energy density from food only was similar across countries and 
between genders (1.8 kcal/g). Nutrient density expressed by the Nutrient Rich Food 9.3 index 
score was slightly lower in the UK than in the USA (28.8 vs. 31.4). Women in the UK had 
higher Nutrient Rich Food 9.3 index score compared to men (30.8 vs. 27.1) with a similar 
trend in the USA (33.4 vs. 29.5). The average ratio of evening to morning energy intake was 
higher in the USA than the UK (3.5 vs. 3.0). Women had lower ratio of evening to morning 
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energy intake in both countries compared to men (2.8 vs. 3.2 in the UK; 3.2 vs. 3.5 in the 
USA). 
3.2. Reliability estimates 
Univariate estimates of the reliability of systolic and diastolic BP based on mean values from 
the four 24>hour recalls per participant were 96% in the UK and slightly lower in the USA 
(96%, 95%) (Table  3.2). The reliability estimate for BMI was 99.9% overall. The reliability 
estimates for eating occasions ranged from about 83% to 86% of the theoretical coefficient. 
The reliability estimate for dietary energy density was slightly lower in the UK than in the 
USA (75% vs. 76%). The reliability estimate for nutrient density was 95% overall. For the 
ratio of evening to morning energy intake, the reliability estimate ranged from about 87% to 
88%. Estimates were similar across population samples and by gender. 
3.3. Correlations 
Partial Pearson correlations between dietary, lifestyle variables and outcome variables for the 
UK and USA participants are presented in (Table 3.3). Gender specific correlations between 
dietary, lifestyle variables and outcome variables are presented in [Tables A.1 (men) and A.2 
(women)].  
Average years of education correlated negatively with BP and BMI (r=>0.10). Hours of 
engagement in moderate and heavy physical activity, smoking and supplement use were not 
correlated with BP, and correlated inversely but only in low order with BMI (r=>0.05 to >
0.07). Following a special diet did not correlate with BP and only in low order with BMI 
(r=0.05). Total energy intake per day correlated positively with systolic BP and BMI (r=0.10 
and 0.20, respectively). Average eating occasions/24>hours was inversely correlated with 
systolic BP and BMI (r=>0.06 and >0.08). Dietary energy density was positively correlated 
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with systolic BP and BMI (r=0.10). Nutrient density was inversely correlated with systolic 
BP and BMI (r=>0.12 and >0.16), and slightly higher in women compared to men (Tables A.1 
and A.2.). The average ratio of evening to morning energy intake was positively correlated 
with systolic BP, diastolic BP, and BMI, but only low order (r=0.04 to 0.03), while the 
correlation was slightly higher for men than women. For nutrient intakes, total carbohydrate 
and total fibre correlated inversely with systolic BP and BMI (r=>0.13 to >0.19). Total fat, 
saturated fatty acid (SFA), mono>unsaturated fatty acid (MFA), and poly>unsaturated fatty 
acid (PFA) all correlated positively with systolic and diastolic BP and BMI. The 24>hour 
urinary excretion of sodium correlated positively with systolic BP and BMI (r=0.12 and 0.33, 
respectively). The 24>hour urinary excretion of potassium correlated inversely with systolic 
and diastolic BP (r=>0.04), and positively with BMI (r=0.10). The 24>hour urinary excretion 
of magnesium did not correlate with systolic BP (r=0.02), and correlated positively with BMI 
(r=0.05). The 24>hour urinary excretion of calcium was positively correlated with systolic BP 
and BMI (r=0.10 and 0.12).  
Table 3.4 shows correlation coefficients between dietary macro and micro nutrients for UK 
and USA participants. Total carbohydrates correlated positively with total fibre (r=0.33), and 
negatively with total protein (r=>0.33), fat (r=-0.75), alcohol, (r=>0.33), 24>hour urinary 
excretion of sodium (r=>0.17), and 24>hour urinary excretion of calcium (r=>0.13). Total 
protein did not correlate with total fat (r=>0.02). Total fibre correlated inversely with SFA 
(r=>0.48) and positively with vegetable protein (r=0.77). The 24>hour urinary excretion of 
sodium correlated positively with 24>hour urinary excretion of potassium (r=0.35) and 24>
hour urinary excretion of magnesium and calcium (r=0.30).  
Gender specific correlations between dietary macro and micro nutrients are presented in 
[Tables A.3 (men) and A.4 (women)]. 
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3.4. Eating occasions 
Compared to participants with <4 eating occasions/24>hours, those with ≥6 eating 
occasions/24>hours were more educated (14.8 vs. 14.2 y), had lower average: systolic BP: 
116.4 vs. 121.4 mm Hg; diastolic BP: 73.0 vs. 75.5 mm Hg; BMI: 27.3 vs. 29.0 kg/m
2
; total 
energy intake: 2127 vs. 2521 kcal/24>hours; dietary energy density: 1.4 vs. 2.2 kcal/g; and 
higher Nutrient Rich Food index score: 35.1 vs. 26.8 (p for trend<0.0001) (Table 3.5). In 
addition, participants with ≥6 eating occasions/24>hours had greater intakes of low or 
medium>fat dairy products (p for trend<0.0001), raw vegetables (p for trend=0.02), cooked 
vegetables (p for trend=0.02), and fruits (p for trend<0.0001) and lower intakes of meats (p 
for trend<0.0001) and potatoes (p for trend<0.004) compared to those with <4 eating 
occasions/24>hours. Individuals with ≥6 eating occasions/24>hours also had significantly 
more intakes of total carbohydrate (p for trend<0.0001), total fibre (p for trend<0.0001), 
vegetable protein (p for trend<0.0001), and lower GI (p for trend=0.0005), GL (p for 
trend<0.0001), total fat (p for trend=0.0002), SFA (p for trend=0.005), MFA (p for 
trend=0.0002), cholesterol (p for trend<0.0001), and alcohol (p for trend<0.0001) compared 
to those with <4 eating occasions/24>hours. Those with ≥6 eating occasions/24>hours had 
lower 24>hour urinary excretion of sodium (p for trend<0.0001), and higher 24>hour urinary 
excretion of potassium, magnesium, and calcium (p for trend<0.0001) compared to those 
with <4 eating occasions/24>hours. Furthermore, information on meal location show that 
26%, 33%, 25%, and 16% of participants with <4, ≥4 to <5, ≥5 to <6, and ≥6 eating 
occasions/24>hours, respectively, were having their evening meals at restaurants or cafeterias. 
3.4.1. Eating occasions and blood pressure 
In 2385 UK and USA INTERMAP participants, adjustment of for lifestyle, dietary and 
urinary risk factors for high BP level (model 3) showed eating occasions higher by 2.6 eating 
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occasions/24>hours (2SD) were associated with systolic and diastolic BP differences of >2.5 
mm Hg (95% CI: >3.7, >1.4 mm Hg, p<0.0001) and >1.2 mm Hg (95% CI: >2.1, >0.4 mm Hg, 
p=0.004) (Table 3.6). Further adjustment for BMI showed lower coefficients: (>1.9, 95% CI: 
>3.0, >0.8 mm Hg, p<0.001) for systolic BP and (>0.9, 95% CI: >1.7, >0.1 mm Hg, p=0.03) for 
diastolic BP. Additional adjustment for dietary fibre (model 3a) showed (with BMI: >1.8, 
95% CI: >2.9, >0.7 mm Hg, p=0.002) for systolic BP and (with BMI: >0.9, 95% CI: >1.7, >
0.03 mm Hg, p=0.04) for diastolic BP. Further adjustment for alcohol intake (model 4) 
showed eating occasions higher by 2.6 eating occasions/24>hours were associated with 
systolic and diastolic BP differences of >1.6 mm Hg (with BMI: 95% CI: >2.7, >0.5 mm Hg, 
p<0.01) and >0.1 mm Hg (with BMI: 95% CI: >1.5, 0.1 mm Hg, p=0.09), respectively, where 
results did not remain statistically significant. 
Using model 4 for censored regression for those on antihypertensive medication use, 487 
participants were right censored and results were compatible to (model 4): systolic BP 
differences were >2.3 mm Hg (95% CI: >3.7, >1.0 mm Hg, p<0.001) and diastolic BP >1.1 
mm Hg (95% CI: >2.0, >0.1 mm Hg, p=0.03). Further adjustment for BMI lowered 
differences to >1.4 mm Hg (95% CI: >2.7, >0.2 mm Hg, p=0.03) for systolic BP, and to >0.5 
mm Hg (95% CI: >1.4, 0.4 mm Hg, p=0.27) for diastolic BP where results were no longer 
statistically significant. With the exclusion of participants with high variability in their diet, 
systolic BP difference associated with 2SD higher intake in eating occasions was compatible 
to that of (model 4) (with BMI, >1.7, 95% CI: >3.0, >0.4 mm Hg, p<0.01) and diastolic BP (>
0.8, 95% CI: >1.7, 0.1 mm Hg, p=0.09). Excluding individuals following a special diet at the 
time of the study showed similar results to (model 4). Further sub>cohort analyses excluded 
those diagnosed with DM and/or CVD, where differences in systolic and diastolic BP 
associated with 2SD higher intake in eating occasions were similar to the aforementioned 
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sub>cohort analyses, but with significant results for diastolic BP (with BMI: 95% CI: >1.8, >
0.1 mm Hg, p=0.04). 
Gender>specific regressions showed that associations of eating occasions with systolic and 
diastolic BP were similarly inverse for men and women, with higher differences in systolic 
and diastolic BP among women (Table A.5). 
3.4.2. Eating occasions and body mass index 
Participants with ≥6 eating occasions/24>hours had the highest percentage of those normal 
weight (36%) and lowest percentage of those obese (23%), while participants with <4 eating 
occasions/24>hours had the lowest percentage of normal weight (25%) and highest 
percentage of obese (36%) (Table 3.5).  
In 2385 UK and USA INTERMAP participants, adjustment of for lifestyle and dietary risk 
factors for high BMI level (model 2) showed eating occasions higher by 2.6 eating 
occasions/24>hours (2SD) were associated with BMI differences of >1.1 kg/m
2
 (95% CI: >1.6, 
>0.6 kg/m
2
) [equivalent to >3.2 kg in weight] (Table 3.7). Additional adjustment for dietary 
fibre (model 2a) showed BMI (>0.8, 95% CI: >1.3, >0.4 kg/m
2
) [equivalent to >2.3 kg in 
weight], while adjustment for alcohol intake showed similar results as (model 2).  
With the exclusion of participants with high variability in their diet, results were compatible 
to (model 3) (>1.3, 95% CI: >1.8, >0.8 kg/m
2
) [equivalent to >3.8 kg in weight]. Excluding 
individuals following a special diet at the time of the study showed similar results to (model 
3). Further sub>cohort analyses excluded those diagnosed with DM and/or CVD, where 
differences in BMI associated with 2SD higher intakes in eating occasions were smaller 
compared to (model 3) (>0.8, 95% CI: >1.3, >0.3 kg/m
2
) [equivalent to >2.3 kg in weight]. 
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Gender>specific regressions showed eating occasions were similarly inversely associated 
with BMI in men and women, with a higher difference in BMI among women (Table A.6). 
No significant interactions with age or gender were detected.  
3.5. Dietary energy density  
3.5.1. Dietary energy density and blood pressure 
Adjustment of for lifestyle, dietary and urinary risk factors for high BP level in model 4 
showed dietary energy density (from food only) higher by 0.8 kcal/g (2SD) was associated 
with systolic and diastolic BP differences of 3.2 mm Hg (95% CI: 2.1, 4.4 mm Hg, 
p<0.0001) and 1.9 mm Hg (95% CI: 1.0, 2.7 mm Hg, p<0.0001) (Table 3.8). Further 
adjustment for BMI showed lower coefficients: 2.2 mm Hg (95% CI: 1.1, 3.3 mm Hg, 
p=0.0001) for systolic BP and 1.3 mm Hg (95% CI: 0.5, 2.1 mm Hg, p<0.01) for diastolic 
BP. 
Using model 4 for censored regression for those on antihypertensive medication use, results 
were compatible to (model 4): systolic BP differences were 3.3 mm Hg (95% CI: 2.0, 4.6 mm 
Hg, p<0.0001) and diastolic BP 1.9 mm Hg (95% CI: 1.0, 2.9 mm Hg, p<0.0001). Further 
adjustment for BMI lowered differences to 1.9 mm Hg (95% CI: 0.7, 3.2 mm Hg, p=0.003) 
for systolic BP, and to 1.1 mm Hg (95% CI: 0.2, 2.0 mm Hg, p=0.02) for diastolic BP. With 
the exclusion of participants with high variability in their diet, systolic and diastolic BP 
differences associated with 2SD difference in dietary energy density were slightly lower than 
that of (model 4) (with BMI, 1.5, 95% CI: 0.2, 2.7 mm Hg, p=0.02 for systolic BP) and (with 
BMI, 0.8, 95% CI: >0.1, 1.7 mm Hg, p=0.09 for diastolic BP), where results were no longer 
statistically significant. Excluding individuals following a special diet at the time of the study 
showed similar systolic and diastolic BP differences to that of (model 4). Further sub>cohort 
analyses excluded those diagnosed with DM and/or CVD, where differences in systolic and 
  101
diastolic BP associated with 2SD higher eating occasions were similar to the aforementioned 
sub>cohort analyses (with BMI, 2.1, 95% CI: 0.9, 3.3 mm Hg, p<0.001) for systolic BP and 
(1.0, 95% CI: 0.2, 1.9 mm Hg, p=0.02) for diastolic BP. 
Gender>specific regressions showed that associations of dietary energy density with systolic 
and diastolic BP were similarly positive for men and women (Table A.7). No significant 
interactions with gender and age and gender were detected.  
3.5.2. Dietary energy density and body mass index 
Adjustment of for lifestyle and dietary risk factors for high BMI level in model 3 showed 
dietary energy density (from food only) higher by 0.8 kcal/g (2SD) was associated with BMI 
differences of 1.9 kg/m
2
 (95% CI: 1.4, 2.3 kg/m
2
) [equivalent to 5.5 kg in weight] (Table 
3.9).  
With the exclusion of participants with high variability in their diet, BMI difference 
associated with 2SD higher dietary energy density was similar to that of (model 3): (1.9, 95% 
CI: 1.4, 2.4 kg/m
2
, p<0.0001). Excluding individuals following a special diet at the time of 
the study showed compatible results to (model 3): (1.8, 95% CI: 1.3, 2.3 kg/m
2
, p<0.0001) 
[equivalent to 5.2 kg in weight]. Furthermore, excluding those diagnosed with DM and/or 
CVD, showed similar results (1.7, 95% CI: 1.3, 2.2 kg/m
2
, p<0.0001) [equivalent to 4.9 kg in 
weight]. 
Gender>specific regressions showed that associations of dietary energy density with BMI 
were similarly positive for men and women (Table A.8). No significant interactions with 
gender or age were detected.  
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3.6. Nutrient density  
Participants in the highest Nutrient Rich Food 9.3 index score quintile (quintile 5, 
median=52.6) were more educated (p for trend<0.0001), had significantly lower systolic BP 
(p for trend<0.0001), diastolic BP (p for trend=0.01), BMI (p for trend<0.0001), total 
energy intake per day (p for trend<0.0001), dietary energy density from food only and from 
food and beverages (p for trend<0.0001) compared to (quintile 1, median=15) (Table 3.10). 
Those in the highest quintile also consumed higher amounts of solid foods (p for 
trend<0.0001), had significantly greater intakes of low or medium>fat dairy products (p for 
trend<0.0001), fish (p for trend<0.0001), raw vegetables (p for trend<0.0001), cooked 
vegetables (p for trend<0.0001), fruits (p for trend<0.0001) and lower intakes of meats (p for 
trend<0.0001) and cakes and pies (p for trend=0.004) compared to those in the lowest 
quintile. Those in the highest quintile had significantly higher intakes of total carbohydrate (p 
for trend<0.0001), total fibre (p for trend<0.0001), total protein (p for trend<0.0001), and 
lower intakes of total fat (p for trend<0.0001), SFA (p for trend<0.0001), MFA (p for 
trend<0.0001), PFA (p for trend<0.0001), and cholesterol (p for trend<0.0001) compared to 
those in the lowest quintile. Compared to quintile 1, those in quintile 5 showed lower 24>hour 
urinary excretion of sodium, calcium (p for trend<0.01) and potassium (p for trend<0.0001), 
while 24>hour urinary excretion of magnesium was higher in quintile 5 (p for trend<0.0001). 
3.6.1. Nutrient density and blood pressure 
In model 4, nutrient density (expressed by Nutrient Rich Food 9.3 index score) higher by 
28.2 (2SD) was associated with systolic and diastolic BP differences of >1.5 mm Hg (95% 
CI: >2.8, >0.3, p<0.001) and >1.2 mm Hg (95% CI: >2.0, >0.3, p<0.01) (Table 3.11). Further 
adjustment for BMI showed lower coefficients: >1.3 mm Hg (95% CI: >2.5, >0.1, p=0.03) for 
  103
systolic BP and >0.7 mm Hg (95% CI: >1.7, 0.1, p=0.09) for diastolic BP, where results did 
not remain statistically significant. 
Gender>specific regressions showed that associations of nutrient density with systolic and 
diastolic BP were similarly inverse for men and women (Tables 3.12 and 3.13); however 
associations of nutrient density with systolic and diastolic BP were not significant in women. 
No significant interactions with age were detected, however significant interaction with 
gender was observed. In men (Table 3.12), using model 4 for censored regression for those 
on antihypertensive medication use, results showed systolic BP differences were (with BMI, >
2.8 mm Hg 95% CI: >4.7, >0.9, p<0.01), however associations with diastolic BP were no 
longer statistically significant after adjustment for BMI (p=0.11). With the exclusion of men 
with high variability in their diet, systolic BP difference associated with 2SD higher in 
nutrient density was (with BMI, >3.2 mm Hg, p=0.001), while diastolic BP associations were 
not significant (with BMI, >1.3 mm Hg, p=0.09). Excluding individuals following a special 
diet at the time of the study showed smaller differences in systolic BP (with BMI, >2.2 mm 
Hg, p=0.01), while diastolic BP associations were not significant (with BMI, >0.7 mm Hg, 
p=0.33). Further sub>cohort analyses excluded those diagnosed with DM and/or CVD, where 
differences in systolic and diastolic BP associated with 2SD higher nutrient density were 
lower than the aforementioned sub>cohort analyses (with BMI, >2.0 mm Hg, p=0.03) and        
(>0.8 mm Hg for diastolic BP, p=0.23). No significant associations between nutrient density 
and systolic and diastolic BP were observed in women (Table 3.13). 
3.6.2. Nutrient density and body mass index  
Participants in quintile 5 had the highest percentage of those normal weight (40%) and lowest 
percentage of those obese (21%), while participants in quintile 1 and quintile 2 had the lowest 
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percentage of normal weight (26% and 22%, respectively) and the highest percentage of 
obese (37% and 36%, respectively) (Table 3.10).  
In model 3, adjustment of for lifestyle and dietary risk factors for high BMI level showed 
nutrient density higher by 28.2 (2SD) was associated with BMI difference of >1.6 kg/m
2
 
(95% CI: >2.1, >1.1 kg/m
2
, p<0.0001) [equivalent to >4.7 kg in weight] (Table 3.14).  
Excluding participants with high variability in their diet showed BMI differences associated 
with 2SD higher nutrient density to be (>1.7, 95% CI: >2.2, >1.2 kg/m
2
) [equivalent to >4.9 kg 
in weight], similar to that of (model 3). Excluding individuals following a special diet at the 
time of the study showed lower difference in BMI compared to (model 3) (>1.5, 95% CI: >1.9, 
>1.1 kg/m
2
) [equivalent to >4.4 kg in weight]. Furthermore, excluding those diagnosed with 
DM and/or CVD showed a lower difference in BMI associated with 2SD difference in 
nutrient density compared to (model 3) (>1.3, 95% CI: >1.8, >0.9 kg/m
2
) [equivalent to >3.8 kg 
in weight]. 
Gender>specific regressions showed that associations of nutrient density with BMI were 
similarly inverse for men and women (Table A.9). No significant interactions with gender or 
age were detected.  
3.7. The ratio of evening to morning energy intake 
By dividing the ratio of evening to morning energy intake into quartiles, no significant 
differences in systolic BP, BMI or total energy were observed across quartiles (Table 3.15). 
Those in the highest quartile (≥2.0) had higher BMI (p for trend=0.07), diastolic BP (p for 
trend=0.004), dietary energy density from food (p for trend<0.01), and from food and 
beverages (p for trend=0.03), and lower nutrient density (p for trend<0.0001) compared to 
those in the lowest quartile (<1.0). Significant differences in food group intake were observed 
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for some food groups. Participants in the lower ratio of evening to morning energy intake had 
greater intakes of low or medium>fat dairy products (p for trend<0.0001) and fruits (p for 
trend=0.02) and lower intakes of meats (p for trend<0.0001) compared to those in the higher 
ratio of evening to morning energy intake. Macro and micro nutrient intakes were different 
among quartiles; those in the highest quartile (≥2.0) had significantly less intakes of total 
carbohydrate (p for trend<0.0001), total fibre (p for trend<0.0001), vegetable protein (p for 
trend<0.0001) and higher intakes of total fat (p for trend=0.004), cholesterol (p for 
trend<0.0001), and alcohol (p for trend<0.0001) compared to those lowest quartile (<1.0). 
Those in the highest quartile also showed lower 24>hour urinary excretion of magnesium (p 
for trend=0.03) compared to those in the lowest quartile. 
3.7.1. The ratio of evening to morning energy intake and blood 
pressure 
In 2385 UK and USA INTERMAP participants, adjustment of for lifestyle, dietary and 
urinary risk factors for high BP showed no significant association of the ratio of evening to 
morning energy intake with systolic BP (Table 3.16). However, the ratio of evening to 
morning energy intake was significantly related to diastolic BP (without BMI, 0.1 mm Hg, 
p=0.03) and was attenuated with adjustment for BMI (0.1 mm Hg, p=0.06). 
In sub>cohort analyses, significant associations were observed for diastolic BP in some 
models: in censored regression, the ratio of evening to morning energy intake higher by 3.6 
(2SD) was associated with diastolic BP differences of (without BMI, 0.1 mm Hg, p=0.06 and 
with BMI, 0.1, p=0.09); with the exclusion of those with high variability in their diet, 
diastolic BP differences were (without BMI, 0.1 mm Hg, p=0.02 and with BMI, 0.1 mm Hg, 
p=0.03); with the exclusion of those following a special diet, diastolic BP differences were 
(without BMI, 0.1 mm Hg, p=0.02 and with BMI, 0.1 mm Hg, p=0.05); with the exclusion 
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of those with DM and/or CVD, diastolic BP differences were (without BMI, 0.1 mm Hg, 
p=0.04 and with BMI, 0.1, p=0.03). 
Gender>specific regressions showed no significant associations of the ratio of evening to 
morning energy intake with systolic and diastolic BP in all sub>cohort analyses, however the 
ratio of evening to morning energy intake was significantly and positively associated with 
diastolic BP in women (without BMI, 0.1 mm Hg, p=0.02) (Table A. 10). 
3.7.2. The ratio of evening to morning energy intake and body mass 
index 
Adjusting for lifestyle and dietary risk factors for high BMI level (model 3) showed a 
positive association of BMI with the ratio of evening to morning energy intake (BMI 
differences of 0.1, 95% CI: >0.03, 0.1 kg/m
2
, p=0.07) [equivalent to 0.3 kg in weight] (Table 
3.17). 
With the exclusion of participants with high variability in their diet, the association was 
attenuated compared to (model 3) (0.1 kg/m
2
, p=0.09). Excluding individuals following a 
special diet at the time of the study showed BMI differences associated with 2SD higher ratio 
of evening to morning energy intake to be similar to (model 3) (0.04 kg/m
2
, p=0.06) 
[equivalent to 0.1 kg in weight]. Furthermore, excluding those diagnosed with DM and/or 
CVD also showed similar results to the (model 3) (0.04 kg/m
2
, p=0.08). 
Gender>specific regressions showed that associations of the ratio of evening to morning 
energy intake with BMI were similarly direct for men and women. No significant interactions 
with gender or age were detected (Table A.11).  
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3.7.3. Eating occasions and the ratio of evening to morning energy 
intake 
Table 3.18 shows the combined association of eating occasions and the ratio of evening to 
morning energy intake. Participants who ate more frequently and consumed most of their 
energy earlier in the day (≥6 eating occasions/24>hours and the ratio of evening to morning 
energy intake ≤1.8) had lower systolic BP (116.2 vs. 120.6 mm Hg, p for T>test=0.001); 
diastolic BP (72.7 vs. 75.3 mm Hg, p for T>test=0.004); BMI (27.6 vs. 28.9 kg/m
2
, p for T>
test=0.02); total energy intake (p for T>test<0.0001); dietary energy density (p for T>
test=0.004); alcohol intake (p for T>test<0.0001); and higher nutrient density (p for T>
test<0.0001); food weight (p for T>test <0.0001); and fruit intake (p for T>test<0.0001) 
compared to those who ate fewer eating occasions/24>hours and consumed most of their food 
later in the day (<4 eating occasions/24>hours and the ratio of evening to morning energy 
intake >1.8).  
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Table  3.1. Baseline characteristics of UK and USA INTERMAP participants, n=2385 
1
 
 UK USA  
Variable Men Women UK all Men Women USA all UK and USA 
n 235 209 444 997 944 1941 2385 
Age (y) 49.3 (5.7) 48.3 (5.5) 48.8 (5.6) 48.9 (5.3) 49.0 (5.4) 49.0 (5.4) 48.9 (5.4) 
Education (y) 13.4 (3.1) 12.3 (2.9) 12.9 (3.0) 15.0 (3.1) 14.6 (2.9) 15.0 (3.0) 14.6 (3.1) 
Engagement in moderate and heavy physical activity (h/24 h) 2.4 (2.7) 2.0 (2.0) 2.2 (2.4) 3.6 (3.3) 3.0 (3.0) 3.3 (3.2) 3.1 (3.1) 
Weight (kg) 83.6 (12.6) 70.2 (14.0) 77.3 (14.9) 88.6 (17.1) 74.1 (17.9) 81.5 (18.9) 80.7 (18.3) 
Height (m) 1.8 (0.1) 1.6 (0.1) 1.7 (0.1) 1.8 (0.1) 1.6 (0.1) 1.7 (0.1) 1.7 (0.1) 
Systolic BP (mm Hg) 123.8 (14.1) 116.2 (13.8) 120.2 (14.4) 120.2 (12.4) 116.5 (14.6) 118.4 (13.6) 118.7 (13.8) 
Diastolic BP (mm Hg) 80.8 (9.2) 73.3 (9.4) 77.3 (10.0) 75.6 (9.5) 71.0 (9.2) 73.3 (9.6) 74.1 (9.8) 
Body mass index (kg/m
2
) 27.4 (3.8) 26.8 (5.1) 27.1 (4.4) 28.8 (4.9) 28.3 (6.5) 28.6 (5.7) 28.3 (5.5) 
Total energy intake (kcal/24 h) 2603 (546) 1899 (382) 2271 (591) 2714 (640) 1978 (422) 2356 (658) 2340 (647) 
Eating occasions per 24 h  5.3 (1.5) 5.6 (1.3) 5.4 (1.4) 4.5 (1.2) 4.8 (1.2) 4.6 (1.2) 4.8 (1.3) 
Dietary energy density         
Food only (kcal/g) 1.9 (0.3) 1.8 (0.4) 1.8 (0.4) 1.9 (0.4) 1.8 (0.4) 1.8 (0.4) 1.8 (0.4) 
Food and beverages (kcal/g) 0.8 (0.2) 0.7 (0.2) 0.8 (0.2) 0.7 (0.2) 0.7 (0.2) 0.9 (0.2) 0.9 (0.2) 
Nutrient density (Nutrient Rich Food 9.3 index score) 
2
 27.1 (9.2) 30.8 (11.1) 28.8 (10.3) 29.5 (13.4) 33.4 (15.9) 31.4 (14.8) 30.9 (14.1) 
Nutrients to encourage score  41.1 (8.2) 44.8 (9.9) 42.9 (9.2) 43.5 (12.8) 47.6 (15.1) 45.5 (14.1) 45.0 (13.4) 
Percent protein 7.9 (1.7) 8.2 (1.8) 8.0 (1.7) 7.9 (1.9) 7.8 (1.8) 7.9 (1.8) 7.9 (1.8) 
Percent dietary fibre 4.7 (1.3) 4.7 (1.3) 4.7 (1.3) 3.4 (1.3) 3.7 (1.3) 3.5 (1.3) 3.8 (1.4) 
Percent vitamin A 4.7 (2.8) 5.2 (2.8) 4.9 (2.8) 6.9 (5.5) 8.8 (7.4) 7.8 (6.6) 7.3 (6.1) 
Percent vitamin E 2.3 (0.8) 2.2 (0.8) 2.2 (0.8) 2.2 (0.9) 2.3 (0.9) 2.2 (0.9) 2.2 (0.9) 
Percent vitamin C 6.1 (3.8) 7.9 (4.9) 6.9 (4.4) 8.1 (5.6) 9.2 (6.1) 8.7 (5.9) 8.3 (5.7) 
Percent calcium 4.1 (1.0) 4.7 (1.2) 4.4 (1.1) 3.4 (1.3) 3.8 (1.4) 3.6 (1.4) 3.8 (1.4) 
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Percent magnesium 3.6 (0.7) 3.8 (0.8) 3.7 (0.8) 3.6 (0.9) 3.7 (1.0) 3.7 (1.0) 3.7 (0.9) 
Percent iron 3.3 (0.7) 3.4 (0.8) 3.4 (0.8) 4.2 (1.6) 4.3 (1.4) 4.3 (1.5) 4.1 (1.4) 
Percent potassium 4.3 (0.8) 4.7 (0.9) 4.5 (0.9) 3.7 (0.9) 3.9 (1.1) 3.8 (1.0) 3.9 (1.0) 
Nutrients to limit score  14.0 (2.3) 14.0 (2.2) 14.0 (2.2) 14.0 (2.4) 14.2 (2.3) 14.1 (2.4) 14.1 (2.3) 
Percent saturated fat 6.8 (1.8) 6.9 (1.8) 6.8 (1.8) 6.1 (1.5) 6.0 (1.6) 6.1 (1.6) 6.2 (1.6) 
Percent added sugar  0.7 (1.0) 0.4 (0.9) 0.6 (1.0) 1.0 (0.9) 1.2 (1.0) 1.1 (1.0) 1.0 (1.0) 
Percent sodium 6.6 (1.4) 6.7 (1.5) 6.6 (1.4) 6.8 (1.6) 7.0 (1.6) 6.9 (1.6) 6.8 (1.6) 
Morning proportion of energy 
3
  0.2 (0.1) 0.2 (0.1) 0.2 (0.1) 0.2 (0.1) 0.2 (0.1) 0.2 (0.1) 0.2 (0.1) 
Evening proportion of energy 
4
  0.6 (0.1) 0.5 (0.1) 0.6 (0.1) 0.6 (0.1) 0.5 (0.1) 0.6 (0.1) 0.5 (0.1) 
Ratio of evening to morning energy intake 
5
 3.2 (2.1) 2.8 (2.2) 3.0 (2.2) 3.5 (1.8) 3.4 (1.6) 3.5 (1.9) 3.4 (1.8) 
Total carbohydrate (%kcal) 43.5 (6.5) 45.0 (6.4) 44.2 (6.5) 48.4 (8.0) 50.5 (7.7) 49.4 (7.9) 48.5 (7.9) 
Total sugar (%kcal) 19.2 (5.4) 21.5 (6.1) 20.3 (5.9) 26.1 (8.3) 27.4 (7.5) 26.7 (7.9) 25.5 (8.0) 
Fructose (%kcal) 3.0 (1.7) 3.6 (1.8) 3.3 (1.8) 5.1 (2.9) 4.9 (2.6) 5.0 (2.8) 4.7 (2.7) 
Galactose (%kcal) 0.1 (0.1) 0.1 (0.1) 0.1 (1.8) 0.03 (0.1) 0.1 (0.1) 0.04 (0.1) 0.04 (0.1) 
Glucose (%kcal) 3.1 (1.5) 3.7 (1.5) 3.4 (1.6) 5.4 (2.7) 5.3 (2.4) 5.4 (2.6) 5.0 (2.5) 
Lactose (%kcal) 2.7 (1.3) 3.5 (1.8) 3.1 (1.6) 2.1 (1.7) 2.4 (1.8) 2.3 (1.8) 2.4 (1.8) 
Maltose (%kcal) 1.2 (1.5) 0.6 (0.7) 0.9 (1.2) 0.6 (0.4) 0.7 (0.5) 0.6 (0.4) 0.7 (0.7) 
Sucrose (%kcal) 9.2 (4.1) 10.0 (4.1) 9.6 (4.1) 10.3 (5.2) 11.3 (4.8) 10.8 (5.1) 10.6 (4.9) 
Glycaemic index 63.0 (4.0) 60.9 (3.3) 62.0 (3.8) 64.3 (8.5) 66.5 (10.3) 65.4 (9.5) 64.7 (8.8) 
Glycaemic load 203.8 (50.6) 148.4 (33.2) 177.7 (51.4) 208.5 (64.7) 163.2 (47.9) 186.5 (61.5) 184.8 (59.8) 
Total fibre (g/1000 kcal) 11.8 (3.3) 11.9 (3.3) 11.8 (3.3) 8.5 (3.1) 9.2 (3.3) 8.8 (3.3) 9.4 (3.5) 
Insoluble fibre (g/1000 kcal) 
6
 -- -- -- 5.1 (2.2) 5.5 (2.2) 5.3 (2.2) -- 
Soluble fibre (g/1000 kcal)  
6
 -- -- -- 2.7 (1.0) 3.0 (1.1) 2.8 (1.0) -- 
Total protein (%kcal) 15.3(2.9) 15.8 (2.9) 15.5 (2.9) 15.2 (3.0) 15.3 (3.0) 15.3 (3.0) 15.3 (3.0) 
Total fat (%kcal) 33.4 (6.2) 33.1 (6.2) 33.3 6.2) 33.4 (6.5) 32.9 (6.9) 33.2 (6.7) 33.2 (6.6) 
Cholesterol (mg/1000 kcal) 120.5 (46.8) 120.5 (49.1) 120.5 (47.9) 131.7 (56.9) 128.8 (56.3) 130.3 (56.6) 128.5 (55.2) 
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Dietary alcohol (g/24 h) 21.0 (23.0) 8.8 (11.6) 15.3 (19.5) 10.9 (17.5) 3.4 (7.4) 7.2 (14.0) 8.7 (15.5) 
24-hour urinary excretion data (mmol/24 h)        
Sodium  160.5 (50.8) 128.9 (39.8) 145.6 (48.5) 183.4 (62.8) 144.1 (48.5) 164.3 (59.6) 160.8 (58.1) 
Potassium 75.7 (21.6) 61.2 (15.1) 68.9 (20.1) 64.9 (21.3) 51.3 (18.0) 58.3 (20.9) 60.3 (21.1) 
Magnesium  4.1 (1.2) 3.4 (0.8) 3.7 (1.1) 4.8 (1.6) 3.8 (1.4) 4.3 (1.6) 4.2 (1.5) 
Calcium 4.3 (2.1) 3.7 (1.7) 4.1 (1.9) 4.6 (2.3) 3.9 (2.0) 4.3 (2.2) 4.2 (2.1) 
Cigarette smoker (%) 37 (15.7) 37 (17.7) 74 (16.7) 193 (19.4) 139 (14.7) 332 (17.1) 406 (17.0) 
Adhering to a special diet (%) 10 (4.3) 16 (7.7) 26 (5.9) 37 (3.7) 79 (8.4) 116 (6.0) 142 (6.0) 
Dietary supplement use (%) 71 (30.2) 108 (51.7) 179 (40.3) 468 (47) 533 (56.5) 1001 (51.6) 1180 (49.5) 
Family history of hypertension in any 1
st
 degree relative (%) 106 (45.1) 109 (52.2) 215 (48.4) 613 (61.5) 690 (73.1) 1303 (67.1) 1518 (63.7) 
History of CVD or DM (%) 24 (10.2) 16 (7.7) 40 (9.0) 148 (14.8) 143 (15.2) 291 (15.0) 331 (13.9) 
Use of antihypertensive and/or CVD treatment (%) 37 (15.7) 26 (12.4) 63 (14.2) 217 (21.8) 207 (21.9) 424 (21.8) 487 (20.4) 
Employed (%) 208 (88.5) 180 (84.7) 388 (87.4) 907 (90.9) 795 (84.2) 1702 (87.7) 2090 (87.6) 
Married (%) 188 (80) 159 (76.1) 347 (78.2) 763 (76.5) 584 (61.9) 1347 (69.4) 1694 (71.0) 
1 
Presented as mean (SD) or percent (%).                                                                                                                                                                                                                                                                                                                        
2 
Nutrient Rich Food 9.3 index score was calculated as the sum of the daily values of nutrients to encourage, subtracting the daily values of nutrients to limit based on 100 kcal:                                                                       
Example;  Nutrient Rich Food 9.3 index score = [(protein g÷50 g + fibre g÷25 g + vitamin A IU÷5000 IU + vitamin C mg÷60 mg + vitamin E IU÷30 IU + calcium mg÷1000 mg + iron mg÷18 mg + magnesium mg÷400 mg + 
potassium mg÷3500 mg) – (saturated fat g÷20 g + added sugars g÷50 g + sodium mg÷2400 mg)] × 100.                                                                                                                                                                                                                                                    
3 
Morning proportion of energy= (average energy intake from 6:00 am to 11:55 am) ÷ (24 h energy intake).                                                                                                                                                                                                     
4 
Evening proportion of energy= (average energy intake from 6:00 pm to 11:55 pm) ÷ (24 h energy intake).                                                                                                                                                                                                    
5 
Ratio of evening to morning energy intake = (evening proportion of energy) ÷ (morning proportion of energy).                                                                                                                                                                                                                                                                       
6 
Data for insoluble and soluble fibre intake are available for the USA samples only. 
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Table  3.2. Ratio of within-to-between person variance for BP, BMI, eating occasions, dietary energy density, 
nutrient density, and the ratio of evening to morning energy intake 
 Ratio of within to between 
variance 
1
 
Mean of 4 measurements: 
observed regression 
coefficient as a % of true 
coefficient 
2
 
UK   
Systolic BP (mm Hg) 0.2 96.2 
Diastolic BP (mm Hg) 0.2 95.7 
Body mass index (kg/m
2
) 0.004 99.9 
Eating occasions per 24 h  0.6 86.0 
Dietary energy density  0.9 75.2 
Nutrient density (Nutrient Rich Food 9.3 index score) 0.2 95.7 
Ratio of evening to morning energy intake 0.5 88.2 
USA   
Systolic BP (mm Hg) 0.2 95.5 
Diastolic BP (mm Hg) 0.2 95.1 
Body mass index (kg/m
2
) 0.003 99.9 
Eating occasions per 24 h  0.7 82.8 
Dietary energy density  0.8 76.1 
Nutrient density (Nutrient Rich Food 9.3 index score) 0.2 95.1 
Ratio of evening to morning energy intake 0.6 87.0 
1 
Ratio of within: between person variance calculated by ANOVA.                                                                                                                                           
2 
1 ÷ [1+ (ratio ÷ 4)] x100. 
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Table  3.3. Partial Pearson correlation coefficients between dietary, lifestyle variables and outcome measures 
of UK and USA INTERMAP participants, n=2385 
1,2
 
 
Systolic BP         
(mm Hg) 
Diastolic BP       
(mm Hg) 
Body mass index  
(kg/m
2
) 
Education (y) -0.11 -0.07 -0.10 
Engagement in moderate and heavy physical activity (h/24 h) -0.03 -0.04 -0.05 
Current smokers (%) 0.02 -0.03 -0.06 
Adhering to a special diet (%) 0.01 -0.01 0.05 
Dietary supplement use (%) -0.04 -0.04 -0.07 
History of CVD or DM (%) 0.09 -0.04 0.11 
Total energy intake (kcal/24 h) 0.09 0.05 0.20 
Eating occasions per 24 h -0.06 -0.05 -0.08 
Dietary energy density-food only (kcal/g) 0.11 0.06 0.14 
Dietary energy density-food and beverages
 
(kcal/g) 0.04 0.05 0.07 
Nutrient density (Nutrient Rich Food 9.3 index score) -0.12 -0.07 -0.16 
Ratio of evening to morning energy intake 0.03 0.04 0.03 
Total carbohydrate (%kcal) -0.13 -0.07 -0.15 
Total fibre (g/1000 kcal) -0.14 -0.10 -0.19 
Total protein (%kcal) 0.001 -0.02 0.08 
Animal protein (%kcal) 0.07 0.03 0.16 
Vegetable protein (%kcal) -0.13 -0.11 -0.15 
Total fat (%kcal) 0.10 0.06 0.19 
Total SFA (%kcal) 0.08 0.06 0.15 
Total MFA (%kcal) 0.12 0.06 0.20 
Total PFA (%kcal) 0.02 0.00 0.08 
Cholesterol (mg/1000 kcal) 0.11 0.05 0.16 
Dietary alcohol (g/24 h) 0.08 0.06 -0.05 
24-hour urinary excretion data (mmol/24 h)    
Sodium  0.12 0.07 0.33 
Potassium -0.04 -0.04 0.10 
Magnesium  -0.02 -0.05 0.05 
Calcium 0.10 0.06 0.12 
1
 Adjusted for age, gender, and population sample. 
2
 Correlation coefficients are statistically significant, except those ranging from -0.03 to 0.03.
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Table  3.4. Partial Pearson correlation coefficients for dietary macro and micro nutrients of UK and USA INTERMAP participants, n=2385 
1,2
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Total carbohydrate (%kcal)  0.33 -0.33 -0.45 0.30 -0.75 -0.59 -0.71 -0.42 -0.49 -0.33 -0.17 0.06 -0.02 -0.13 
Total fibre (g/1000 kcal) 0.33  0.15 -0.23 0.77 -0.40 -0.48 -0.39 -0.08 -0.34 -0.06 -0.04 0.34 0.22 -0.04 
Total protein (%kcal) -0.33 0.15  0.88 0.15 -0.02 -0.05 -0.01 -0.09 0.37 -0.05 0.16 0.24 0.13 0.12 
Animal protein (%kcal) -0.45 -0.23 0.88  -0.33 0.14 0.16 0.14 -0.09 0.52 0.00 0.15 0.12 0.03 0.12 
Vegetable protein (%kcal) 0.30 0.77 0.15 -0.33  -0.31 -0.43 -0.31 0.02 -0.35 -0.14 0.02 0.21 0.19 -0.02 
Total fat (%kcal) -0.75 -0.40 -0.02 0.14 -0.31  0.81 0.93 0.60 0.41 -0.14 0.20 -0.16 -0.02 0.12 
Total SFA (%kcal) -0.59 -0.48 -0.05 0.16 -0.43 0.81  0.68 0.12 0.41 -0.11 0.14 -0.15 -0.04 0.14 
Total MFA (%kcal) -0.71 -0.39 -0.01 0.14 -0.31 0.93 0.68  0.47 0.39 -0.12 0.18 -0.15 -0.02 0.09 
Total PFA (%kcal) -0.42 -0.08 -0.09 -0.09 0.02 0.60 0.12 0.47  0.06 -0.11 0.12 -0.08 0.03 0.02 
Cholesterol (mg/1000 kcal) -0.49 -0.34 0.37 0.52 -0.35 0.41 0.41 0.39 0.06  0.02 0.16 -0.11 -0.07 0.11 
Dietary alcohol (g/24 h) -0.33 -0.06 -0.05 0.01 -0.14 -0.14 -0.11 -0.12 -0.11 0.02  -0.05 0.02 -0.01 0.01 
Urinary sodium (mmol/24 h) -0.17 -0.04 0.16 0.15 0.02 0.20 0.14 0.18 0.12 0.16 -0.05  0.35 0.30 0.31 
Urinary potassium (mmol/24 h) 0.06 0.34 0.24 0.12 0.21 -0.16 -0.15 -0.15 -0.08 -0.11 0.02 0.35  0.46 0.24 
Urinary magnesium (mmol/24 h) -0.02 0.22 0.13 0.03 0.19 -0.02 -0.04 -0.02 0.03 -0.07 -0.01 0.30 0.46  0.42 
Urinary calcium (mmol/24 h) -0.13 -0.04 0.12 0.12 -0.02 0.12 0.14 0.09 0.02 0.11 0.01 0.31 0.24 0.42  
1 
Adjusted for age, gender, and population sample.                                                                                                                                                                                                                                                                                                                                      
2
 Correlation coefficients are statistically significant, except those ranging from -0.03 to 0.03.
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Table  3.5. Variables by category of eating occasions per day for UK and USA INTERMAP participants, 
n=2385
1,2
 
 Number of eating occasions/24 h  
Variable <4  ≥4 to <5 ≥5 to <6 ≥6    
 Mean SE Mean SE Mean SE Mean SE P for 
trend 
n 577  795  601  412   
Men (%) 64  52  45  43   
Education (y) 
3
 14.2 0.1 14.6 0.1 14.7 0.1 14.8 0.1 0.002 
Engagement in moderate and 
heavy physical activity (h/24 h) 
3
 
3.1 0.1 3.0 0.1 3.2 0.1 3.0 0.1 0.59 
Systolic BP (mm Hg) 
3
 121.4 0.6 118.3 0.5 118.8 0.5 116.4 0.7 2.83×10
-07
 
Diastolic BP (mm Hg) 
3
 75.5 0.4 73.8 0.3 74.3 0.4 73.0 0.5 0.0003 
Body mass index (kg/m
2
) 
3
 29.0 0.2 28.4 0.2 28.1 0.2 27.3 0.3 0.0001 
Total energy intake (kcal/24 h) 2520.6 25.9 2398.5 21.2 2286.8 18.4 2126.7 22.3 1.07×10
-17
 
Food energy (kcal/24 h) 2083.7 22.8 1986.3 18.7 1910.7 16.2 1730.2 19.6 1.91×10
-31
 
Beverage energy (kcal/24 h) 436.9 10.3 412.2 8.5 376.1 9.8 396.5 12.0 0.0003 
Food weight (g/24 h) 961.2 13.4 1084.3 11.0 1146.0 12.7 1227.5 15.6 1.76×10
-37
 
Beverage weight (g/24 h) 
4
 1606.6 31.2 1566.7 25.7 1573.9 29.7 1684.7 36.3 0.05 
Dietary energy density           
Food only (kcal/g) 2.2 0.01 1.8 0.01 1.7 0.02 1.4 0.02 0.0004 
Food and beverages
 
(kcal/g) 1.0 0.01 0.9 0.01 0.8 0.01 0.7 0.01 0.08 
Nutrient density                               
(Nutrient Rich Food 9.3 index 
score)
3
 
26.8 0.6 30.1 0.5 32.4 0.5 35.1 0.7 2.79×10
-20
 
Morning proportion of energy 
5
 0.2 0.01 0.2 0.01 0.2 0.01 0.2 0.01 5.86×10
-05
 
Evening proportion of energy 
6
 0.7 0.01 0.5 0.01 0.4 0.01 0.4 0.01 0.06 
Ratio of evening to morning energy 
intake 
7
 
4.5 0.9 3.0 0.7 2.1 0.8 2.4 0.9 0.09 
Food Groups (g/1000 kcal)          
Whole fat dairy  27.3 1.7 26.3 1.4 27.3 1.6 21.8 2.0 0.13 
Low or medium-fat dairy 66.6 3.6 83.0 3.0 95.1 3.5 110.4 4.2 5.14×10
-14
 
Meat 32.2 0.9 26.8 0.8 26.1 0.9 20.9 1.1 1.87×10
-13
 
Fish  7.4 0.5 8.0 0.4 6.8 0.5 7.4 0.6 0.37 
Raw vegetables  22.8 1.2 25.1 1.0 28.6 1.2 31.6 1.4 0.02 
Cooked vegetables  41.6 1.7 45.1 1.4 50.0 1.6 56.7 2.0 0.02 
Potatoes  40.9 1.3 37.5 1.1 36.4 1.2 33.9 1.5 0.05×10
-01
 
Fruit  31.0 2.5 47.4 2.1 59.7 2.4 74.6 2.9 3.13×10
-29
 
Cakes and pies  6.5 0.5 6.1 0.4 5.4 0.5 5.3 0.6 0.32 
Nutrients           
Total carbohydrate (%kcal) 46.4 0.3 48.3 0.3 48.8 0.3 50.7 0.4 2.32×10
-16
 
Glycaemic index 65.4 0.4 65.1 0.4 65.0 0.3 63.3 0.4 0.05×10
-03
 
Glycaemic load 197.4 1.9 188.0 1.5 184.9 1.3 172.2 1.6 8.49×10
-22
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Total fibre (g/1000 kcal) 8.6 0.1 9.2 0.1 9.9 0.1 10.3 0.2 1.07×10
-16
 
Insoluble fibre (g/1000 kcal) 4.7 0.1 5.2 0.1 5.7 0.1 5.9 0.1 3.71×10
-18
 
Soluble fibre (g/1000 kcal) 2.6 0.04 2.8 0.04 3.0 0.05 3.1 0.06 2.72×10
-15
 
Total protein (%kcal) 15.5 0.1 15.4 0.1 15.2 0.1 15.0 0.1 0.06 
Animal protein (%kcal) 10.4 0.1 10.0 0.1 9.6 0.1 9.4 0.2 4.84×10
-07
 
Vegetable protein (%kcal) 4.9 0.1 5.3 0.1 5.5 0.1 5.5 0.1 1.06×10
-11
 
Total fat (%kcal) 33.7 0.3 33.4 0.2 33.5 0.3 31.9 0.3 0.0002 
Total SFA (%kcal) 11.3 0.1 11.1 0.1 11.2 0.1 10.6 0.1 0.05×10
-01
 
Total MFA (%kcal) 12.3 0.1 12.1 0.1 12.2 0.1 11.5 0.1 0.0002 
Total PFA (%kcal) 6.8 0.1 7.0 0.1 6.9 0.1 6.7 0.1 0.29 
Cholesterol (mg/1000 kcal) 139.6 2.3 130.9 1.9 123.7 2.2 114.5 2.6 6.74×10
-12
 
Dietary alcohol (g/24 h) 
3
 11.8 0.6 8.7 0.5 7.4 0.6 6.4 0.7 3.98×10
-08
 
24-hour urinary excretion data 
(mmol/24 h) 
3
 
         
Sodium  160.7 2.7 163.7 1.9 161.8 2.2 151.7 2.3 6.86×10
-04
 
Potassium  53.7 0.8 58.5 0.6 62.5 0.7 68.3 0.9 2.22×10
-32
 
Magnesium  3.9 0.1 4.1 0.1 4.3 0.1 4.6 0.1 2.87×10
-16
 
Calcium  3.9 0.1 4.1 0.1 4.5 0.1 4.5 0.1 5.14×10
-07
 
Weight status (%) 
8
  
Normal weight  147 (25%) 225 (28%) 192 (32%) 147 (36%)  
Overweight  225 (39%) 321 (41%) 229 (38%) 167 (41%)  
Obese 205 (36%) 249 (31%) 180 (30%) 98 (23%) 0.002 
Evening meal location (%) 
8
      
Restaurants or cafeterias 150 (26%) 262 (33%) 150 (25%) 66 (16%) 0.0002 
Use of antihypertensive and/or 
CVD treatment 
8
 
117 (20.3%) 173 (22%) 119 (20%) 78 (19%) 0.66 
1 
Presented as mean and SE. 
2 
Model 1 adjusted for gender, age, and population sample.                                                                                                                                                               
3 
Model 1a adjusted for variables in Model 1 plus total energy intake. 
4 
Drinking water excluded.                                                                                                                                                                                                                       
5 
Morning proportion of energy= (average energy intake from 6:00 am to 11:55 am) ÷ (24 h energy intake). 
6 
Evening proportion of energy= (average energy intake from 6:00 pm to 11:55 pm) ÷ (24 h energy intake). 
7
 Ratio of evening to morning energy intake =(evening proportion of energy) ÷ (morning proportion of energy). 
8  
Chi square. 
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Table  3.6. Estimated mean systolic and diastolic BP differences per 2SD higher intake of eating occasions in UK and USA INTERMAP participants 
1
 
 Systolic BP Diastolic BP 
 Not adjusted for BMI Adjusted for BMI Not adjusted for BMI Adjusted for BMI 
Models n Difference, 
mm Hg 
95% CI p Difference, 
mm Hg 
95% CI p Difference, 
mm Hg 
95% CI p Difference, 
mm Hg 
95% CI p 
Model 1a 2385 -3.3 -4.4, -2.2 2.43×10
-08
 -2.4 -3.5, -1.3 1.33×10
-05
 -1.5 -2.3, -0.7 0.0004 -1.0 -1.8, -0.2 0.01 
Model 2 2385 -2.9 -4.0, -1.8 6.43×10
-07
 -2.2 -3.3, -1.1 7.73×10
-05
 -1.3 -2.1, -0.5 0.002 -0.9 -1.7, -0.1 0.03 
Model 3 2385 -2.5 -3.7, -1.4 2.04×10
-05
 -1.9 -3.0, -0.8 0.08×10
-02
 -1.2 -2.1, -0.4 0.004 -0.9 -1.7, -0.1 0.03 
Model 3a 2385 -2.3 -3.4, -1.1 0.0001 -1.8 -2.9, -0.7 0.002 -1.1 -2.0, -0.3 0.09×10
-01
 -0.9 -1.7, -0.03 0.04 
Model 4 2385 -2.2 -3.4, -1.1 0.0002 -1.6 -2.7, -0.5 0.06×10
-01
 -1.1 -1.9, -0.2 0.01 -0.1 -1.5, 0.1 0.09 
Sensitivity analyses using 
model 4 
             
Censored regression 
2
 1898 -2.3 -3.7, -1.0 0.07×10
-02
 -1.4 -2.7, -0.2 0.03 -1.1 -2.0, -0.1 0.03 -0.5 -1.4, 0.4 0.27 
Excluding those with high 
variability in their diet 
2
 
1870 -2.4 -3.6, -1.2 2.28×10
-05
 -1.7 -3.0, -0.4 0.08×10
-01
 -1.3 -2.2, -0.4 0.01 -0.8 -1.7, 0.1 0.09 
Excluding those following a 
special diet 
2
 
2243 -2.4 -3.6, -1.2 6.87×10
-08
 -1.7 -2.8, -0.5 0.004 -1.2 -2.1, -0.4 0.06×10
-01
 -0.8 -1.7, 0.01 0.05 
Excluding those diagnosed 
with DM and/or CVD 
3
 
2054 -2.5 -3.7, -1.2 2.33×10
-08
 -1.9 -3.1, -0.8 0.001 -1.2 -2.1, -0.3 0.08×10
-01
 -0.9 -1.8, -0.1 0.04 
Model 1a adjusted for total energy intake, gender, age, and population sample. 
Model 2 Adjusted for variables in Model 1a plus adherence to a special diet, engagement in moderate and heavy physical activity (h/24 h), dietary supplement use, smoking, years of education (years completed), DM or CVD 
diagnosis, and family history of high BP. 
Model 3 adjusted for variables in model 2 plus 24-hour urinary excretion of sodium and potassium (mmol/24-hours). 
Model 3a adjusted for variables in model 3 plus total fibre intake (g/1000 kcal). 
Model 4 adjusted for variables in model 3 plus alcohol intake (g/24 h).                                                                                                                                                                                                                                                                                              
1 
2SD of eating occasions=2.6.                                                                                                                                                                                                                                                                                                                                                                                             
2 
2SD of eating occasions=2.5.                                                                                                                                                                                                                                                                                                                                                              
3 
Not adjusted for DM or CVD diagnosis. 
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Table  3.7. Estimated mean BMI difference per 2SD higher intake of eating occasions in UK and USA 
INTERMAP participants 
1
 
   BMI  
Models n Difference, kg/m
2
 95% CI p 
Model 1a 2385 -1.1 -1.5, -0.6 5.73×10
-06
 
Model 2  2385 -1.1 -1.6, -0.6 3.28×10
-06
 
Model 2a 2385 -0.8 -1.3, -0.4 0.0004 
Model 3  2385 -1.1 -1.6, -0.7 2.71×10
-06
 
Sensitivity analyses using model 3     
Excluding those with high variability in their diet 
2
 1870 -1.3 -1.8, -0.8 5.87×10
-07
 
Excluding those following a special diet 
2
 2243 -1.1 -1.6, -0.7 5.03×10
-06
 
Excluding those diagnosed with DM and/or CVD  2054 -0.8 -1.3, -0.3 0.001 
Model 1a adjusted for total energy intake, gender, age, and population sample.  
Model 2 adjusted for variables in Model 1a plus adherence to a special diet, engagement in moderate and heavy physical activity        
(h/24 h), dietary supplement use, smoking, and years of education (years completed).                                                                                           
Model 2a adjusted for variables in Model 2 plus total fibre intake (g/1000 kcal).  
Model 3 adjusted for variables in Model 2 plus alcohol intake (g/24 h).                                                                                                                              
1
 2SD of eating occasions=2.6.                                                                                                                                                                                                                 
2 
2SD of eating occasions=2.5. 
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Table  3.8. Estimated mean systolic and diastolic BP differences per 2SD higher dietary energy density in UK and USA INTERMAP participants 
1
 
 Systolic BP Diastolic BP 
 Not adjusted for BMI Adjusted for BMI Not adjusted for BMI Adjusted for BMI 
Models n Difference, 
mm Hg 
95% CI p Difference, 
mm Hg 
95% CI p Difference, 
mm Hg 
95% CI p Difference, 
mm Hg 
95% CI p 
Model 1 2385 4.1 2.9, 5.2 1.52×10
-12
 2.6 1.5, 3.6 2.92×10
-06
 1.8 1.1, 2.6 5.46×10
-06
 1.1 0.3, 1.9 0.07×10
-01
 
Model 2 2385 3.6 2.5, 4.7 6.95×10
-10
 2.4 1.3, 3.5 2.56×10
-05
 1.8 1.0, 2.6 9.45×10
-06
 1.2 0.4, 2.0 0.004 
Model 3 2385 3.1 1.9, 4.2 2.58×10
-07
 2.0 0.9, 3.1 0.05×10
-02
 1.8 0.9, 2.6 3.39×10
-05
 1.2 0.4, 2.0 0.05×10
-01
 
Model 4 2385 3.2 2.1, 4.4 4.09×10
-08
 2.2 1.1, 3.3 0.0001 1.9 1.0, 2.7 1.04×10
-05
 1.3 0.5, 2.1 0.002 
Sensitivity analyses using 
model 4 
             
Censored regression  1898 3.3 2.0, 4.6 1.38×10
-06
 1.9 0.7, 3.2 0.003 1.9 1.0, 2.9 5.56×10
-05
 1.1 0.2, 2.0 0.02 
Excluding those with high 
variability in their diet  
1870 3.2 2.0, 4.3 0.0001 1.5 0.2, 2.7 0.02 1.7 0.4, 2.3 0.004 0.8 -0.1, 1.7 0.09 
Excluding those following a 
special diet 
 
 
2243 3.2 2.0, 4.3 1.13×10
-06
 2.1 0.9, 3.2 0.0004 1.8 1.0, 2.7 8.53×10
-05
 1.3 0.4, 2.1 0.004 
Excluding those diagnosed 
with DM and/or CVD 
2
 
2054 3.2 2.0, 4.4 2.62×10
-07
 2.1 0.9, 3.3 0.05×10
-02
 1.7 0.8, 2.5 0.0002 1.0 0.2, 1.9 0.02 
Model 1 adjusted for gender, age, and population sample.  
Model 2 Adjusted for variables in Model 1 plus adherence to a special diet, engagement in moderate and heavy physical activity (h/24 h), dietary supplement use, smoking, years of education (years completed), DM or 
CVD diagnosis, and family history of high BP. 
Model 3 adjusted for variables in model 2 plus 24-hour urinary excretion of sodium and potassium (mmol/24-hours).                                                                                                                                                                                           
Model 4 adjusted for variables in Model 3 plus alcohol intake (g/24 h).                                                                                                                                                                                                                                                                                                      
1
 2SD of dietary energy density (kcal/g)=0.8.                                                                                                                                                                                                                                                                                                                          
2 
Not adjusted for DM or CVD diagnosis. 
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Table  3.9. Estimated mean BMI difference per 2SD higher dietary energy density in UK and USA INTERMAP 
participants 
1
 
   BMI  
Models n Difference, kg/m
2
 95% CI p 
Model 1 2385 1.9 1.5, 2.4 5.82×10
-16
 
Model 2 2385 1.8 1.4, 2.3 9.73×10
-15
 
Model 3 2385 1.9 1.4, 2.3 1.00×10
-14
 
Sensitivity analyses using model 3     
Excluding those with high variability in their diet  1870 1.9 1.4, 2.4 3.03×10
-12
 
Excluding those following a special diet  2243 1.8 1.3, 2.3 9.41×10
-13
 
Excluding those diagnosed with DM and/or CVD  2054 1.7 1.3, 2.2 2.33×10
-12
 
Model 1 adjusted for gender, age, and population sample.  
Model 2 adjusted for variables in Model 1 plus adherence to a special diet, engagement in moderate and heavy physical activity           
(h/24 h), dietary supplement use, smoking, and years of education (years completed). 
Model 3 adjusted for variables in Model 2 plus alcohol intake (g/24 h).                                                                                                                    
1
 2SD of dietary energy density (kcal/g)=0.8. 
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Table  3.10. Variables by quintiles of nutrient density (Nutrient Rich Food 9.3 index score) in UK and USA 
INTERMAP participants, n=2385 
1,2
 
  Nutrient Rich Food 9.3 index score  
 Quintile 1 Quintile 2 Quintile 3 Quintile 4 Quintile 5  
Variable Mean SE Mean SE Mean SE Mean SE Mean SE P for trend 
n 477 477 477 477 477  
Nutrient Rich Food 9.3 
index score (median) 
15.0 22.5 28.5 36.0 52.6  
Education (y) 
3
 13.7 0.1 14.1 0.1 14.7 0.1 15.1 0.1 15.2 0.1 5.32×10
-21
 
Engagement in 
moderate and heavy 
physical activity      
(h/24 h) 
3
 
3.3 0.1 3.1 0.1 3.0 0.1 2.9 0.1 2.9 0.1 0.19 
Systolic BP (mm Hg) 
3
 121.0 0.6 120.0 0.6 117.4 0.6 118.7 0.6 117.0 0.6 8.56×10
-06
 
Diastolic BP (mm Hg) 
3
 74.8 0.4 75.1 0.4 73.4 0.4 74.3 0.4 73.2 0.4 0.05×10
-01
 
BMI (kg/m
2
) 
3
 28.7 0.2 28.8 0.2 28.6 0.2 28.0 0.2 27.2 0.2 1.22×10
-05
 
Total energy         
(kcal/24 h) 
2507.0 24.0 2371.1 23.5 2350.2 23.6 2206.2 23.6 2178.7 24.0 3.76×10
-25
 
Food energy       
(kcal/24 h) 
2014.2 21.7 1956.7 21.2 1970.9 21.3 1837.7 21.3 1803.3 21.7 8.05×10
-14
 
Beverage energy 
(kcal/24 h) 
492.8 11.0 414.4 10.8 379.2 10.8 368.5 10.9 375.4 11.0 2.32×10
-17
 
Food weight                         
(g/24 h) 
952.5 14.3 1014.1 14.0 1110.9 14.0 1131.8 14.0 1269.7 14.3 5.44×10
-56
 
Beverage weight    
(g/24 h)
 4
 
1736.4 33.8 1615.9 33.1 1540.7 33.2 1531.8 33.3 1567.5 33.8 7.70×10
-05
 
Dietary energy density             
Food only (kcal/g) 2.1 0.01 2.0 0.01 1.8 0.01 1.7 0.01 1.5 0.01 4.65×10
-288
 
Food and 
beverages
 
(kcal/g) 
1.0 0.01 1.0 0.01 1.0 0.01 0.9 0.01 0.8 0.01 2.74×10
-39
 
Food Groups        
(g/1000 kcal) 
           
Whole fat dairy  34.6 1.8 28.4 1.8 23.9 1.8 22.8 1.8 20.2 1.8 2.76×10
-07
 
Low or medium-fat 
dairy 
53.1 3.8 68.6 3.8 85.4 3.8 106.0 3.8 121.9 3.8 2.09×10
-40
 
Meat  29.9 1.0 29.5 1.0 28.5 1.0 25.1 1.0 21.4 1.0 5.03×10
-10
 
Fish  5.3 0.6 6.7 0.6 6.6 0.6 8.2 0.6 10.5 0.6 1.33×10
-09
 
Raw vegetables  16.5 1.2 18.7 1.2 26.3 1.2 33.9 1.2 44.9 1.2 6.57×10
-68
 
Cooked vegetables 27.8 1.7 38.4 1.6 46.8 1.7 56.5 1.7 76.8 1.7 2.46×10 
-92
 
Fruit  17.7 2.5 29.6 2.4 46.0 2.4 64.9 2.4 98.9 2.5 1.44×10
-121
 
Cakes and pies  7.3 0.6 5.8 0.6 6.3 0.6 5.2 0.6 4.3 0.6 0.004 
Nutrients            
Total carbohydrate 
(%kcal) 
46.3 0.3 46.3 0.3 47.5 0.3 49.5 0.3 52.4 0.3 3.97×10
-46
 
Total fibre           
(g/1000 kcal) 
6.6 0.1 8.0 0.1 9.0 0.1 10.5 0.1 13.0 0.1 1.50×10
-281
 
Total protein (%kcal) 13.8 0.1 14.9 0.1 15.5 0.1 16.0 0.1 16.4 0.1 2.12×10
-48
 
Animal protein 
(%kcal) 
9.4 0.1 9.9 0.1 10.1 0.1 10.2 0.1 9.9 0.1 0.001 
Vegetable protein 
(%kcal) 
4.3 0.1 4.8 0.1 5.3 0.1 5.7 0.1 6.4 0.1 4.12×10
-137
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Total fat (%kcal) 36.7 0.3 35.6 0.3 34.2 0.3 31.4 0.3 28.3 0.3 1.65×10
-111
 
Total SFA (%kcal) 12.9 0.1 12.1 0.1 11.3 0.1 10.2 0.1 8.8 0.1 7.69×10
-135
 
Total MFA (%kcal) 13.4 0.1 13.0 0.1 12.4 0.1 11.3 0.1 10.1 0.1 2.80×10
-98
 
Total PFA (%kcal) 7.1 0.1 7.2 0.1 7.1 0.1 6.7 0.1 6.3 0.1 6.48×10
-11
 
Cholesterol         
(mg/1000 kcal) 
141.0 2.4 137.3 2.4 131.3 2.4 121.4 2.4 110.4 2.5 2.96×10
-20
 
Dietary alcohol        
(g/24 h) 
3
 
8.9 0.7 9.1 0.7 8.5 0.7 8.5 0.7 8.6 0.7 0.96 
24-hour urinary 
excretion data 
(mmol/24 h) 
3
 
           
Sodium 159.9 2.5 164.4 2.5 164.6 2.5 156.2 2.5 154.1 2.5 0.07×10
-01
 
Potassium  72.0 0.8 64.2 0.8 60.8 0.8 54.0 0.8 49.6 0.8 1.73×10
-87
 
Magnesium  3.8 0.1 4.0 0.1 4.2 0.1 4.2 0.1 4.6 0.1 5.05×10
-16
 
Calcium  4.2 0.1 4.2 0.1 4.3 0.1 4.2 0.1 4.1 0.1 5.51×10
-01
 
Weight status (%) 
5
       
Normal weight  122 (26%) 106 (22%) 141(30%) 151(31%) 191(40%)  
Overweight  176 (37%) 201(42%) 182(38%) 198(42%) 185(39%)  
Obese 179 (37%) 170 (36%) 154(32%) 128(27%) 101(21%) <0.0001 
1 
Presented as mean and SE. 
2 
Model 1 adjusted for gender, age, and population sample. 
3 
Model 1a adjusted for variables in Model 1 plus total energy intake. 
4 
Drinking water excluded.                                                                                                                                                                                                                                                           
5 
Chi square. 
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Table  3.11. Estimated mean systolic and diastolic BP differences per 2SD higher nutrient density (Nutrient Rich Food 9.3 index score) in UK and USA 
INTERMAP participants 
1
 
 Systolic BP Diastolic BP  
Not adjusted for BMI Adjusted for BMI  Not adjusted for BMI Adjusted for BMI 
Models n Difference, 
mm Hg 
95% CI p Difference, 
mm Hg 
95% CI p Difference, 
mm Hg 
95% CI p Difference, 
mm Hg 
95% CI p 
Model 1a 2385 -2.9 -4.0, -1.7 7.69×10
-10
 -2.3 -3.4, -1.3 0.001 -1.4 -2.2, -0.6 0.05×10
-02
 -0.8 -1.6, -0.01 0.05 
Model 2 2385 -2.4 -3.6, -1.3 7.34×10
-07
 -2.0 -3.1, -0.8 0.09×10
-01
 -1.3 -2.1, -0.5 0.002 -0.8 -1.6, 0.04 0.06 
Model 3 2385 -1.6 -2.8, -0.3 0.07×10
-02
 -1.4 -2.5, -0.2 0.02 -1.2 -2.1, -0.3 0.08×10
-01
 -0.8 -1.6, 0.1 0.08 
Model 4 2385 -1.5 -2.8, -0.3 0.08×10
-02
 -1.3 -2.5, -0.1 0.03 -1.2 -2.0, -0.3 0.09×10
-01
 -0.7 -1.7, 0.1 0.09 
Sensitivity analyses 
using model 4 
             
Censored regression 
2
 1898 -2.4 -3.8, -1.0 0.001 -1.4 -2.7, -0.1 0.04 -1.5 -2.5, -0.5 0.003 -0.9 -1.8, 0.1 0.07 
Excluding those with 
high variability in 
their diet 
2
 
1870 -2.1 -3.3, -0.8 0.001 -1.5 -2.9, -0.2 0.02 -1.3 -2.4, -0.2 0.09×10
-01
 -0.9 -2.0, 0.2 0.06 
Excluding those 
following a special 
diet 
3
 
2243 -2.1 -3.3, -0.8 0.001 -1.3 -2.5, -0.1 0.04 -1.2 -2.1, -0.3 0.09×10
-01
 -0.8 -1.7, 0.1 0.08 
Excluding those 
diagnosed with DM 
and/or CVD 
4,5
 
2054 -2.1 -3.4, -0.9 0.001 -1.4 -2.5, -0.3 0.03 -1.2 -2.1, -0.3 0.01 -0.7 -1.6, 0.1 0.10 
Model 1a adjusted for total energy intake, gender, age, and population sample. 
Model 2 Adjusted for variables in Model 1a plus adherence to a special diet, engagement in moderate and heavy physical activity (h/24 h), dietary supplement use, smoking, years of education (years 
completed), DM or CVD diagnosis, and family history of high BP. 
Model 3 adjusted for variables in model 2 plus 24-hour urinary excretion of sodium and potassium (mmol/24-hours).                                                                                                                                                                         
Model 4 adjusted for variables in Model 3 plus alcohol intake (g/24 h).                                                                                                                                                                                                                                                           
1
 2SD of Nutrient Rich Food 9.3 index score=28.2.                                                                                                                                                                                                                                                                                                        
2
 2SD of Nutrient Rich Food 9.3 index score=28.0.                                                                                                                                                                                                                                                                                                      
3
 2SD of Nutrient Rich Food 9.3 index score=27.6.                                                                                                                                                                                                                                                                                                               
4
 2SD of Nutrient Rich Food 9.3 index score=28.5.                                                                                                                                                                                                                                                                                                     
5
 Not adjusted for DM or CVD diagnosis. 
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Table  3.12. Estimated mean systolic and diastolic BP differences per 2SD higher nutrient density (Nutrient Rich Food 9.3 index score) in UK and USA 
INTERMAP men participants 
1
 
 Systolic BP Diastolic BP 
Not adjusted for BMI Adjusted for BMI Not adjusted for BMI Adjusted for BMI 
Models n Difference, 
mm Hg 
95% CI p Difference, 
mm Hg 
95% CI p Difference, 
mm Hg 
95% CI p Difference, 
mm Hg 
95% CI p 
Model 1a 1232 -4.3 -5.9, -2.7 1.94×10
-07
 -3.4 -4.9, -1.9 1.62×10
-05
 -1.4 -2.6, -0.2 0.02 -0.8 -2.0, 0.4 0.17 
Model 2 1232 -3.7 -5.3, -2.0 1.70×10
-05
 -2.9 -4.5, -1.3 0.0004 -1.3 -2.5, -0.02 0.05 -0.7 -2.0, 0.5 0.23 
Model 3 1232 -2.5 -4.1, -0.8 0.004 -3.3 -5.0, -1.5 0.0003 -1.2 -2.5, 0.1 0.08 -0.7 -2.0, 0.6 0.31 
Model 4 1232 -2.3 -4.0, -0.7 0.06×10
-02
 -3.2 -4.9, -1.4 0.0004 -1.2 -2.5, 0.2 0.09 -0.02 -0.9, 0.4 0.35 
Sensitivity analyses 
using model 4 
             
Censored regression 1898 -3.7 -5.7, -1.7 0.0002 -2.8 -4.7, -0.9 0.05×10
-01
 -2.0 -3.5, -0.5 0.01 -1.1 -2.6, 0.3 0.11 
Excluding those with 
high variability in 
their diet
 
 
956 -3.9 -5.8, -1.9 0.0001 -3.2 -5.1, -1.3 0.001 -1.8 -3.3, -0.3 0.02 -1.3 -2.7, 0.2 0.09 
Excluding those 
following a special 
diet 
2
 
1185 -3.2 -4.9, -1.4 0.05×10
-02
 -2.2 -3.9, -0.5 0.01 -1.3 -2.7, 0.1 0.06 -0.7 -2.0, 0.7 0.33 
Excluding those 
diagnosed with DM 
and/or CVD 
3,4
 
1060 -2.8 -4.6, -1.0 0.003 -2.0 -3.7, -0.2 0.03 -1.4 -2.8, -0.03 0.05 -0.8 -2.2, 0.5 0.23 
Model 1a adjusted for total energy intake, age, and population sample. 
Model 2 Adjusted for variables in Model 1a plus adherence to a special diet, engagement in moderate and heavy physical activity (h/24 h), dietary supplement use, smoking, years of education (years 
completed), DM or CVD diagnosis, and family history of high BP. 
Model 3 adjusted for variables in model 2 plus 24-hour urinary excretion of sodium and potassium (mmol/24-hours).                                                                                                                                                    
Model 4 adjusted for variables in Model 3 plus alcohol intake (g/24 h).                                                                                                                                                                                                                                                           
1 
2SD of Nutrient Rich Food 9.3 index score=25.4.                                                                                                                                                                                                                                                                                                                                
2 
2SD of Nutrient Rich Food 9.3 index score=25.2.                                                                                                                                                                                                                                                                                     
3 
2SD of Nutrient Rich Food 9.3 index score=25.8.                                                                                                                                                                                                                                                                                     
4
 Not adjusted for DM or CVD diagnosis. 
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Table  3.13. Estimated mean systolic and diastolic BP differences per 2SD higher nutrient density (Nutrient Rich Food 9.3 index score) in UK and USA INTERMAP women 
participants 
1
 
 Systolic BP Diastolic BP 
Not adjusted for BMI Adjusted for BMI Not adjusted for BMI Adjusted for BMI 
Models n Difference, 
mm Hg 
95% CI p Difference, 
mm Hg 
95% CI p Difference, 
mm Hg 
95% CI p Difference, 
mm Hg 
95% CI p 
Model 1a 1232 -2.7 -4.3, -1.2 0.06×10
-02
 -1.5 -3.0, -0.04 0.04 -1.2 -2.2, -0.2 0.02 -0.7 -1.7, 0.3 0.17 
Model 2 1232 -1.2 -2.7, -0.4 0.01 -2.1 -3.7, 0.5 0.14 -1.1 -2.2, -0.02 0.05 -0.7 -1.7, 0.4 0.22 
Model 3 1232 -0.3 -1.9, 1.4 0.34 -0.8 -2.5, 0.9 0.74 -0.9 -2.1, 0.2 0.12 -0.7 -1.8, 0.5 0.25 
Model 4 1232 -0.8 -2.5, 0.9 0.34 -0.3 -1.9, 1.4 0.74 -0.9 -2.1, 0.2 0.11 -0.7 -1.8, 0.5 0.25 
Sensitivity analyses using model 4              
Censored regression 
2
 1898 -0.8 -2.8, 1.1 0.43 -0.3 -2.2, 1.7 0.89 -0.8 -2.2, 0.5 0.19 -0.6 -1.9, 0.7 0.42 
Excluding those with high variability 
in their diet 
2
 
914 -0.8 -2.7, 1.2 0.44 -0.3 -2.1, 1.5 0.89 -0.8 -2.1, 0.5 0.21 -0.5 -1.8, 0.7 0.41 
Excluding those following a special 
diet 
3
 
1058 -0.8 -2.6, 1.0 0.36 -0.4 -2.1, 1.4 0.66 -0.9 -2.2, 0.3 0.14 -0.7 -1.9, 0.5 0.24 
Excluding those diagnosed with DM 
and/or CVD
 4,5
 
994 -1.4 -3.1, 0.4 0.13 -0.8 -2.5, 0.9 0.37 -0.9 -2.1, 0.3 0.15 -0.6 -1.8, 0.6 0.32 
Model 1a adjusted for total energy intake, age, and population sample. 
Model 2 Adjusted for variables in Model 1a plus adherence to a special diet, engagement in moderate and heavy physical activity (h/24 h), dietary supplement use, smoking, years of education (years completed), 
DM or CVD diagnosis, and family history of high BP. 
Model 3 adjusted for variables in model 2 plus 24-hour urinary excretion of sodium and potassium (mmol/24-hours).                                                                                                                                                                                                   
Model 4 adjusted for variables in Model 3 plus alcohol intake (g/24 h).                                                                                                                                                                                                                                                                                 
1
 2SD of Nutrient Rich Food 9.3 index score=30.4.                                                                                                                                                                                                                                                                                                                        
2
 2SD of Nutrient Rich Food 9.3 index score=30.1.                                                                                                                                                                                                                                                                                                                         
3
 2SD of Nutrient Rich Food 9.3 index score=29.7.                                                                                                                                                                                                                                                                                                                                                                                                                             
4
 2SD of Nutrient Rich Food 9.3 index score=30.6.                                                                                                                                                                                                                                                                                                                             
5
 Not adjusted for DM or CVD diagnosis. 
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Table  3.14. Estimated mean BMI difference per 2SD higher nutrient density (Nutrient Rich Food 9.3 index 
score) in UK and USA INTERMAP participants 
1
 
   BMI  
Models n Difference, kg/m
2
 95% CI p 
Model 1a 2385 -1.5 -2.0, -1.1 3.31×10
-11
 
Model 2 2385 -1.5 -2.0, -1.1 9.26×10
-11
 
Model 3 2385 -1.6 -2.1, -1.1 2.88×10
-11
 
Sensitivity analyses using model 3     
High variability in their diet 
2
 1870 -1.7 -2.2, -1.2 1.01×10
-09
 
Excluding those following a special diet 
3
 2243 -1.5 -1.9, -1.1 1.81×10
-09
 
Excluding those diagnosed with DM and/or CVD 
4
 2054 -1.3 -1.8, -0.9 5.93×10
-08
 
Model 1a adjusted for total energy intake, gender, age, and population sample.  
Model 2 adjusted for variables in Model 1a plus adherence to a special diet, engagement in moderate and heavy physical activity  
(h/24 h), dietary supplement use, smoking, and years of education (years completed). 
Model 3 adjusted for variables in Model 2 plus alcohol intake (g/24 h).                                                                                                                         
1 
2SD of Nutrient Rich Food 9.3 index score=28.2.                                                                                                                                                                                   
2
 2SD of Nutrient Rich Food 9.3 index score=28.0.                                                                                                                                                                                                                                              
3
 2SD of Nutrient Rich Food 9.3 index score=27.6.                                                                                                                                                                                                                                                    
4
 2SD of Nutrient Rich Food 9.3 index score=28.5. 
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Table  3.15. Variables by quartiles of the ratio of evening to morning energy intake in UK and USA INTERMAP 
participants, n=2385 
1,2
 
  The ratio of evening to morning energy intake  
 <1.0 ≥1.0 to <1.5 ≥1.5 to <2.0 ≥2.0  
Variable Mean SE Mean SE Mean SE Mean SE P for 
trend 
n 594  595  595  595   
Men (%) 47  51  49  59   
Education (y) 
3
 14.3 0.1 14.6 0.1 14.7 0.1 14.7 0.1 0.09 
Engagement in moderate and 
heavy physical activity (h/24 h) 
3
 
3.2 0.1 3.1 0.1 2.9 0.1 3.0 0.1 0.34 
Systolic BP (mm Hg) 
3
 118.1 0.5 119.6 0.5 118.2 0.5 119.3 0.5 0.12 
Diastolic BP (mm Hg) 
3
 73.4 0.4 74.4 0.4 73.7 0.4 75.2 0.4 0.004 
BMI (kg/m
2
) 
3
 28.0 0.2 28.0 0.2 28.1 0.2 28.5 0.2 0.07 
Total energy (kcal/24 h) 2304.0 21.8 2322.4 21.7 2333.0 21.6 2332.4 21.7 0.76 
Food energy (kcal/24 h) 1913.3 19.4 1931.1 19.4 1917.6 19.3 1905.6 19.4 0.82 
Beverage energy (kcal/24 h) 390.7 9.9 391.3 9.9 415.4 9.8 426.8 9.9 0.02 
Food weight (g/24 h) 1103.0 13.3 1124.0 13.2 1104.0 13.2 1067.0 13.3 0.17×10
-01
 
Beverage weight (g/24 h) 
4
 1575.3 30.0 1568.4 29.9 1649.2 29.8 1600.6 30.0 0.22 
Dietary energy density           
Food only (kcal/g) 1.7 0.02 1.7 0.02 1.7 0.02 1.8 0.02 0.05×10
-01
 
Food and beverages
 
(kcal/g) 0.9 0.01 0.9 0.01 0.9 0.01 0.9 0.01 0.03 
Nutrient density                               
(Nutrient Rich Food 9.3 index 
score) 
3
 
31.5 0.5 31.8 0.5 31.6 0.5 28.4 0.5 1.25×10
-05
 
Food Groups (g/1000 kcal)          
Whole fat dairy  28.3 1.6 24.6 1.6 23.8 1.6 27.4 1.6 0.15 
Low or medium-fat dairy 91.0 3.5 88.8 3.5 94.4 3.5 73.2 3.5 9.14×10
-05
 
Meat  25.3 0.9 25.4 0.9 27.5 0.9 29.2 0.9 4.60×10
-03
 
Fish  7.3 0.5 6.7 0.5 7.3 0.5 8.4 0.5 0.15 
Raw vegetables  26.4 1.2 28.0 1.2 30.1 1.2 27.6 1.2 0.15 
Cooked vegetables 48.6 1.6 51.7 1.6 48.3 1.6 48.4 1.6 0.38 
Potatoes  37.9 1.2 37.9 1.2 39.1 1.2 34.7 1.2 0.07 
Fruit  54.4 2.5 54.1 2.5 51.2 2.5 44.7 2.5 0.19×10
-01
 
Cakes and pies  5.7 0.5 5.6 0.5 5.6 0.5 6.2 0.5 0.85 
Nutrients          
Total carbohydrate (%kcal) 49.3 0.3 49.0 0.3 48.6 0.3 46.7 0.3 8.81×10
-09
 
Total fibre (g/1000 kcal) 9.7 0.1 9.7 0.1 9.5 0.1 8.8 0.1 3.21×10
-06
 
Total protein (%kcal) 15.4 0.1 15.3 0.1 15.3 0.1 15.3 0.1 0.93 
Animal protein (%kcal) 9.8 0.1 9.7 0.1 9.9 0.1 10.1 0.1 0.20 
Vegetable protein (%kcal) 5.4 0.1 5.4 0.1 5.3 0.1 5.0 0.1 7.75×10
-07
 
Total fat (%kcal) 33.1 0.3 33.0 0.3 32.8 0.3 34.1 0.3 0.004 
Total SFA (%kcal) 11.0 0.1 10.9 0.1 11.0 0.1 11.3 0.1 0.13 
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Total MFA (%kcal) 12.0 0.1 11.9 0.1 11.9 0.1 12.4 0.1 0.003 
Total PFA (%kcal) 6.9 0.1 6.9 0.1 6.7 0.1 7.1 0.1 0.004 
Cholesterol (mg/1000 kcal) 123.6 2.2 124.4 2.2 130.4 2.2 135.2 2.2 3.93×10
-04
 
Dietary alcohol (g/24 h) 
3
 7.1 0.6 7.9 0.6 8.8 0.6 11.1 0.6 1.19×10
-05
 
24-hour urinary excretion data 
(mmol/24 h) 
3
 
         
Sodium 160.7 2.2 161.6 2.2 160.3 2.2 156.9 2.2 0.46 
Potassium  60.3 0.8 59.7 0.8 61.3 0.8 59.0 0.8 0.18 
Magnesium  4.2 0.1 4.1 0.1 4.3 0.1 4.0 0.1 0.03 
Calcium  4.2 0.1 4.2 0.1 4.4 0.1 4.1 0.1 0.25 
Weight status (%) 
5
  
Normal weight  174 (30%) 180 (30%) 194 (32%) 162 (27%)  
Overweight  219 (37%) 248 (42%) 234 (39%) 240 (40%)  
Obese 201 (33%) 167 (29%) 167 (28%) 193 (33%) 0.12 
1 
Presented as mean and SE. 
2 
Model 1 adjusted for gender, age, and population sample. 
3 
Model 1a adjusted for variables in Model 1 plus total energy intake. 
4 
Drinking water excluded.                                                                                                                                                                                                                                                  
5 
Chi square. 
  128
Table  3.16. Estimated mean systolic and diastolic BP differences per 2SD higher ratio of evening to morning energy intake in UK and USA INTERMAP participants 
1
 
 Systolic BP  Diastolic BP  
 Not adjusted for BMI Adjusted for BMI  Not adjusted for BMI Adjusted for BMI 
Models n Difference, 
mm Hg 
95% CI p Difference, 
mm Hg 
95% CI p Difference, 
mm Hg 
95% CI p Difference, 
mm Hg 
95% CI p 
Model 1 2385 0.06 -0.01, 0.1 0.08 0.1 -0.02, 0.1 0.20 0.1 0.01, 0.1 0.03 0.1 -0.01, 0.1 0.07 
Model 2 2385 0.06 -0.01, 0.1 0.09 0.1 -0.03, 0.1 0.20 0.1 0.01, 0.1 0.03 0.1 -0.01, 0.1 0.07 
Model 3 2385 0.06 -0.01, 0.1 0.09 0.1 -0.03, 0.1 0.21 0.1 0.01, 0.1 0.03 0.1 -1.0, 0.9 0.06 
Model 4 2385 0.06 -0.01, 0.1 0.09 0.1 -0.03, 0.1 0.20 0.02 0.01, 0.1 0.03 0.1 -1.0, 0.1 0.06 
Sensitivity analyses using model 4              
Censored regression 
2
 1898 0.1 -0.04, 0.2 0.20 0.1 -0.1, 0.2 0.35 0.1 -0.01, 0.2 0.06 0.1 -0.01, 0.2 0.09 
Excluding those with high variability in their 
diet 
2
 
1870 0.1 -0.1, 0.2 0.06 0.1 0.2, 0.04 0.23 0.1 0.02, 0.2 0.03 0.1 0.02, 0.2 0.02 
Excluding those following a special diet 
3
 2243 0.1 -0.1, 0.2 0.06 0.1 -0.03, 0.2 0.18 0.1 0.01, 0.2 0.02 0.1 0.01, 0.1 0.05 
Excluding those diagnosed with DM and/or 
CVD 
3,4
 
2054 0.1 -0.04, 0.2 0.23 0.1 -0.04, 0.1 0.19 0.1 0.01, 0.2 0.04 0.1 0.01, 0.2 0.03 
Model 1 adjusted for gender, age, and population sample.  
Model 2 Adjusted for variables in Model 1 plus adherence to a special diet, engagement in moderate and heavy physical activity (h/24 h), dietary supplement use, smoking, years of education (years completed), DM 
or CVD diagnosis, and family history of high BP. 
Model 3 adjusted for variables in model 2 plus 24-hour urinary excretion of sodium and potassium (mmol/24-hours).                                                                                                                                                                                                                                                           
Model 4 adjusted for variables in Model 3 plus alcohol intake (g/24 h).                                                                                                                                                                                                                                                                                   
1 
2SD of ratio of evening to morning energy intake=3.6.                                                                                                                                                                                                                                                                                                                                                           
2 
2SD of ratio of evening to morning energy intake=3.4.                                                                                                                                                                                                                                                                                                            
3 
2SD of ratio of evening to morning energy intake=3.5.                                                                                                                                                                                                                                                                                                                             
4
 Not adjusted for DM or CVD diagnosis. 
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Table  3.17. Estimated mean BMI difference per 2SD higher ratio of evening to morning energy intake 
in UK and USA INTERMAP participants 
1
 
   BMI   
Models n Difference, kg/m
2
 95% CI p 
Model 1 2385 0.1 -0.01, 0.1 0.08 
Model 2 2385 0.1 -0.01, 0.1 0.08 
Model 3 2385 0.1 -0.03, 0.1 0.07 
Sensitivity analyses using model 3     
Excluding those with high variability in their diet 
2
 1870 0.1 -0.03, 0.1 0.09 
Excluding those following a special diet 
3
 2243 0.04 -0.02, 0.1 0.06 
Excluding those diagnosed with DM and/or CVD 
3
 2054 0.04 -0.01, 0.1 0.08 
Model 1 adjusted for gender, age, and population sample.  
Model 2 adjusted for variables in Model 1 plus adherence to a special diet, engagement in moderate and heavy physical activity 
(h/24 h), dietary supplement use, smoking, and years of education (years completed). 
Model 3 adjusted for variables in Model 2 plus alcohol intake (g/24 h).                                                                                                              
1
 2SD of ratio of evening to morning energy intake=3.6.                                                                                                                                                           
2 
2SD of ratio of evening to morning energy intake=3.4.                                                                                                                                                  
3 
2SD of ratio of evening to morning energy intake=3.5. 
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Table  3.18. Comparison between extreme low and high eating occasions by the ratio of evening to 
morning energy intake in UK and USA INTERMAP participants, n=520 
1, 2
 
Variables/ 
eating occasions and the ratio of 
evening to morning energy intake 
<4 eating occasions/24 h              
and >1.8 
≥6 eating occasions/24 h  
and ≤1.8 
 
 
Mean SE Mean SE P for T-test 
n 317  203   
Men (%) 68  41   
Education (y) 
3
 14.4 0.2 14.8 0.2 0.13 
Engagement in moderate and heavy 
physical activity (h/24 h) 
3
 
2.9 0.2 3.3 0.2 0.20 
Systolic BP (mm Hg) 
3
 120.6 0.8 116.2 1.0 0.001 
Diastolic BP (mm Hg) 
3
 75.3 0.6 72.7 0.6 0.004 
BMI (kg/m
2
) 
3
 28.9 0.3 27.6 0.4 0.18×10
-01
 
Total energy (kcal/24 h) 2528.9 39.0 2283.3 32.5 5.23×10
-06
 
Food energy (kcal/24 h) 2121.4 35.3 1829.9 30.3 2.49×10
-15
 
Beverage energy (kcal/24 h) 407.5 20.1 453.4 17.2 0.09 
Food weight (g/24 h) 952.1 20.5 1152.9 23.9 5.00×10
-19
 
Beverage weight (g/24 h) 
4
 1612.7 51.4 1710.4 60.0 0.23 
Dietary energy density       
Food only (kcal/g) 2.2 0.02 1.6 0.03 0.004 
Food and beverages
 
(kcal/g) 0.9 0.02 0.8 0.02 0.58 
Nutrient density                               
(Nutrient Rich Food 9.3 index score) 
3
 
26.9 0.8 35.8 1.0 9.02×10
-11
 
Food Groups (g/1000 kcal)      
Whole fat dairy  28.3 2.5 22.1 2.9 0.11 
Low or medium-fat dairy 61.7 5.2 110.5 6.0 4.37×10
-09
 
Meat  33.4 1.4 21.8 1.6 1.92×10
-07
 
Fish  7.9 0.7 6.4 0.8 0.20 
Raw vegetables  26.1 1.7 26.7 1.9 0.81 
Cooked vegetables 40.6 2.4 55.8 2.8 0.05 
Potatoes  40.9 1.8 31.1 2.1 0.06×10
-02
 
Fruit  31.1 3.5 84.2 4.1 8.03×10
-20
 
Cakes and pies  5.7 0.7 5.9 0.8 0.86 
Dietary alcohol (g/24 h) 
3
 12.3 1.1 5.6 1.3 1.21×10
-04
 
1 
Presented as mean and SE. 
2 
Model 1 adjusted for gender, age, and population sample. 
3 
Model 1a adjusted for variables in Model 1 plus total energy intake. 
4 
Drinking water excluded. 
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4. RESULTS PART II 
The second part of the results presents associations of glycaemic index, glycaemic load, 
and dietary fibre and its individual components to BP and BMI separately.  
4.1. Descriptive statistics 
Descriptive characteristics of study samples are available in detail in (section 3.1, Table 
3.1). Average (SD) GI was lower in the UK compared to the USA [62.0 (3.8) vs. 65.4 
(9.5)]. GI was lower in women than in men in the UK [60.9 (3.3) vs. 63.0 (4.0)], while 
in the USA GI was higher for women compared to men [66.5 (10.3) vs. 64.3(8.5)]. A 
similar trend was observed for GL, lower in the UK compared to the USA: 177.7 (51.4) 
vs. 186.5 (61.5). However, GL was lower in women of both countries compared to 
men; UK: 148.4 (33.2) vs. 203.8 (50.6); USA: 163.2 (47.9) vs. 208.5 (64.7). Average 
intake (SD; %kcal) of total sugar was lower in the UK than in the USA [20.3 (5.9) vs. 
26.7 (7.9)], and was lower for men in both countries compared to women.  
Average intake (SD; g/1000 kcal) of total fibre was higher in the UK compared to the 
USA [11.8 (3.3) vs. 8.8 (3.3)]. In the UK, men and women had similar intakes, while in 
the USA, women had slightly higher intakes [9.2 (3.3) vs. 8.5 (3.1)]. In the USA, 
average insoluble fibre intake was 5.3 (2.2); higher in women than in men [5.5 (2.2) vs. 
5.1 (2.2)]. Average soluble fibre intake was 2.8 (1.0); higher in women [3.0 (1.1)] than 
in men [2.7 (1.0)]. 
4.2. Correlations  
In the USA samples, partial Pearson correlation coefficients adjusted for age, sex, and 
population sample shows GI was not correlated with total sugar (r=>0.01), total fibre 
(r=>0.03), insoluble fibre (r=>0.03), soluble fibre (r=>0.01), and correlated positively 
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with total fat (r=0.05) and total carbohydrate (r=0.07), and inversely with total protein 
(r=>0.05) (Table 4.1). In gender specific correlations, similar findings were observed 
for men and women [Tables A.12 (men) and A.13 (women)]. 
GL was positively correlated with total carbohydrate (r=0.44), total sugar (r=0.39), 
inversely with total protein (r=>0.31), total fat (r=>0.21), and total fibre (r=>0.04) 
(Table 4.1). Similar correlations were observed for men and women separately (Tables 
A.12 and A.13). 
Total dietary fibre was positively correlated with insoluble (r=0.96) and soluble 
(r=0.89) fibre, with similar findings for men and women separately. The intake of 
insoluble fibre was positively correlated with soluble fibre (r=0.80), and similarly for 
men and women separately. The intake of total fibre correlated positively with total 
carbohydrate (r=0.30), slightly less in men (r=0.27) than women (r=0.33). The intake 
of total fibre did not correlate with total sugar (r=0.02), with similar findings in men 
and women separately. 
The intake of total fibre was positively correlated with total protein (r=0.16), 24>hour 
urinary excretion of magnesium (r=0.24), 24>hour urinary excretion of potassium 
(r=0.35), and negatively with total fat (r=>0.38), alcohol (r=>0.05), 24>hour urinary 
excretion of sodium (r=>0.04), but not with 24>hour urinary excretion of calcium        
(r=>0.02) (Table 4.1), with similar correlation coefficients in men and women 
separately (Tables A.12 and A.13). 
4.3. Glycaemic index and glycaemic load 
Across gender>specific quintiles of GI in (Table 4.2), systolic BP, diastolic BP, and 
BMI were not significantly different across groups. However, there was a positive 
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association with quintile of GI and total energy intake (p for trend=0.0002), energy 
from food (p for trend<0.0001), dietary energy density from food and from food and 
beverages (p for trend<0.0001), and an inverse association with energy from beverages 
(p for trend=0.0001), food weight (p for trend=0.003), beverage weight (p for 
trend=0.005), and nutrient density (p for trend<0.0001). 
Those in the highest quintile had less intakes of low or medium>fat dairy products (p 
for trend<0.0001), raw vegetables (p for trend=0.005), cooked vegetables (p for 
trend<0.0001), and fruits (p for trend<0.0001) compared to those in the lowest 
quintiles.  
For macro and micro nutrient intakes, individuals in the highest quintile of GI had 
significantly greater intakes of total carbohydrate (p for trend=0.01), starch (p for 
trend<0.0001), total fat (p for trend<0.0001), SFA (p for trend=0.001), MFA (p for 
trend=0.0001), PFA (p for trend=0.002), and cholesterol (p for trend=0.04). There was 
an inverse association with quintile of GI and total protein (p for trend<0.0001), 24>
hour urinary excretion of potassium (p for trend<0.0001) and magnesium (p for 
trend=0.001), and a positive association with 24>hour urinary excretion of sodium (p 
for trend=0.0002). 
4.3.1. Glycaemic index, glycaemic load and blood pressure 
In multivariable regression analyses, there was no significant association between GI 
and BP (model 2) (Table 4.3). Sensitivity analyses including of censored regression 
adjusted for BMI showed a significant difference in systolic BP (0.01, 95% CI: 0.01, 
0.02 mm Hg, p=0.01), and diastolic BP (0.02, 95% CI: 0.01, 0.03 mm Hg, p=0.001). 
Further analyses showed small differences in diastolic BP only in the sub>cohort 
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excluding those following a special diet (with BMI, 0.8, 95% CI: 0.1, 1.5 mm Hg, 
p=0.04). 
Similarly, GL was not significantly associated with BP (model 2) (Table 4.4). 
Sensitivity analyses of censored regression adjusted for BMI showed a small, but 
significant difference in diastolic BP only (0.04, 95% CI: 0.02, 0.06 mm Hg, p=0.03). 
Further analyses showed small and significant differences in diastolic BP only in the 
sub>cohort excluding those following a special diet (without BMI, 1.7, 95% CI: 0.1, 3.3 
mm Hg, p=0.04). 
Gender>specific regressions showed similar findings, as both GI, GL were not 
associated with BP (Tables A.14 and A.15). No significant interactions with age or 
gender were detected.  
4.3.2. Glycaemic index, glycaemic load and body mass index 
In multivariable regression analyses, GI was positively associated with BMI, although 
the results were not statistically significant (model 2) (Table 4.5). In sub>cohort 
analyses, associations were similarly non>significant for the three sub>cohorts under 
investigation: (excluding those with high variability in their diet, excluding those 
following a special diet, and excluding those diagnosed with DM and/or CVD). 
A similar trend was found for the regression of GL against BMI where non>significant 
associations were observed (model 2) (Table 4.6). Further sub>cohort analyses showed 
no change in any of the three sub>cohorts under investigation: (excluding those with 
high variability in their diet, excluding those following a special diet, and excluding 
those diagnosed with DM and/or CVD). 
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Gender>specific regressions showed similar findings, both GI, GL were not associated 
with BMI (Tables A.16 and A.17). No significant interactions with age or gender were 
detected.  
4.4. Total and individual components of fibre 
4.4.1. Total and individual components of fibre and blood 
pressure 
Total fibre intake higher by 7 g/1000 kcal was associated with systolic BP lower by 3.0, 
95% CI: >4.3, >1.6 mm Hg, p<0.0001 and diastolic BP lower by 1.5, 95% CI: >2.4, >0.5 
mm Hg, p=0.003 (model 2), additionally adjusted for total sugar (%) (Table 4.7). 
Further adjustment for BMI slightly reduced the association for systolic BP: >1.7, 95% 
CI: >3.0, >0.4 mm Hg, p=0.01, while the association of total fibre with diastolic BP was 
no longer statistically significant: >0.7, 95% CI: >1.7, 0.2 mm Hg, p=0.14. Further 
adjustments for nutrients high in fibre>rich foods showed different results for different 
nutrients (with adjustment for BMI): additional adjustment for 24>hour urinary 
excretion of magnesium excretion (model 3) showed total fibre intake higher by 7 
g/1000 kcal was associated with a systolic BP difference similar to (model 2): (>1.7,
 
95% CI: >3.0, >0.3 mm Hg, p=0.02); additional adjustment for 24>hour urinary 
excretion of potassium excretion (model 4) attenuated the association between total 
fibre and systolic BP and was no longer statistically significant; additional adjustment 
for 24>hour urinary excretion of calcium excretion (model 5) resulted in a systolic BP 
difference similar to that of (model 2): (>1.8, 95% CI: >3.1, >0.4 mm Hg, p=0.01). 
Further regression analyses on sub>cohorts (adjusted for BMI) showed inverse 
associations held constant, but reduced with censored regression (systolic BP: >0.5; 
95% CI: >0.6, >0.1 mm Hg, p=0.001), and in a sub>cohort excluding individuals with 
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high variability in their diet (systolic BP: >1.4, 95% CI: >2.9, 0.04 mm Hg, p=0.06). 
Regression analyses including a sub>cohort (excluding those following a special diet) 
and a sub>cohort (excluding those diagnosed with DM and/or CVD) showed 
compatible results to (model 2): (systolic BP: >1.7 and >1.8,
 
95% CI: >3.2, >0.5 mm Hg, 
p=0.02, 0.009, respectively). 
In gender>specific regression analysis, total fibre was inversely associated with systolic 
BP, with and without BMI adjustment. The association in women was stronger 
compared to men [adjusted for BMI, 95% CI: >4.2, >0.2 mm Hg, p=0.03 vs. 95% CI: >
3.2, >0.1 mm Hg, p=0.04] (Table A.18) 
Insoluble fibre higher by 4.4 g/1000 kcal was associated with systolic BP lower by 2.0 
mm Hg (95% CI: –3.9, >0.1 mm Hg, p=0.04), additionally adjusted for BMI, total sugar 
(%) and soluble fibre (Table 4.8). Further adjustments for nutrients high in fibre>rich 
foods showed different results for different nutrients (with adjustment for BMI): 
additional adjustment for 24>hour urinary excretion of magnesium excretion (model 3) 
showed insoluble fibre intake higher by 4.4 g/1000 kcal was associated with a systolic 
BP difference similar to (model 2): (>1.9,
 
95% CI: >3.8, >0.1 mm Hg, p=0.04); 
additional adjustment for 24>hour urinary excretion of potassium excretion (model 4) 
attenuated the association between insoluble fibre and systolic BP (systolic BP: >1.8, 
95% CI: >3.7, 0.1 mm Hg, p=0.06); additional adjustment for 24>hour urinary excretion 
of calcium (model 5) resulted in a systolic BP difference similar to that of (model 2): (>
2.0, 95% CI: >3.8, >0.1 mm Hg, p=0.04). Further regression analyses on sub>cohorts 
(adjusted for BMI) showed inverse associations held constant, but was reduced with 
censored regression (systolic BP: >0.3; 95% CI: >0.5, >0.1 mm Hg, p=0.002), and was 
no longer statistically significant in sub>cohort analyses: (a sub>cohort excluding 
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individuals with high variability in their diet, a sub>cohort excluding those following a 
special diet). 
In gender>specific regression analysis, insoluble fibre was inversely associated with 
systolic BP, with and without BMI adjustment. The association in women was stronger 
compared to men [adjusted for BMI, 95% CI: >5.5, >0.2 mm Hg, p=0.04 vs. 95% CI: >
3.7, >0.1 mm Hg, p=0.05] (Table A.19). 
Soluble fibre was not significantly associated with BP in any of the models, 
additionally adjusted for insoluble fibre (Table 4.9). Further censored regression and 
sub>cohort analyses showed no change in association. Gender>specific regressions 
showed compatible findings (Table A.20). 
4.4.2. Total and individual components of fibre and body mass 
index 
Total fibre intake higher by 7 g/1000 kcal (2SD) was inversely associated with BMI in 
all models (model 2: >1.7, 95% CI: >2.3, >1.2 kg/m
2
, p<0.0001) [equivalent to >4.9 kg in 
weight], additionally adjusted for total sugar (%) (Table 4.10). Analyses with 
adjustments for nutrients high in fibre>rich foods showed compatible results to (model 
2): additional adjustment for 24>hour urinary excretion of magnesium excretion (model 
3) showed total fibre intake higher by 7 g/1000 kcal was associated with BMI 
difference of (>1.9,
 
95% CI: >2.5, >1.3 kg/m
2
, p<0.0001) [equivalent to >5.5 kg in 
weight]; additional adjustment for 24>hour urinary excretion of potassium excretion 
(model 4) resulted in BMI difference of (>2.3, 95% CI: >2.9, >1.7 kg/m
2
, p<0.0001) 
[equivalent to >6.7 kg in weight]; additional adjustment for 24>hour urinary excretion of 
calcium excretion (model 5) resulted in BMI difference of (>1.7, 95% CI: >2.3, >1.2 
kg/m
2
, p<0.0001) [equivalent to >4.9 kg in weight]. Further sub>cohort analyses showed 
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inverse associations held constant and compatible to (model 2): (BMI differences 
ranging between >1.5 to >1.7 kg/m
2
, p<0.0001; equivalent to >4.4 to >4.9 kg in weight). 
In gender>specific regressions, 7 g/1000 kcal of total fibre intake was similarly 
inversely associated with BMI, with a higher average difference in BMI among women 
than men [95% CI: >2.9, >1.2 kg/m
2
, p<0.0001 vs. 95%CI: >2.0, >0.6 kg/m
2
, p=0.0003] 
(Table A.21). No significant interactions with age or gender were detected.  
Insoluble fibre higher by 4.4 g/1000 kcal was associated with BMI (model 2) lower by 
1.7, 95% CI: >2.5, >0.9 kg/m
2
, p<0.0001 [equivalent to >4.9 kg in weight], additionally 
adjusted for total sugar and soluble fibre (Table 4.11). Analyses with adjustments for 
nutrients high in fibre>rich foods showed compatible results to (model 2): additional 
adjustment for 24>hour urinary excretion of magnesium excretion (model 3) showed 
insoluble fibre intake higher by 4.4 g/1000 kcal was associated with BMI difference of 
(>1.8,
 
95% CI: >2.6, >1.0 kg/m
2
, p<0.0001) [equivalent to >5.2 kg in weight]; additional 
adjustment for 24>hour urinary excretion of potassium excretion (model 4) resulted in 
BMI difference of (>1.9, 95% CI: >2.7, >1.1 kg/m
2
, p<0.0001) [equivalent to >5.5 kg in 
weight]; additional adjustment for 24>hour urinary excretion of calcium excretion 
(model 5) resulted in BMI difference of (>1.7, 95% CI: >2.5, >0.9 kg/m
2
, p<0.0001) 
[equivalent to >4.9 kg in weight]. Further sub>cohort analyses showed inverse 
associations held constant and compatible to (model 2): (BMI differences ranging 
between >1.5 to >1.8 kg/m
2
, p<0.001; equivalent to >4.4 to >5.2 kg in weight). 
In gender>specific regressions, 4.4 g/1000 kcal of insoluble fibre intake was similarly 
inversely associated with BMI in men and women separately (Table A.22). No 
significant interactions with age or gender were detected.  
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Association of soluble fibre with BMI was not statistically significantly in any of the 
models, additionally adjusted for total sugar and insoluble fibre (Table 4.12). Further 
sub>cohort analyses showed similar results. Gender>specific regressions showed 
compatible findings (Table A.23). 
4.4.3. Glycaemic index and total fibre combined 
Because dietary fibre is inversely associated with BP and BMI, UK and USA 
participants were classified jointly by GI and total fibre intake. Participants were cross>
classified by both variables into quartiles, with the following median values (GI: 57.4, 
61.8, 65.0, 73.0; total fibre: 6.0, 8.1, 10.1, 13.5) (Figure 4.1, Figure 4.2, and Figure 
4.3). After adjustment for age, gender, total energy (kcal/24>hours), protein (%), total 
fat (%), and population sample (model 1), results showed that there was an inverse 
association between systolic BP and total fibre intake by GI groups; i.e., compared to 
participants with the lowest GI and highest fibre intake, those with the highest GI and 
lowest fibre intake had the highest systolic BP level (p for T>test=0.05) (Figure 4.1). 
There was also an inverse association between diastolic BP and total fibre intake by GI 
groups; where those with the highest GI and lowest fibre intake had the highest 
diastolic BP level (p for T>test=0.02) compared to participants with the lowest GI and 
highest fibre intake (Figure 4.2). Finally, there was an inverse association between BMI 
and total fibre intake by GI groups; where those with the highest GI and lowest fibre 
intake had the highest BMI level (p for T>test =0.05) compared to participants with the 
lowest GI and highest fibre intake (Figure 4.3). 
Gender>specific analyses showed no significant difference in systolic BP, diastolic BP, 
or BMI between the lowest GI and highest fibre intake and the highest GI and lowest 
fibre intake (Figures A.1, A.2, A.3, A.4, A.5, A.6).  
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Table  4.1. Partial Pearson correlation coefficients for dietary macro and micro nutrients of USA INTERMAP participants, n=1941 
1,2
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Total 
carbohydrate 
(%kcal) 
 0.36 0.78 0.52 0.16 0.53 0.09 0.23 0.54 0.07 0.44 0.30 0.31 0.31 -0.37 -0.47 0.28 -0.78 -0.62 -0.73 -0.45 -0.30 -0.18 0.03 -0.03 -0.13 
Starch                 
(%kcal) 
0.36  -0.31 -0.26 0.06 -0.27 -0.07 0.03 -0.24 0.12 0.10 0.42 0.40 0.41 0.04 -0.27 0.64 -0.35 -0.39 -0.35 -0.12 -0.09 0.04 0.05 0.06 -0.03 
Total sugar                    
(%kcal) 
0.78 -0.31  0.70 0.12 0.72 0.14 0.21 0.71 -0.01 0.39 0.02 0.04 0.03 -0.40 -0.30 -0.15 -0.55 -0.37 -0.50 -0.38 -0.24 -0.21 -0.01 -0.07 -0.12 
Fructose          
(%kcal) 
0.52 -0.26 0.70  0.03 0.93 -0.13 0.11 0.10 -0.09 0.22 0.03 0.04 0.03 -0.28 -0.21 -0.08 -0.40 -0.35 -0.35 -0.21 -0.13 -0.18 -0.06 -0.10 -0.12 
Galactose    
(%kcal) 
0.16 0.06 0.12 0.03  0.04 0.12 0.09 0.04 -0.06 0.01 0.14 0.13 0.14 0.02 -0.03 0.10 -0.18 -0.14 -0.18 -0.11 -0.02 -0.07 0.09 0.10 0.03 
Glucose         
(%kcal) 
0.53 -0.27 0.72 0.93 0.04  -0.13 0.20 0.12 -0.04 0.25 -0.03 -0.01 -0.02 -0.32 -0.24 -0.12 -0.42 -0.35 -0.36 -0.23 -0.10 -0.16 -0.07 -0.10 -0.13 
Lactose           
(%kcal) 
0.09 -0.07 0.14 -0.13 0.12 -0.13  0.03 -0.02 -0.01 0.07 0.04 0.07 0.01 0.22 0.23 -0.03 -0.13 0.04 -0.17 -0.18 -0.10 -0.04 0.32 0.14 0.18 
Maltose         
(%kcal) 
0.23 0.03 0.21 0.11 0.09 0.20 0.03  0.05 0.11 0.14 0.10 0.07 0.10 -0.15 -0.15 0.02 -0.20 -0.12 -0.20 -0.13 0.02 -0.08 0.03 0.03 -0.06 
Sucrose         
(%kcal) 
0.54 -0.24 0.71 0.10 0.04 0.12 -0.02 0.05  0.06 0.32 -0.12 -0.09 -0.09 -0.40 -0.27 -0.21 -0.28 -0.13 -0.25 -0.24 -0.23 -0.13 -0.12 -0.10 -0.11 
Glycaemic 
index            
0.07 0.12 -0.01 -0.09 -0.06 -0.04 -0.01 0.11 0.06  0.47 -0.03 -0.03 -0.01 -0.05 -0.05 0.03 0.05 0.04 0.06 0.05 -0.18 0.06 -0.02 0.02 0.02 
Glycaemic      
load 
0.44 0.10 0.39 0.22 0.01 0.25 0.07 0.14 0.32 0.47  -0.04 0.04 0.01 -0.31 -0.30 0.03 -0.21 -0.13 -0.18 -0.14 -0.18 0.15 0.15 0.08 0.09 
Total fibre 
(g/1000 kcal) 
0.30 0.42 0.02 0.03 0.14 -0.03 0.04 0.10 -0.12 -0.03 -0.04  0.96 0.89 0.16 -0.22 0.76 -0.38 -0.47 -0.37 -0.08 -0.05 -0.04 0.35 0.24 -0.02 
Insoluble 
fibre 
(g/1000 
kcal) 
0.31 0.40 0.04 0.04 0.13 -0.01 0.07 0.07 -0.09 -0.03 0.04 0.96  0.80 0.14 -0.22 0.75 -0.34 -0.44 -0.33 -0.05 -0.12 -0.03 0.33 0.23 -0.02 
Soluble 
fibre 
(g/1000 
kcal) 
0.31 0.41 0.03 0.03 0.14 -0.02 0.01 0.10 -0.09 -0.01 0.01 0.89 0.80  0.18 -0.18 0.72 -0.36 -0.45 -0.34 -0.10 -0.10 -0.02 0.34 0.21 -0.01 
Total protein 
(%kcal) 
-0.37 0.04 -0.40 -0.28 0.02 -0.32 0.22 -0.15 -0.40 -0.05 -0.31 0.16 0.14 0.18  0.88 0.17 0.02 -0.02 0.02 -0.07 -0.03 0.15 0.26 0.14 0.13 
Animal 
protein 
(%kcal) 
-0.47 -0.27 -0.30 -0.21 -0.03 -0.24 0.23 -0.15 -0.27 -0.05 -0.30 -0.22 -0.22 -0.18 0.88  -0.32 0.17 0.20 0.17 -0.07 -0.01 0.14 0.14 0.03 0.12 
Vegetable 
protein 
(%kcal) 
0.28 0.64 -0.15 -0.08 0.10 -0.12 -0.03 0.02 -0.21 0.03 0.03 0.76 0.75 0.72 0.17 -0.32  -0.30 -0.43 -0.30 0.02 -0.13 0.01 0.22 0.20 -0.01 
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Total fat              
(%kcal) 
-0.78 -0.35 -0.55 -0.40 -0.18 -0.42 -0.13 -0.20 -0.28 0.05 -0.21 -0.38 -0.34 -0.36 0.02 0.17 -0.30 1.00 0.81 0.93 0.63 -0.13 0.22 -0.14 -0.01 0.12 
Total SFA            
(%kcal) 
-0.62 -0.39 -0.37 -0.35 -0.14 -0.35 0.04 -0.12 -0.13 0.04 -0.13 -0.47 -0.44 -0.45 -0.02 0.20 -0.43 0.81  0.70 0.17 -0.11 0.16 -0.13 -0.03 0.15 
Total PFA         
(%kcal) 
-0.73 -0.35 -0.50 -0.35 -0.18 -0.36 -0.17 -0.20 -0.25 0.06 -0.18 -0.37 -0.33 -0.34 0.02 0.17 -0.30 0.93 0.70  0.47 -0.11 0.21 -0.14 -0.02 0.10 
Total MFA           
(%kcal) 
-0.45 -0.12 -0.38 -0.21 -0.11 -0.23 -0.18 -0.13 -0.24 0.05 -0.14 -0.08 -0.05 -0.10 -0.07 -0.07 0.02 0.63 0.17 0.47  -0.10 0.13 -0.07 0.02 0.01 
Dietary alcohol 
(g/24 h) 
-0.30 -0.09 -0.24 -0.13 -0.02 -0.10 -0.10 0.02 -0.23 -0.18 -0.18 -0.05 -0.12 -0.10 -0.03 -0.01 -0.13 -0.13 -0.11 -0.11 -0.10  -0.06 0.01 -0.01 0.01 
Urinary sodium 
(mmol/24 h) 
-0.18 0.04 -0.21 -0.18 -0.07 -0.16 -0.04 -0.08 -0.13 0.06 0.15 -0.04 -0.03 -0.02 0.15 0.14 0.01 0.22 0.16 0.21 0.13 -0.06  0.37 0.31 0.32 
Urinary 
potassium 
(mmol/24 h) 
0.03 0.05 -0.01 -0.06 0.09 -0.07 0.32 0.03 -0.12 -0.02 0.15 0.35 0.33 0.34 0.26 0.14 0.22 -0.14 -0.13 -0.14 -0.07 0.01 0.37  0.48 0.25 
Urinary 
magnesium 
(mmol/24 h) 
-0.03 0.06 -0.07 -0.10 0.10 -0.10 0.14 0.03 -0.10 0.02 0.08 0.24 0.23 0.21 0.14 0.03 0.20 -0.01 -0.03 -0.02 0.02 -0.01 0.31 0.48  0.43 
Urinary calcium 
(mmol/24 h) 
-0.13 -0.03 -0.12 -0.12 0.03 -0.13 0.18 -0.06 -0.11 0.02 0.09 -0.02 -0.02 -0.01 0.13 0.12 -0.01 0.12 0.15 0.10 0.01 0.01 0.32 0.25 0.43  
1 
Adjusted for age, gender, and population sample. 
2
 Correlation coefficients are statistically significant, except those ranging from -0.03 to 0.03. 
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Table  4.2. Variables by quintiles of glycaemic index in UK and USA INTERMAP participants, n=2385 
1,2
 
 Glycaemic index      
  Quintile 1 Quintile 2 Quintile 3 Quintile 4 Quintile 5   
Variable mean SE mean SE mean SE mean SE mean SE P for trend 
n 594   595   595   595         
Median 56.7  60.8  63.3  66.4  74.4   
Men (%) 41   42   41   42    41     
Education (y) 
3
 14.7 0.1 14.6 0.1 14.4 0.1 14.5 0.1 14.6 0.1 0.50 
Engagement in moderate and 
heavy physical activity (h/24 h) 
3
 
3.1 0.1 3.0 0.1 3.0 0.1 3.1 0.1 3.0 0.1 0.99 
Systolic BP (mm Hg) 
3
 117.9 0.6 119.0 0.6 119.2 0.6 119.2 0.6 118.8 0.6 0.55 
Diastolic BP (mm Hg) 
3
 73.8 0.4 74.8 0.4 74.2 0.4 74.2 0.4 73.9 0.4 0.52 
Body mass index (kg/m
2
) 
3
 27.7 0.2 28.5 0.2 28.5 0.2 28.3 0.2 28.4 0.2 0.15 
Total energy (kcal/24 h) 2239.0 24.1 2365.4 24.1 2341.1 24.1 2383.0 24.1 2313.4 24.6 0.0002 
Food energy (kcal/24 h) 1788.4 21.4 1947.5 21.4 1936.6 21.4 1976.8 21.4 1935.0 21.8 1.65×10
-09
 
Beverage energy (kcal/24 h) 445.7 11.0 414.2 11.0 397.6 11.0 399.8 11.0 372.8 11.2 0.0001 
Food weight (g/24 h) 1112.3 14.8 1136.6 14.8 1081.6 14.8 1088.7 14.8 1056.4 15.1 0.003 
Beverage weight (g/24 h) 
4
 1707.0 33.3 1571.8 33.3 1554.2 33.3 1553.4 33.3 1607.4 34.0 0.05×10
-01
 
Dietary energy density                        
Food only (kcal/g) 1.7 0.02 1.8 0.02 1.8 0.02 1.9 0.02 1.9 0.02 4.14×10
-21
 
Food and beverages (kcal/g) 0.8 0.01 0.9 0.01 1.0 0.01 1.0 0.01 0.9 0.01 2.75×10
-15
 
Nutrient density                            
(Nutrient Rich Food 9.3 index 
score)
3
 
36.0 0.6 31.3 0.6 28.4 0.6 28.4 0.6 29.9 0.6 3.73×10
-22
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Food Groups (g/1000 kcal)                       
Whole fat dairy  24.9 1.8 28.5 1.8 25.7 1.8 25.2 1.8 25.8 1.9 0.64 
Low or medium-fat dairy 110.4 3.9 94.0 3.9 76.9 3.9 70.6 3.9 82.4 4.0 4.37×10
-13
 
Meat 25.6 1.0 27.0 1.0 27.8 1.0 28.8 1.0 25.0 1.0 0.05 
Fish  7.8 0.6 8.2 0.6 7.6 0.6 7.2 0.6 6.5 0.6 0.33 
Raw vegetables  32.4 1.3 27.8 1.3 27.3 1.3 26.4 1.3 26.1 1.3 0.05×10
-01
 
Cooked vegetables  58.0 1.8 52.8 1.8 45.8 1.8 45.5 1.8 43.7 1.8 6.90×10
-09
 
Potatoes  30.7 1.4 36.9 1.4 40.6 1.4 40.6 1.4 38.4 1.4 6.70×10
-07
 
Fruit  68.7 2.7 54.3 2.7 43.8 2.7 43.4 2.7 46.3 2.8 2.38×10
-12
 
Cakes and pies  5.1 0.6 6.1 0.6 7.1 0.6 5.4 0.6 5.2 0.6 0.08 
Nutrients                        
Total Carbohydrate (%kcal) 47.3 0.3 48.9 0.3 48.7 0.3 48.5 0.3 48.7 0.4 0.01 
Starch (%kcal) 22.5 0.2 22.9 0.2 22.9 0.2 23.5 0.2 24.2 0.2 8.30×10
-06
 
Estimated Total Sugar (%kcal) 25.1 0.3 26.2 0.3 26.0 0.3 25.3 0.3 24.7 0.3 0.09×10
-01
 
Fructose (%kcal) 5.0 0.1 5.0 0.1 4.8 0.1 4.6 0.1 4.1 0.1 1.13×10
-07
 
Galactose (%kcal) 0.1 0.02 0.04 0.01 0.03 0.01 0.04 0.01 0.04 0.01 5.46×10
-12
 
Glucose (%kcal) 5.0 0.1 5.1 0.1 5.1 0.1 5.0 0.1 4.6 0.1 0.01 
Lactose (%kcal) 2.8 0.1 2.6 0.1 2.2 0.1 2.1 0.1 2.4 0.1 2.24×10
-11
 
Maltose (%kcal) 0.6 0.03 0.6 0.03 0.6 0.03 0.8 0.03 0.9 0.03 6.49×10
-20
 
Sucrose (%kcal) 9.4 0.2 10.9 0.2 11.3 0.2 10.9 0.2 10.6 0.2 2.83×10
-08
 
Total fibre (g/1000 kcal) 10.7 0.1 9.3 0.1 8.6 0.1 8.8 0.1 9.6 0.1 2.82×10
-27
 
Total protein (%kcal) 15.8 0.1 15.5 0.1 15.1 0.1 15.0 0.1 15.1 0.1 1.21×10
-05
 
Animal protein (%kcal) 10.1 0.1 10.1 0.1 9.9 0.1 9.7 0.1 9.5 0.1 0.01 
Vegetable protein (%kcal) 5.5 0.1 5.2 0.1 5.1 0.1 5.2 0.1 5.4 0.1 3.48×10
-06
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Total fat (%kcal) 32.0 0.3 33.2 0.3 33.9 0.3 33.8 0.3 33.2 0.3 4.91×10
-05
 
Total SFA (%kcal) 10.6 0.1 11.1 0.1 11.4 0.1 11.1 0.1 11.1 0.1 0.001 
Total MFA (%kcal) 11.6 0.1 12.0 0.1 12.3 0.1 12.3 0.1 12.1 0.1 0.0001 
Total PFA (%kcal) 6.6 0.1 6.9 0.1 7.0 0.1 7.1 0.1 6.9 0.1 0.002 
Cholesterol (mg/1000 kcal) 121.5 2.5 128.5 2.5 129.5 2.5 131.9 2.5 130.1 2.5 0.04 
24-hour urinary excretion data 
(mmol/24 h) 
3
 
           
Sodium  151.1 2.5 162.5 2.5 158.4 2.5 167.1 2.5 160.3 2.5 0.0002 
Potassium  63.2 0.9 62.0 0.9 57.5 0.9 57.4 0.9 60.3 0.9 2.19×10
-07
 
Magnesium  4.3 0.1 4.2 0.1 4.0 0.1 4.1 0.1 4.3 0.1 0.001 
Calcium  4.2 0.1 4.3 0.1 4.1 0.1 4.2 0.1 4.4 0.1 0.18 
Weight status (%) 
5
                       
Normal weight  149 31.3 138 28.9 141 29.6 148 31.0 135 28.3   
Overweight  207 43.5 187 39.1 185 38.9 174 36.4 189 39.6   
Obese 120 25.2 153 32.0 150 31.5 156 32.6 153 32.1 0.26 
1 
Presented as mean and SE. 
2 
Model 1 adjusted for gender, age, and population sample. 
3 
Model 1a adjusted for variables in Model 1 plus total energy intake. 
4 
Drinking water excluded.                                                                                                                                                                                                                                                                                                                                                 
5 
Chi square. 
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Table  4.3. Estimated mean systolic and diastolic BP differences per 2SD higher glycaemic index in UK and USA INTERMAP participants 
1
 
   Systolic BP 
  
Diastolic BP 
  
   Not adjusted for BMI Adjusted for BMI 
  
Not adjusted for BMI Adjusted for BMI 
  
Model n Difference, 
mm Hg 
95% CI p Difference, 
mm Hg 
95% CI p Difference, 
mm Hg 
95% CI p Difference, 
mm Hg 
95% CI p 
Glycaemic index                          
Model 1 2385 0.04 -1.0, 1.1 0.95 0.3 -0.7, 1.4  0.52 0.5 -0.2, 1.3 0.16 0.7 0.1, 1.4 0.05 
Model 2 2385 0.4  -0.7, 1.4 0.50 0.2 -0.8, 1.2 0.66 0.7 -0.04, 1.5 0.06 0.6 -0.6, 1.4  0.08 
Sensitivity analyses using model 2                          
Censored regression  1898 0.01 0.02, 0.01 0.02 0.01 0.01, 0.02 0.01 0.02 0.01, 0.03 0.002 0.02 0.01, 0.03 0.001 
Excluding those with high 
variability in their diet  
1870 0.7 -0.5, 1.8 0.29 0.4 -0.8, 1.5 0.54 0.8 -0.01, 1.6 0.05 0.6 -0.2, 1.4 0.11 
Excluding those following a special 
diet  
2243 0.3 -0.8, 1.4 0.58 0.02 -0.8, 1.3 0.60 0.8 0.05, 1.6 0.04 0.8 0.1, 1.5 0.04 
Excluding those diagnosed with 
DM and/or CVD 
2,3
 
2054 0.3 -0.9, 1.5 0.61 0.2 -0.8, 1.9 0.69 0.8 -0.01, 1.5 0.07 0.7 -0.01, 1.5 0.07 
Model 1 adjusted f for age, gender, total energy intake (kcal/24-hours), total protein (%kcal), total fat (%kcal), and population sample.                                                                                                                                                                                              
Model 2 adjusted for variables in Model 2 plus adherence to a special diet, engagement in moderate and heavy physical activity (h/24 h), smoking, dietary supplement use, years of education (years completed), 
alcohol intake (g/24-hours), DM or CVD diagnosis, family history of high BP, 24-hour urinary excretion of sodium (mmol/24-hours).                                                                                                                                                   
1
 2SD of GI=17.6.                                                                                                                                                                                                                                                                                                                                                                                                   
2 
2SD of GI=16.7.                                                                                                                                                                                                                                                                                                                                                                                                                                                             
3
 Not adjusted for DM or CVD diagnosis. 
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Table  4.4. Estimated mean systolic and diastolic BP differences per 2SD higher glycaemic load in UK and USA INTERMAP participant 
1
 
   Systolic BP 
  
Diastolic BP 
  
   Not adjusted for BMI Adjusted for BMI 
  
Not adjusted for BMI Adjusted for BMI 
  
Model n Difference, 
mm Hg 
95% CI p Difference, 
mm Hg 
95% CI p Difference, 
mm Hg 
95% CI p Difference, 
mm Hg 
95% CI p 
Glycaemic load                          
Model 1 2385 0.3 -2.2, 2.8 0.82 3.0 1.1, 4.9 0.002 0.9 -0.8, 2.7 0.30 2.3 0.9, 3.6 0.001 
Model 2 2385 0.6 -1.7, 2.9 0.62 0.2 -2.2, 2.6 0.87 1.4 -0.2, 3.0 0.09 1.1 -2.7, 0.6 0.22 
Sensitivity analyses using model 2              
Censored regression 
2
 1898 0.01 -0.02, 0.02 0.23 0.01 -0.02, 0.04 0.28 0.04 0.02, 0.1 0.03 0.04 0.02, 0.06 0.03 
Excluding those with high variability 
in their diet 
2
 
1870 0.6 -3.4, 2.3 0.69 0.3 -2.5, 3.0                                                                                                                             0.85 1.5 -3.3, 0.3 0.10 1.4 -0.5, 3.2  0.16 
Excluding those following a special 
diet 
3
 
2243 0.6 -2.9, 1.8 0.65 0.2 -2.2, 2.6 0.86 1.7 0.1, 3.3 0.04 1.3 -0.4, 3.0 0.13 
Excluding those diagnosed with DM 
and/or CVD 
4,5  
                                                                                                                             
2054 0.5 -2.0, 3.0 0.66 0.5 -1.9, 2.9 0.66 1.6 -0.1, 3.4 0.06 1.6 -0.03, 3.3 0.05 
Model 1 adjusted f for age, gender, total energy intake (kcal/24-hours), total protein (%kcal), total fat (%kcal), and population sample.                                                                                                                                                                                              
Model 2 adjusted for variables in Model 2 plus adherence to a special diet, engagement in moderate and heavy physical activity (h/24 h), smoking, dietary supplement use, years of education (years completed), 
alcohol intake (g/24-hours), DM or CVD diagnosis, family history of high BP, 24-hour urinary excretion of sodium (mmol/24-hours).                                                                                                                                                       
1 
2SD of GL=119.6.                                                                                                                                                                                                                                                                                                                                                                                              
2 
2SD of GL=114.4.                                                                                                                                                                                                                                                                                                                                                                    
3 
2SD of GL=120.3.                                                                                                                                                                                                                                                                                                                                                                          
4 
2SD of GL=119.4.                                                                                                                                                                                                                                                                                                                                                                                                                                                                               
5
 Not adjusted for DM or CVD diagnosis. 
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Table  4.5. Estimated mean BMI difference per 2SD higher glycaemic index in UK and USA INTERMAP 
participants 
1
 
   BMI  
Model n Difference, kg/m
2
 95% CI p 
Glycaemic index     
Model 1 2385 0.1 -0.4, 0.5 0.82 
Model 2 2385 0.01 -0.4, 0.4 0.96 
Sensitivity analyses using model 2     
Excluding those with high variability in their diet  1870 -0.3 -0.7, 0.2 0.29 
Excluding those following a special diet  2243 0.1 -0.4, 0.5 0.78 
Excluding those diagnosed with DM and/or CVD 
2
 2054 0.01 -0.5, 0.5 0.95 
Model 1 adjusted for age, gender, total energy intake (kcal/24-hours), total protein (%kcal), total fat (%kcal), and population 
sample.                                                                                                                                                                                                                              
Model 2 adjusted for variables in Model 1 plus adherence to a special diet, engagement in moderate and heavy physical activity 
(h/24 h), smoking, dietary supplement use, years of education (years completed), and alcohol intake (g/24-hours).                                  
1
 2SD of GI=17.6.                                                                                                                                                                                                                             
2 
2SD of GI=16.7. 
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Table  4.6. Estimated mean BMI difference per 2SD higher glycaemic load in UK and USA INTERMAP 
participants 
1
 
   BMI  
Model n Difference, kg/m
2
 95% CI p 
Glycaemic load     
Model 1 2385 0.1 -0.9, 1.2 0.78 
Model 2 2385 0.1 -0.9, 1.1 0.88 
Sensitivity analyses using model 2     
Excluding those with high variability in their diet 
2
 1870 -0.002 -1.3, 0.9 0.75 
Excluding those following a special diet 
3
 2243 0.02 -1.0, 1.0 0.97 
Excluding those diagnosed with DM and/or CVD 
4
 2054 0.2 -0.9, 1.2 0.74 
Model 1 adjusted for age, gender, total energy intake (kcal/24-hours), total protein (%kcal), total fat (%kcal), and population 
sample.                                                                                                                                                                                                                              
Model 2 adjusted for variables in Model 1 plus adherence to a special diet, engagement in moderate and heavy physical activity 
(h/24 h), smoking, dietary supplement use, years of education (years completed), and alcohol intake (g/24-hours).                                   
1 
2SD of GL=119.6.                                                                                                                                                                                                             
2 
2SD of GL=114.4.                                                                                                                                                                                                                                                                                            
3 
2SD of GL=120.3.                                                                                                                                                                                                                        
4 
2SD of GL=119.4. 
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Table  4.7. Estimated mean systolic and diastolic BP differences per 2SD higher intakes of total fibre in USA INTERMAP participants 
1
 
  Systolic BP 
  
Diastolic BP 
  
  Not adjusted for BMI Adjusted for BMI 
  
Not adjusted for BMI Adjusted for BMI 
  
Model n Difference, 
mm Hg 
95% CI p Difference, 
mm Hg 
95% CI p Difference, 
mm Hg 
95% CI p Difference, 
mm Hg 
95% CI p 
Total fibre 
2
                          
Model 1 1941 -3.5 -4.8, -2.2 3.23×10
-07
 -2.4 -3.7, -1.1 0.0002 -1.7 -2.7, -0.8 0.0003 -1.1 -2.0, -0.2 0.02 
Model 2 1941 -3.0 -4.3, -1.6 2.79×10
-05
 -1.7 -3.0, -0.4 0.01 -1.5 -2.4, -0.5 0.003 -0.7 -1.7, 0.2 0.14 
Model 3 1941 -3.0 -4.3, -1.7 2.99×10
-05
 -1.7 -3.0, -0.3 0.02 -1.4 -2.4, -0.4 0.06×10
-01
 -0.6 -1.5, 0.4 0.26 
Model 4 1941 -2.8 -4.4, -1.6 0.0001 -1.1 -2.6, 0.3 0.12 -1.3 -2.3, -0.2 0.02 -0.2 -1.2, 0.8 0.67 
Model 5 1941 -3.0 -4.2, -1.4 2.32×10
-05
 -1.8 -3.1, -0.4 0.01 -1.5 -2.4, -0.5 0.003 -0.7 -1.7, 0.2 0.12 
Sensitivity analyses using 
model 2 
                         
Censored regression 
3
 1517 -0.7 -0.9, -0.2 1.45×10
-06
 -0.5 -0.6, -0.1 0.001 -0.3 -0.4, -0.1 0.0003 -0.2 -0.3, -0.1 0.04 
Excluding those with high 
variability in their diet 
3 
 
1506 -2.5 -4.0, -0.9 0.002 -1.4 -2.9, 0.04 0.06 -1.3 -2.3, -0.3 0.01 -0.7 -1.7, 0.3 0.17 
Excluding those following 
a special diet 
4 
 
1825 -2.9 -4.2, -1.5 6.32×10
-05
 -1.7 -3.0, -0.3 0.02 -1.5 -2.5, -0.5 0.003 -0.8 -1.7, 0.2 0.10 
Excluding those diagnosed 
with DM and/or CVD 
5
 
1650 -3.1 -4.5, -1.7 2.52×10
-05
 -1.8 -3.2, -0.5 0.09×10
-01
 -1.7 -2.7, -0.7 0.001 -0.9 -1.9, 0.1 0.08 
Model 1 adjusted for age, gender, total energy intake (kcal/24-hours), total protein (%kcal), total fat (%kcal), and population sample.                                                                                                                                                                                         
Model 2 adjusted for variables in Model 2 plus adherence to a special diet, engagement in moderate and heavy physical activity (h/24 h), smoking, dietary supplement use, years of education (years completed), 
alcohol intake (g/24-hours), DM or CVD diagnosis, family history of high BP, 24-hour urinary excretion of sodium (mmol/24-hours).                                                                                                                                                                                                                                                    
Model 3 for variables in Model 2 plus 24-hour urinary excretion of magnesium (mmol/24 h).                                                                                                                                                                                                                                          
Model 4 for variables in Model 2 plus 24-hour urinary excretion of potassium (mmol/24 h).                                                                                                                                                                                                                                                                 
Model 5 for variables in Model 2 plus 24-hour urinary excretion of calcium (mmol/24 h).                                                                                                                                                                                                                                                       
1
 2SD of total fibre (g/1000 kcal)=6.6.                                                                                                                                                                                                                                                                                                                                     
2 
Additionally adjusted for total sugar (%).                                                                                                                                                                                                                                                                                                                      
3
 2SD of total fibre (g/1000 kcal)=6.3.                                                                                                                                                                                                                                                                                                                                
4
 2SD of total fibre (g/1000 kcal)=6.4.                                                                                                                                                                                                                                                                                                                                                                                                                                                 
5
 Not adjusted for DM or CVD diagnosis.                                                                                                                                                                                                                                                                                                                          
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Table  4.8. Estimated mean systolic and diastolic BP differences per 2SD higher intake of insoluble fibre in USA INTERMAP participants 
1
 
  Systolic BP 
  
Diastolic BP 
  
   Not adjusted for BMI Adjusted for BMI 
  
Not adjusted for BMI Adjusted for BMI 
  
Model n Difference, 
mm Hg 
95% CI p Difference, 
mm Hg 
95% CI p Difference, 
mm Hg 
95% CI p Difference, 
mm Hg 
95% CI p 
Insoluble fibre 
2
                          
Model 1 1941 -3.3 -5.2, -1.3 0.001 -2.1 -4.0, -0.3 0.03 -1.9 -3.2, -0.5 0.08×10
-01
 -1.2 -2.5, 0.1 0.08 
Model 2 1941 -3.2 -5.1, -1.2 0.002 -2.0 -3.9, -0.1 0.04 -1.7 -3.1, -0.4 0.01 -1.0 -2.4, 0.3 0.12 
Model 3 1941 -3.2 -5.1, -1.2 0.001 -1.9 -3.8, -0.1 0.04 -1.7 -3.0, -0.3 0.02 -0.9 -2.2, 0.4 0.17 
Model 4 1941 -3.1 -5.0, -1.1 0.002 -1.8 -3.7, 0.1 0.06 -1.7 -3.0, -0.3 0.02 -0.8 -2.1, 0.5 0.21 
Model 5 1941 -1.7 -3.1, -0.4 0.01 -2.0 -3.8, -0.1 0.04 -1.7 -3.1, -0.4 0.01 -1.0 -2.3, 0.3 0.12 
Sensitivity analyses using model 2                          
Censored regression 
3
 1517 -0.4 -0.6, -0.2 2.53×10
-05
 -0.3 -0.5, -0.1 0.002 -0.3 -0.5, -0.2 0.0004 -0.2 -0.4, -0.1 0.02 
Excluding those with high 
variability in their diet 
3 
 
1506 -2.8 -5.0, -0.6 0.01 -1.9 -3.9, 0.2 0.08 -1.3 -2.8, 0.1 0.08 -0.8 -2.2, 0.7 0.31 
Excluding those following a special 
diet  
1825 -3.2 -5.3, -1.2 0.002 -1.9 -3.9, 0.1 0.06 -2.1 -3.5, -0.6 0.05×10
-01
 -1.2 -2.6, 0.2 0.08 
Excluding those diagnosed with 
DM and/or CVD 
4,5 
 
1650 -3.2 -5.2, -1.1 0.003 -2.0 -3.9, 0.1 0.06 -1.9 -3.3, -0.4 0.01 -1.1 -2.5, 0.3 0.13 
Model 1 adjusted for age, gender, total energy intake (kcal/24-hours), total protein (%kcal), total fat (%kcal), and population sample.                                                                                                                                                                                                       
Model 2 adjusted for variables in Model 2 plus adherence to a special diet, engagement in moderate and heavy physical activity (h/24 h), smoking, dietary supplement use, years of education (years completed), 
alcohol intake (g/24-hours), DM or CVD diagnosis, family history of high BP, 24-hour urinary excretion of sodium (mmol/24-hours).                                                                                                                                                                                                                                                        
Model 3 for variables in Model 2 plus 24-hour urinary excretion of magnesium (mmol/24 h).                                                                                                                                                                                                                                                      
Model 4 for variables in Model 2 plus 24-hour urinary excretion of potassium (mmol/24 h).                                                                                                                                                                                                                                                                 
Model 5 for variables in Model 2 plus 24-hour urinary excretion of calcium (mmol/24 h).                                                                                                                                                                                                                                    
1
 2SD of insoluble fibres (g/1000 kcal)=4.4.                                                                                                                                                                                                                                                                                                                            
2
 Additionally adjusted for total sugar (%) and soluble fibre (g/1000 kcal).                                                                                                                                                                                                                                                                        
3
 2SD of insoluble fibres (g/1000 kcal)=4.3.                                                                                                                                                                                                                                                                                                                       
4
 2SD of insoluble fibres (g/1000 kcal)=4.5.                                                                                                                                                                                                                                                                                                                                                                                                                        
5
 Not adjusted for DM or CVD diagnosis. 
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Table  4.9. Estimated mean systolic and diastolic BP difference per 2SD higher intake of soluble fibre in USA INTERMAP participants 
1
 
   Systolic BP Diastolic BP 
   Not adjusted for BMI Adjusted for BMI Not adjusted for BMI Adjusted for BMI 
Variable n Difference, 
mm Hg 
95% CI p Difference, 
mm Hg 
95% CI p Difference, 
mm Hg 
95% CI p Difference, 
mm Hg 
95% CI p 
Soluble fibre 
2
                          
Model 1 1941 -0.2 -2.3, 1.9 0.86 -0.5 -2.5, 1.6 0.66 0.1 -1.4, 1.5 0.94 -0.1 -1.5, 1.3 0.89 
Model 2 1941 0.1 -2.0, 2.2 0.94 -0.02 -2.0, 2.0 0.99 0.1 -1.4, 1.6 0.92 0.02 -1.4, 1.4 0.98 
Model 3 1941 0.1 -2.1, 2.2 0.96 -0.03 -2.3, 1.7 0.99 0.1 -1.4, 1.6 0.90 0.1 -1.4, 1.5 0.95 
Model 4 1941 0.2 -1.9, 2.3 0.86 0.3 -2.0, 2.1 0.76 0.2 -1.3, 1.7 0.79 0.3 -1.2, 1.7 0.97 
Model 5 1941 0.02 -2.1, 2.1 0.98 -0.1 -2.1, 1.9 0.94 0.1 -1.4, 1.5 0.95 -0.02 -1.4, 1.4 0.98 
Sensitivity analyses using model 2                          
Censored regression 
3
 1517 0.01 -0.01, 0.03 0.53 0.01 -0.01, 0.03 0.35 0.01 -0.02, 0.03 0.52 0.01 -0.02, 0.03 0.28 
Excluding those with high variability in 
their diet 
3 
 
1506 0.1 -2.1, 2.2 0.95 0.01 -2.1, 2.1 0.99 -0.1 -1.5, 1.4 0.92 -0.1 -1.5, 1.3 0.88 
Excluding those following a special diet 
4 
 1825 0.5 -1.6, 2.6 0.65 0.2 -1.8, 2.3 0.82 0.5 -1.0, 1.8 0.51 0.3 -1.1, 1.8 0.64 
Excluding those diagnosed with DM 
and/or CVD 
4,5 
 
1650 0.1 -2.1, 2.3 0.96 0.01 -2.1, 2.1 0.98 0.2 -1.4, 1.7 0.85 0.1 -1.4, 1.6 0.87 
Model 1 adjusted for age, gender, total energy intake (kcal/24-hours), total protein (%kcal), total fat (%kcal), and population sample.                                                                                                                                                                                                       
Model 2 adjusted for variables in Model 2 plus adherence to a special diet, engagement in moderate and heavy physical activity (h/24 h), smoking, dietary supplement use, years of education (years completed), 
alcohol intake (g/24-hours), DM or CVD diagnosis, family history of high BP, 24-hour urinary excretion of sodium (mmol/24-hours).                                                                                                                                                                                                                                                    
Model 3 for variables in Model 2 plus 24-hour urinary excretion of magnesium (mmol/24 h).                                                                                                                                                                                                                                                      
Model 4 for variables in Model 2 plus 24-hour urinary excretion of potassium (mmol/24 h).                                                                                                                                                                                                                                                                 
Model 5 for variables in Model 2 plus 24-hour urinary excretion of calcium (mmol/24 h).                                                                                                                                                                                                                                    
1
 2SD of soluble fibres (g/1000 kcal)=2.2.   
2
 Additionally adjusted for total sugar (%) and insoluble fibre (g/1000 kcal).                                                                                                                                                                                                                                                                
3
 2SD of soluble fibres (g/1000 kcal)=2.0.                                                                                                                                                                                                                                                                                                                                      
4
 2SD of soluble fibres (g/1000 kcal)=2.1.                                                                                                                                                                                                                                                                                                                        
                           
5
 Not adjusted for DM or CVD diagnosis. 2SD  
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Table  4.10. Estimated mean BMI difference per 2SD higher intake of total fibre in USA INTERMAP 
participant 
1
 
   BMI  
Model n Difference, kg/m
2
 95% CI p 
Total fibre (g/1000 kcal) 
2
     
Model 1 1941 -1.5 -2.0, -0.9 2.02×10
-07
 
Model 2 1941 -1.7 -2.3, -1.2 2.45×10
-09
 
Model 3 1941 -1.9 -2.5, -1.3 1.25×10
-10
 
Model 4 1941 -2.3 -2.9, -1.7 2.64×10
-14
 
Model 5 1941 -1.7 -2.3, -1.2 3.53×10
-09
 
Sensitivity analyses using model 2     
Excluding those with high variability in their diet 
3
 1506 -1.5 -2.2, -0.9 3.82×10
-06
 
Excluding those following a special diet 
4
 1825 -1.7 -2.3, -1.1 2.18×10
-08
 
Excluding those diagnosed with DM and/or CVD  1650 -1.7 -2.2, -1.1 4.03×10
-08
 
Model 1 adjusted for age, gender, total energy intake (kcal/24-hours), total protein (%kcal), total fat (%kcal), and population 
sample.                                                                                                                                                                                                               
Model 2 adjusted for variables in Model 1 plus adherence to a special diet, engagement in moderate and heavy physical 
activity (h/24 h), smoking, dietary supplement use, years of education (years completed), and alcohol intake (g/24-hours).                                                                                                                              
Model 3 for variables in Model 2 plus 24-hour urinary excretion of magnesium (mmol/24 h).                                                                                                                              
Model 4 for variables in Model 2 plus 24-hour urinary excretion of potassium (mmol/24 h).                                                                            
Model 5 for variables in Model 2 plus 24-hour urinary excretion of calcium (mmol/24 h).                                                                         
1
 2SD of total fibre (g/1000 kcal)=6.6.                                                                                                                                                                                                                                                          
2 
Additionally adjusted for total sugar (%).                                                                                                                                                                                                                                                                            
3
 2SD of total fibre (g/1000 kcal)=6.3.                                                                                                                                                                                                                                                                                            
4
 2SD of total fibre (g/1000 kcal)=6.4.                                                                                                                                                                                           
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Table  4.11. Estimated mean BMI difference per 2SD higher intake of insoluble fibre in USA 
INTERMAP participants 
1
 
   BMI 
 
Model n Difference, kg/m
2
 95% CI p 
Insoluble fibre (g/1000 kcal) 
2
   
   
Model 1 1941 -1.6 -2.4, -0.8 0.0002 
Model 2 1941 -1.7 -2.5, -0.9 3.75×10
-05
 
Model 3 1941 -1.8 -2.6, -1.0 8.95×10
-06
 
Model 4 1941 -1.9 -2.7, -1.1 2.19×10
-06
 
Model 5 1941 -1.7 -2.5, -0.9 4.06×10
-05
 
Sensitivity analyses using model 2     
Excluding those with high variability in their diet 
3
 1506 -1.5 -2.4, -0.6 0.002 
Excluding those following a special diet  1825 -1.8 -2.7, -1.0 6.10×10
-07
 
Excluding those diagnosed with DM and/or CVD 
4
 1650 -1.7 -2.4, -0.7 0.0003 
Model 1 adjusted for age, gender, total energy intake (kcal/24-hours), total protein (%kcal), total fat (%kcal), and population 
sample.                                                                                                                                                                                                                       
Model 2 adjusted for variables in Model 1 plus adherence to a special diet, engagement in moderate and heavy physical 
activity (h/24 h), smoking, dietary supplement use, years of education (years completed), and alcohol intake (g/24-hours).                                                          
Model 3 for variables in Model 2 plus 24-hour urinary excretion of magnesium (mmol/24 h).                                                                                                                              
Model 4 for variables in Model 2 plus 24-hour urinary excretion of potassium (mmol/24 h).                                                                                                                              
Model 5 for variables in Model 2 plus 24-hour urinary excretion of calcium (mmol/24 h).                                                                                    
1
 2SD of insoluble fibres (g/1000 kcal)=4.4.                                                                                                                                                                                                                
2
 Additionally adjusted for total sugar (%) and soluble fibre (g/1000 kcal).                                                                                                                                                                                                           
3
 2SD of insoluble fibres (g/1000 kcal)=4.3.                                                                                                                                                                                                                                                                                    
4
 2SD of insoluble fibres (g/1000 kcal)=4.5.                                                                                                                                                                                       
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Table  4.12. Estimated mean BMI difference per 2SD higher intake of soluble fibre in USA INTERMAP 
participants 
1
 
   BMI 
 
Model n Difference, kg/m
2
 95% CI p 
Soluble fibre (g/1000 kcal) 
2
  
   
Model 1 1941 0.3 -0.5, 1.2 0.45 
Model 2 1941 0.1 -0.8, 1.0 0.80 
Model 3 1941 0.1 -0.8, 1.0 0.86 
Model 4 1941 -0.2 -1.1, 0.7 0.62 
Model 5 1941 0.1 -0.7, 1.0 0.78 
Sensitivity analyses using model 2     
Excluding those with high variability in their diet 
3
 1506 -0.1 -1.1, 0.8 0.77 
Excluding those following a special diet 
4
 1825 0.02 0.9, 1.0 0.93 
Excluding those diagnosed with DM and/or CVD
 4
 1650 -0.3 -1.2, 0.6 0.54 
Model 1 adjusted for age, gender, total energy intake (kcal/24-hours), total protein (%kcal), total fat (%kcal), and population 
sample.                                                                                                                                                                                                                  
Model 2 adjusted for variables in Model 1 plus adherence to a special diet, engagement in moderate and heavy physical 
activity (h/24 h), smoking, dietary supplement use, years of education (years completed), and alcohol intake (g/24-hours).                                                                               
Model 3 for variables in Model 2 plus 24-hour urinary excretion of magnesium (mmol/24 h).                                                                                                                              
Model 4 for variables in Model 2 plus 24-hour urinary excretion of potassium (mmol/24 h).                                                                                                                              
Model 5 for variables in Model 2 plus 24-hour urinary excretion of calcium (mmol/24 h).                                                                        
1
 2SD of soluble fibres (g/1000 kcal)=2.2.   
2
 Additionally adjusted for total sugar (%) and insoluble fibre (g/1000 kcal).                                                                                                                                                                                                                            
3
 2SD of soluble fibres (g/1000 kcal)=2.0.                                                                                                                                                                                                                                                            
4
 2SD of soluble fibres (g/1000 kcal)=2.1.                                                                                                                                                                                                                                                                         
  
Figure  4.1. Glycaemic index and total fibre intake in relation to s
participants, n=2385 
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Figure  4.2. Glycaemic index and total fibre intake in relation to diastolic 
participants, n=2385 
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Figure  4.3. Glycaemic index and total fibre intake in relation to body mass index in UK and USA 
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5. DISCUSSION 
5.1. Main findings 
• A higher number of eating occasions per day was associated with lower BP and 
BMI, as well as lower dietary energy density and higher nutrient density. 
• Higher evening relative to morning energy intake was directly associated with 
BMI. 
• Glycaemic index and glycaemic load were not associated with BP or BMI. 
• Total and insoluble fibre intakes were inversely associated with BP and BMI. 
• Soluble fibre was not associated with BP or BMI.  
• Participants with the highest GI and lowest fibre intake had the highest BP and 
BMI levels compared to participants with the lowest GI and highest fibre intake. 
This study has demonstrated that frequent consumption of meals was associated with 
lower BP and BMI, which maybe due to a lower dietary energy density and a higher 
nutritional quality eating pattern. The inverse association between eating frequency and 
systolic BP was independent of BMI. In multivariable regression analysis adjusted for 
lifestyle and dietary confounders, eating occasions higher by 2SD were associated with 
systolic BP lower by 1.6 mm Hg, and the adjustment for BMI only slightly reduced the 
regression coefficient values (Table 3.6). In addition, eating occasions higher by 2SD 
were associated with BMI lower by 1.1 kg/m
2 
[equivalent to >3.2 kg in weight], 
adjusted for lifestyle and dietary confounders (Table 3.7). These findings support the 
first and second hypotheses: an inverse association between the number of eating 
occasions, nutrient density and BP, BMI; a direct association of dietary energy density 
and both BP and BMI. 
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Multivariable regression analysis showed that the ratio of evening to morning energy 
intake was directly associated with BMI, whereas this consumption pattern was not 
associated with BP level. These findings support the hypothesis that a direct association 
exists between the ratio of evening to morning energy intake and BMI, however not 
BP. In gender>specific analysis, the ratio of evening to morning energy intake was 
significantly and directly associated with BMI in women (Table A.11). 
When the association of GI, GL and BP, BMI was analysed, the results showed no 
evidence of a direct association in any of the models (Table 4.3, 4.4, 4.5, and 4.6). 
These findings do no support the hypothesis of a direct association between GI, GL and 
BP, BMI. Only the results of censored regression for antihypertensive medication use 
revealed a direct and significant association between GI, GL and systolic and diastolic 
BP, independent of BMI. However, differences in systolic and diastolic BP associated 
with 2SD higher GI, GL were small (ranging from 0.01 mm Hg for systolic BP to 0.04 
mm Hg for diastolic BP).  
Total fibre intake higher by 7 g/1000 kcal was associated with systolic and diastolic BP 
lower by 1.7 and 0.7 mm Hg, respectively, independent of BMI. The findings obtained 
for insoluble fibre were similar to total fibre, with an inverse association with systolic 
BP, independent of soluble fibre intake and BMI (Table 4.8). Finally, no evidence in 
support of an inverse association between soluble fibre and BP was found (Table 4.9).  
Total and insoluble fibre intakes were inversely associated with BMI and were 
independent of the intake of nutrients known to be present in high quantities in fibre>
rich foods. Total fibre intake higher by 7 g/1000 kcal was associated with BMI lower 
by 1.7 kg/m
2
 [equivalent to >4.9 kg in weight], with multivariable adjustment (Table 
4.10). Similarly, insoluble fibre intake higher by 4 g/1000 kcal was associated with 
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BMI lower by 1.7 kg/m
2
 (Table 4.11). However, there was no evidence supporting an 
inverse association between soluble fibre intake and BMI (Table 4.12). These findings 
support the hypothesis that an inverse association exists between dietary fibre and BP, 
BMI, however not with soluble fibre.  
5.1.1. Eating behaviour 
A limited number of intervention studies have included BP in their outcome measure 
when investigating the relation between eating frequency and health, reporting lower 
BP level with high number of meals/day compared to fewer number of meals/day 
119
. 
Improvements in risk factors related to CVD, such as lower LDL, total cholesterol, 24>
hour insulin and insulin>glucose output were reported when participants were provided 
with small>frequent meals compared to large>less frequent meals/day 
120
. However, 
other similar trials found no difference in lipid profile or BP between groups assigned 
to low and high meal frequency treatments 
121,122
. These differences may potentially be 
attributed to inconsistencies in trial length, frequency of BP measurements, and 
participants’ dietary compliance.  
The findings of the INTERMAP study demonstrate that frequent eating is associated 
with lower BMI. This outcome is in accordance with eight population studies
112>
114,127,129>132
, four of which were conducted on large samples and have revealed similar 
relationships 
112,114,130,131
. However, in another eight studies, no evidence of an inverse 
relationship between eating frequency and body weight was found 
115,116,128,133>137
.  
Inconsistencies in findings reported in published studies may be attributed to studies 
being of small sample size with low statistical power 
429
, differences in dietary 
assessment methods 
141
, presence of under>reporters of energy 
142
, and the lack of a 
unified definition of what constitutes an eating occasion 
118,141,143,148,160
, especially 
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when the number of meals is self>reported 
137
. Thus, it is essential that epidemiologic 
studies employ consistent and rigorously validated assessment methods, as energy 
intake under>reporting is common, especially among women 
150,152>154
, overweight, 
obese 
145,146
, or older participants 
147
. As multiple 24>hour dietary recalls are more 
representative of typical food intake, they reduce the effect of random error due to day>
to>day variability in food intake 
157,158
. Another limitation typically affecting studies of 
eating frequency and body weight stems from the absence of an adjustment for physical 
activity level 
116,128
, which has been reported as a potential confounder in the 
association between eating frequency and body weight 
159
.  
Possible mechanisms through which eating frequency is associated with BP 
and BMI 
The biological basis of the putative beneficial effect on BP and BMI and total energy 
intake of greater eating frequency is likely to be multifactorial. Findings of several 
clinical feeding trials suggest that eating on only a few occasions during the day may 
have a negative effect on appetite control 
119,430
. Evidence indicates that, when meal 
frequency is increased, a number of hormonal and nutritional signals may enhance 
appetite suppression (e.g., ghrelin). This, in turn, may result in a reduction in energy 
intake 
431
, as well as delayed gastric emptying, leading to a decreased feeling of       
hunger 
432
. Similarly, research findings indicate that isocaloric increase in meal 
frequency in the morning may lead to a decrease in subjective feelings of hunger, 
possibly due to a complex interaction of anoretic signals from an increase in glucagon>
like peptide 1(GLP>1) and a decrease in ghrelin 
433
. Results of a randomised cross>over 
trial involving 12 men revealed that higher plasma free>fatty acids (p=0.01), and lower 
plasma GLP>1 (p=0.01) were reported in individuals who ate later in the day and in 
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large portions, compared to those that had regular breakfast and several smaller meals 
throughout the day prior to preload 
434
.  
The findings of the INTERMAP study also demonstrate an inverse association between 
eating frequency and dietary energy density. This is in line with the findings of a recent 
systematic review of cohort studies and RCTs, which indicated that most research in 
this field supports an inverse association between body weight and dietary energy 
density 
166
. Having fewer meals in a 24>hour period that consist of large portions of 
energy>dense food may promote overeating 
435
, which may be explained by the increase 
in ghrelin and the decrease in PYY associated with higher dietary energy density 
203
, 
especially that people tend to consume a consistent weight of food 
179,204,205
.  
Increased frequency of eating occasions has also been linked to improvements in 
glucose homeostasis in both prospective cohort studies 
436
 and clinical trials 
437>440
. 
Impaired glucose homeostasis has been associated with high BP level and obesity in 
adults 
441
. In a randomised cross>over pilot study, a causal relationship between 
breakfast frequency and quality and both appetite control and glycaemic control was 
established 
442
. Having fewer, larger meals a day resulted in a larger AUC of insulin 
response (p=0.01), higher fasting total cholesterol (3.43 vs. 3.14 mmol/l) and higher 
LDL (1.82 vs. 1.55 mmol/l), compared to those who consumed breakfast and generally 
ate smaller meals (p=0.001) 
443
.  
In the INTERMAP study, the consumption of a larger amount of food in the evening, 
compared to what is ingested in the morning, was directly associated with BMI. 
Furthermore, when participants were classified jointly by frequency of eating occasions 
and the ratio of evening to morning energy intake, individuals whose diets are 
characterised by a higher ratio of evening to morning energy intake were found to, on 
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average, consume their overall food intake on fewer eating occasions. It is possible that 
those individuals generally consumed larger servings, with the larger portion of their 
diet consumed in the evening. Evidence from studies on shift work provides more 
insight into the association between the time of energy intake and being overweight. 
Shift workers, particularly those that often work during the night, tend to have higher 
night>time food intake and consume larger quantities of energy dense foods 
251,444
, and 
are thus at risk of body weight gain 
241
. The observed direct association between 
evening relative to morning energy intake and BMI in the INTERMAP study may be 
linked to the possible decline in insulin sensitivity during the evening, which is caused 
by an elevation in NEFA 
254
. Findings suggest that lifestyle and dietary behaviours play 
a key role in managing healthy body weight. Participants whose total food intake is 
consumed through fewer eating occasions may typically have a lifestyle associated with 
dining out in the evening, with the meals consumed consisting of energy>dense foods 
with lower nutrient density (e.g., deep>fried foods), along with excessive alcohol 
consumption. In addition, there may be limited access to low energy>dense foods of 
high nutrient density (e.g., fruit and vegetables).  
In addition, fibre intake may have played a role in the observed inverse associations 
between BP, BMI and eating occasions, since associations were reduced when dietary 
fibre was adjusted for. This lead to further investigation into the association between 
dietary fibre, GI, GL and BP, BMI.  
5.1.2. Glycaemic index, glycaemic load and dietary fibre 
The analyses conducted as part of this study did not establish a direct association 
between GI, GL and BP or BMI. Only a few observational and cross>sectional studies 
investigated the association between GI, GL and BP, and showed inconsistent        
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findings 
308>310
, with some findings significantly inverse in White women only 
310
, or 
non>significant 
309
. Randomised feeding trials showed inconsistent findings as well, 
with some showing significant reductions in BP level following a low GI diet 
306
, and 
similar trials showing non>significant reductions in BP 
307
. For the association with 
body weight, prospective cohort studies showed that a high GI, GL was related to a 
small change in body weight, and GI, GL was inversely but non significantly related to 
body weight 
340,445
. Intervention trials examining the effect of a low GI, GL diet on 
BMI found non>significant reductions in BMI or body weight 
305,322>324,326>328,330>
332,334,336
, while only a few revealed significant reductions 
303,318,319,321,325,335
. These 
inconsistencies may be attributed to differences in reported GI, GL values, absence of 
caloric restriction, short trial duration, and participants’ adherence to the prescribed diet 
treatments 
320,321,325,327,336
. While low glycaemic diets have been linked to increased 
satiety, affecting subsequent food intake 
446>448
, and improved blood lipids and insulin 
sensitivity, these findings were only reported in one prospective cohort and one RCT 
study 
283,284
. 
One particular large cross>sectional study 
339
, the IRAS study, did not support the 
hypothesis that low GI, GL diets are associated with lower BP and BMI levels. Their 
findings indicate that increased fibre intake is more associated with lower fasting 
insulin level, waist circumference, and BMI compared to GI, GL 
339
, thus further 
investigation into the role of dietary fibre was conducted for the present study.  
Results of the INTERMAP study, involving USA participants only, revealed significant 
inverse relationships between total and insoluble dietary fibre and BP, BMI when data 
were analysed using models controlling for a wide range of potential lifestyle and 
dietary confounders. However, there was no evidence to support an inverse association 
between soluble fibre and BP, BMI. To the author’s knowledge, the present study is the 
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first to use multivariable models adjusted extensively for lifestyle and dietary 
confounders to examine the associations between total, insoluble, and soluble fibre 
intake and BP, BMI, while controlling mutually for the other types of fibre.  
Previous cross>sectional studies reported inverse associations between total fibre and 
BP 
360>365
, while others found no association 
363,366,368,369
. There have been few 
prospective cohort studies that found inverse relations between total fibre intake and BP 
change 
346
, or risk of developing hypertension 
364,365
. Some findings were significant in 
white men and women only 
346
 or findings were attenuated after adjustment for dietary 
confounders 
365
. It is worth noting that in these studies, results were based on models 
adjusted mainly for lifestyle factors, with less emphasis on dietary confounders. More 
specifically, in several studies, the models used adjusted for non>dietary confounders 
only 
360>363,366,368
, with only a few including some dietary confounders 
363,366,368
. The 
INTERMAP study used multivariable nutrient density models, adjusted for total energy 
intake and for objective measures of dietary intake from urinary data, which are not 
available in most studies. In addition, in studies examining the association of fibre and 
BP, BP was generally not the main outcome; thus, the BP measurement frequency was 
typically low, including one 
369
 or two 
363,368
, and was, in some cases,                          
self>reported 
364,365
. Additionally, the majority of these studies used data based on 
single 
363,368
 or self>reported FFQs 
364,365
, or alternatively single 24>hour dietary              
recalls 
363,369
. In the INTERMAP study, however, results were derived from high 
quality dietary data collected over four visits, with higher correlations between dietary 
and urinary variables in comparison to previously reported values 
449
. Meta>analysis of 
randomized placebo>controlled trials measuring the effect of total fibre 
supplementation on BP concluded non>significant reductions in BP 
384
. The variability 
in the results obtained in different trials may be attributed to the dose and type of fibre 
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(dietary, supplementary), the length of trial, and the washout period 
380,381,383,385,389,392
 
(especially when change in BP level is the primary study outcome), as well as the age 
of participants, sample size 
380,381,383,385,392
, and the inclusion of a body weight reduction 
plan 
379,380,382,388,392
. 
For the association between total fibre intake and body weight, some                           
cross>sectional 
339,395
 and prospective cohort studies 
346,402
 showed invers associations 
with BMI, while other cross>sectional 
396,398
 and prospective cohort 
397
 studies reported 
no association. Intervention studies revealed small 
403,404
 or non>significant reductions 
in body weight with fibre intake 
401,406,407
 
The independent association between different types of fibre and BP, BMI has been 
less thoroughly explored, as an extensive literature review conducted as a part of this 
study revealed only one cross>sectional analysis (the SU.VI.MAX) exploring different 
types of fibre in relation to risk of high BP and high BMI 
378
. This study explored the 
association between total, insoluble, and soluble fibre and CVD risk factors, while 
adjusting for some dietary confounders (saturated fat, carbohydrates, and alcohol) 
378
. 
The reported findings were compatible with those of the INTERMAP study, in that 
they revealed significant associations between total and insoluble dietary fibre and both 
BP and BMI, but not with soluble fibre 
378
.  
The mechanism by which fibre intake affects BP may be attributed to a variety of 
factors, including increase in nitric oxide release (a vasodilator) 
450
; improvement in 
endothelial function by inhibiting sodium absorption 
451
, although inconclusive 
452
; and 
improvement in CVD risk factors 
453
. Moreover, higher fibre intake was linked to the 
improvements in insulin sensitivity and hyperglycaemia, which resulted in more 
optimal BP levels and body weight status 
454,455
. Insoluble and soluble fibre cause lower 
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postprandial glucose responses and LDL cholesterol levels 
456
. Additionally, in large 
population>based studies, insoluble fibre has been strongly linked to a lower risk of 
type 2 diabetes 
456,457
. A recent meta>analysis including 328,212 individuals found 
inverse associations between high cereal fibre and risk of developing diabetes, but fruit 
or vegetable intakes were not associated 
353
. The reduction in the risk of developing 
diabetes can be attributed to the mechanisms of both insoluble and soluble dietary fibre, 
which act in tandem to achieve optimal effects, including improvements in insulin 
sensitivity, reduced levels of inflammatory markers (C>reactive protein), and hormonal 
response (i.e., increased satiety). While it can be hypothesised that improvement in 
insulin sensitivity is likely to be the factor behind the ability of insoluble fibre to lower 
diabetes risk, the exact mechanism is yet to be identified 
458
. Health benefits of 
insoluble fibre include an increase in faecal bulk, consequently accelerating transit time 
through the intestine 
350
. Some evidence suggests that soluble fibre can increase satiety, 
thus decreasing overall energy intake 
459
; however, this mechanism is controversial 
403,404
.  
Furthermore, differences in gut microbial population have been observed in relation to 
fibre intake; fewer Bacteroidetes and more Firmicutes were found in obese individuals, 
resulting from low fibre intake 
460
. In addition, when participants were classified jointly 
by GI and dietary total fibre intake, lower BP and BMI levels were associated with 
diets low in GI and high in dietary fibre. Diets with a high GI and low in dietary fibre 
(e.g., white rice, refined bread, potato) may lead to higher demand for insulin, 
aggravated by insulin resistance 
461,462
. Pancreas exhaustion may occur when it fails to 
meet the demand for more insulin. It may occur in relation to glucose toxicity in beta 
cells, however, this condition is reversible 
463,464
.  
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Based on the aforementioned evidence, it can be posited that the inverse associations 
between insoluble fibre and BP observed in the INTERMAP study may be driven by 
potassium present in fibre>rich foods, as the identified association was no longer 
statistically significant after adjusting for potassium. Potassium is one of the key 
electrolytes in the human body and is essential for acid>electrolyte balance, cell 
function, muscle contraction, and many more physiological functions, including BP 
regulation 
465,466
. Two meta>analyses of RCTs revealed that potassium intake could be 
effective in reducing BP in normotensive and hypertensive individuals 
27,467
. Similarly, 
a recent meta>analysis of RCTs and cohort studies concluded that higher potassium 
intake showed overall reductions in systolic and diastolic BP of 3.49 (95% CI: 1.82, 
5.15 mm Hg) and 1.96 (95% CI: 0.86, 3.06 mm Hg), respectively 
468
. A low potassium 
level may disrupt the renin>angiotensin>aldosterone system, causing elevation in BP 
level in rats 
469
.  
5.2. Study strengths and limitations 
The INTERMAP study aimed to identify the role of macro and micronutrients in the 
aetiology of high BP. Its quality and contribution to the academic research and clinical 
practice are best exemplified by its unique characteristics, which include the large and 
diverse population samples (four in Japan, three in China, two in the UK, and eight in 
the US), highly standardised multiple measures of dietary intake, urinary excretion, and 
BP (four 24>hour dietary recalls, two 24>hour urine collections, eight BP 
measurements), and the ability to successfully control for a wide range of known 
confounders.  
Moreover, extensive measures were applied to increase the precision and accuracy of 
the data collection process. The staff responsible for this part of the study underwent 
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rigorous training with local, national, and international checks on completeness and 
accuracy. The importance of complete and accurate information was also explained to 
the study participants to minimise observer and participant bias. Measures of body 
weight, height, BP, and urinary data were repeated to better reflect dietary intake and 
average BP and BMI levels. Also, in order to improve the result precision, data relating 
to any possible under>reporters of dietary energy intake were excluded from the 
analyses. Regression models were adjusted extensively for dietary and non>dietary 
factors sequentially, allowing the model to account for their possible effect on BP 
and/or BMI. Consequently, the correlations between dietary and urinary variables in 
INTERMAP were higher than those previously reported from other population>wide 
studies
449
.  
As previously noted, the inconsistencies between the findings reported from the 
INTERMAP study and those of previous studies, in particular those related to the 
relationship between eating frequency and body weight, may be attributed to 
methodological issues that affected the previous outcomes. These most likely include, 
but are not limited to, under>reporting of energy, variations in definitions of eating 
occasions, and validity and reliability of dietary assessment methods 
118,160
. The present 
study addressed these limitations by the use of multiple highly standardised 24>hour 
dietary recalls and refraining from the inclusion of participants who potentially may 
have under>reported their energy intake. In addition, exclusion of beverages from the 
eating occasion count is believed to have ensured that findings were not influenced by 
consumption of beverages. 
As with any research, the current study is subject to several limitations. For example, 
the cross>sectional design does not allow for the inference of causal relationships. Thus, 
findings of cross>sectional studies should be confirmed prospectively, or by a RCT. 
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Owing to this limitation, age>related rise in BP, for example, could be underestimated 
due to the study design.  
As an ideal measure of dietary intake is currently unavailable, it is possible that the 
study findings are affected by systematic and random errors. Systematic errors are 
associated with observer bias (e.g., leading questions), energy under>reporting, and 
errors in food composition tables as ingredients change over time 
470,471
. Systematic 
error leads to consistent under> or over>estimation of intakes. Random errors, on the 
other hand, stem from the expected variability in the day>to>day food intake, instrument 
error in estimating portion size, and differences in food composition tables, as nutrient 
content varies with factors including variety, size, growing conditions, maturity, storage 
and cooking 
472
. This has important implications for regression analysis: if random 
measurement error is present in the independent variable of a simple linear regression 
analysis, the gradient of the regression slope will be attenuated. This effect, known as 
regression dilution bias occurs because compared with the true intake, a greater number 
of extreme high and low values are observed in the predictor variable and as a result the 
gradient of the association is attenuated 
472
. Potential for these errors can be minimised 
by repeated measurements, extensive observer training, standardised methods, open>
ended questions, and on>going quality control measures 
473
. However, despite including 
as many error prevention methods as practically possible, misreporting is inevitable, 
and the effects of regression dilution bias cannot be fully eliminated 
474
. It has been 
documented that participants in population>wide studies, especially those who are 
classed as obese, have a tendency to omit from their food intake diary items that are 
considered ‘unhealthy’ 
475
.  
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An additional limitation is that the average eating event over a four>day period may not 
be representative of long>term dietary habits, which are subject to seasonal and festive 
changes. It is also possible that study participants would, even if inadvertently, change 
their food intake during the study, as they become more aware of what foods they 
consume, due to the need to record every eating event at the clinic interview.  
Further limitation arises in interpretation of the results for eating frequency and BMI 
because of possible reverse causality, as participants may skip meals in order to lose 
body weight.  
Even the BP measurement is a source of several limitations, despite extensive measures 
being applied to increase data precision. The key limitations arise from the potential 
increased anxiety with the discomfort of cuff placement 
476
 and observer bias in 
collecting second readings 
477
. Reverse causality may also be an issue affecting the 
measured BP levels, where individuals may have altered their dietary intake towards a 
‘healthier’ diet, following diagnosis with elevated BP levels.  
Finally, it should be noted that multicollinearity may introduce type I or type II errors 
in multivariable regression models. Multicollinearity is of concern when highly 
correlated variables are included together in regression analysis. As the effects of 
collinearity can lead to inflation or attenuation of the coefficients, excluding highly 
correlated variables from the regression model is necessary, and sequential adjustment 
is required 
478,479
.  
5.3. Future work 
To understand the implications of these findings on the public health management of 
adverse BP levels and obesity, there is need for further research. A randomized 
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controlled feeding trial, addressing all previous limitations, is suggested. The aim is to 
examine the impact of a low meal frequency that is high in dietary energy density and a 
high meal frequency that is low in dietary energy density on BP and body weight.  
The scarcity of information available on the separate effects of insoluble and soluble 
fibre on BP leads to a necessity to conduct RCTs. However, given the discrepancy in 
the findings reported by previous RCTs, it is necessary for future studies of this type to 
account for all the recognised limitations. For example, in a crossover design, 
participants should be assigned to a diet high in insoluble or soluble dietary fibre, with 
a long lasting treatment for each diet. Another future plan is to further analyse food 
groups based on their insoluble>soluble fibre content using the INTERMAP data set.  
5.4. Conclusions  
Having more frequent meals of low dietary energy density and high nutrient quality 
may be effective in managing high BP levels and the obesity epidemic in industrialised 
countries. Findings of this study show that 2 to 3 additional eating occasions per day 
are associated with systolic BP lower by 3 mm Hg and BMI lower by 1.1 kg/m
2
 
(equivalent to >3.2 kg in weight). High BP levels and obesity are a growing concern in 
the developing world, and thus, the findings of this and similar studies may help 
identify globally applicable strategies in combating unhealthy lifestyles and eating 
habits.  
Additionally, intakes of dietary fibre higher by 7 g/1000 kcal (about 1 cup of 
raspberries), may contribute to a systolic BP level lower by 3 mm Hg and a BMI level 
lower by 1.7 kg/m
2
 (equivalent to >5.0 kg in weight). Moreover, increasing the intake of 
food sources rich in insoluble fibre and potassium may be beneficial for BP control.  
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In sum, eating more frequent meals throughout the day, especially in the morning, may 
also be an effective way to reduce the risk of developing diseases related to excess 
body weight and unhealthy lifestyle. Our findings support the notion that consuming a 
diet rich in fibre and low in GI values is a valuable approach to bettering one’s health.  
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Table A. 1. Partial Pearson correlation coefficients between dietary, lifestyle variables and outcome measures of UK 
and USA INTERMAP men, n=1232 
1,2
 
 Systolic BP (mm Hg) Diastolic BP (mm Hg) Body mass index 
(kg/m
2
) 
Education (y) -0.12 -0.07 -0.06 
Engagement in moderate and heavy physical activity (h/24 h) 0.01 -0.03 -0.07 
Current smokers (%) 0.04 -0.04 -0.11 
Adhering to a special diet (%) 0.05 0.01 0.04 
Taking dietary supplements (%) -0.05 -0.05 -0.03 
History of CVD or DM (%) 0.06 -0.04 0.10 
Total energy intake (kcal/24 h) 0.05 0.01 0.14 
Eating occasions per 24 h -0.09 -0.05 -0.03 
Dietary energy density-food only (kcal/g) 0.10 0.05 0.12 
Dietary energy density-food and beverages
 
(kcal/g) -0.01 0.00 0.04 
Nutrient density (Nutrient Rich Food 9.3 index score) -0.13 -0.05 -0.12 
Ratio of evening to morning energy intake 0.01 0.01 0.06 
Total carbohydrate (%kcal) -0.11 -0.04 -0.15 
Total fibre (g/1000 kcal) -0.13 -0.08 -0.16 
Total protein (%kcal) -0.03 -0.04 0.10 
Animal protein (%kcal) 0.03 0.01 0.16 
Vegetable protein (%kcal) -0.14 -0.11 -0.13 
Total fat (%kcal) 0.06 0.01 0.21 
Total SFA (%kcal) 0.06 0.03 0.16 
Total MFA (%kcal) 0.08 0.02 0.21 
Total PFA (%kcal) -0.03 -0.02 0.10 
Cholesterol (mg/1000 kcal) 0.06 0.01 0.15 
Dietary alcohol (g/24 h) 0.13 0.07 -0.05 
24-hour urinary excretion data (mmol/24 h)    
Sodium  0.08 0.05 0.31 
Potassium  -0.05 -0.05 0.15 
Magnesium  -0.01 -0.08 0.07 
Calcium  0.08 0.06 0.15 
1
 Adjusted for age and population sample  
2
 Correlation coefficients are statistically significant, except those ranging from -0.03 to 0.03 
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Table A. 2. Partial Pearson correlation coefficients between dietary, lifestyle variables and outcome measures of UK and 
USA INTERMAP women, n=1150 
1,2
 
 Systolic BP (mm 
Hg) 
Diastolic BP (mm 
Hg) 
Body mass index 
(kg/m
2
) 
Education (y) -0.10 -0.08 -0.13 
Engagement in moderate and heavy physical activity (h/24 h) -0.07 -0.05 -0.04 
Current smokers (%) 0.00 -0.03 -0.02 
Adhering to a special diet (%) -0.01 -0.04 0.06 
Taking dietary supplements (%) -0.03 -0.01 -0.10 
History of CVD or DM (%) 0.12 -0.04 0.13 
Total energy intake (kcal/24 h) 0.15 0.11 0.31 
Eating occasions per 24 h -0.08 -0.08 -0.07 
Dietary energy density-food only (kcal/g) 0.14 0.09 0.17 
Dietary energy density-food and beverages
 
(kcal/g) 0.09 0.07 0.16 
Nutrient density (Nutrient Rich Food 9.3 index score) -0.11 -0.09 -0.19 
Ratio of evening to morning energy intake 0.04 0.06 0.06 
Total carbohydrate (%kcal) -0.15 -0.11 -0.15 
Total fibre (g/1000 kcal) -0.15 -0.12 -0.21 
Total protein (%kcal) 0.03 0.01 0.06 
Animal protein (%kcal) 0.10 0.06 0.15 
Vegetable protein (%kcal) -0.14 -0.12 -0.18 
Total fat (%kcal) 0.13 0.10 0.18 
Total SFA (%kcal) 0.09 0.09 0.14 
Total MFA (%kcal) 0.14 0.10 0.19 
Total PFA (%kcal) 0.06 0.03 0.06 
Cholesterol (mg/1000 kcal) 0.15 0.09 0.18 
Dietary alcohol (g/24 h) 0.01 0.04 -0.06 
24-hour urinary excretion data (mmol/24 h)    
Sodium  0.18 0.10 0.36 
Potassium  -0.04 -0.04 0.06 
Magnesium  -0.02 -0.01 0.04 
Calcium  0.11 0.06 0.09 
1
 Adjusted for age and population sample  
2
 Correlation coefficients are statistically significant, except those ranging from -0.03 to 0.03. 
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Table A. 3. Partial Pearson correlation coefficients for dietary macro and micro nutrients of UK and USA INTERMAP men, n=1232 
1,2
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Total carbohydrate (%kcal)  0.31 -0.35 -0.47 0.32 -0.70 -0.56 -0.66 -0.35 -0.49 -0.39 -0.13 0.05 -0.03 -0.11 
Total fibre (g/1000 kcal) 0.31  0.11 -0.25 0.76 -0.37 -0.48 -0.36 -0.02 -0.34 -0.09 -0.05 0.28 0.17 -0.09 
Total protein (%kcal) -0.35 0.11  0.88 0.13 0.02 -0.01 0.03 -0.06 0.37 -0.04 0.16 0.23 0.11 0.10 
Animal protein (%kcal) -0.47 -0.25 0.88  -0.34 0.16 0.20 0.16 -0.08 0.52 0.02 0.15 0.14 0.04 0.13 
Vegetable protein (%kcal) 0.32 0.76 0.13 -0.34  -0.29 -0.43 -0.28 0.06 -0.35 -0.19 0.01 0.17 0.13 -0.07 
Total fat (%kcal) -0.70 -0.37 0.02 0.16 -0.29  0.81 0.93 0.58 0.42 -0.16 0.21 -0.12 0.01 0.12 
Total SFA (%kcal) -0.56 -0.48 -0.01 0.20 -0.43 0.81  0.70 0.09 0.43 -0.12 0.16 -0.11 -0.01 0.17 
Total MFA (%kcal) -0.66 -0.36 0.03 0.16 -0.28 0.93 0.70  0.43 0.39 -0.14 0.19 -0.12 0.01 0.08 
Total PFA (%kcal) -0.35 -0.02 -0.06 -0.08 0.06 0.58 0.09 0.43  0.05 -0.13 0.13 -0.07 0.04 0.02 
Cholesterol (mg/1000 kcal) -0.49 -0.34 0.37 0.52 -0.35 0.42 0.43 0.39 0.05  0.03 0.14 -0.08 -0.05 0.12 
Dietary alcohol (g/24 h) -0.39 -0.09 -0.04 0.02 -0.19 -0.16 -0.12 -0.14 -0.13 0.03  -0.07 0.00 -0.01 0.01 
Urinary sodium (mmol/24 h) -0.13 -0.05 0.16 0.15 0.01 0.21 0.16 0.19 0.13 0.14 -0.07  0.36 0.30 0.32 
Urinary potassium (mmol/24 h) 0.05 0.28 0.23 0.14 0.17 -0.12 -0.11 -0.12 -0.07 -0.08 0.00 0.36  0.45 0.21 
Urinary magnesium (mmol/24 h) -0.03 0.17 0.11 0.04 0.13 0.01 -0.01 0.01 0.04 -0.05 -0.01 0.30 0.45  0.40 
Urinary calcium (mmol/24 h) -0.11 -0.09 0.10 0.13 -0.07 0.12 0.17 0.08 0.02 0.12 0.01 0.32 0.21 0.40  
1
Adjusted for age and population sample.                                                                                                                                                                                                                                                                                                                        
2
 Correlation coefficients are statistically significant, except those ranging from -0.03 to 0.03. 
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Table A. 4. Partial Pearson correlation coefficients for dietary macro and micro nutrients of UK and USA INTERMAP women, n=1152 
1,2
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Total carbohydrate (%kcal)  0.35 -0.31 -0.43 0.28 -0.81 -0.63 -0.76 -0.49 -0.50 -0.25 -0.21 0.07 -0.01 -0.15 
Total fibre (g/1000 kcal) 0.35  0.18 -0.20 0.78 -0.44 -0.48 -0.42 -0.15 -0.34 -0.03 -0.04 0.42 0.28 0.02 
Total protein (%kcal) -0.31 0.18  0.88 0.17 -0.06 -0.09 -0.04 -0.11 0.38 -0.06 0.17 0.25 0.13 0.13 
Animal protein (%kcal) -0.43 -0.20 0.88  -0.32 0.11 0.12 0.13 -0.09 0.54 -0.05 0.15 0.11 0.00 0.11 
Vegetable protein (%kcal) 0.28 0.78 0.17 -0.32  -0.34 -0.43 -0.34 -0.03 -0.36 -0.04 0.03 0.27 0.25 0.04 
Total fat (%kcal) -0.81 -0.44 -0.06 0.11 -0.34  0.81 0.93 0.62 0.40 -0.11 0.18 -0.21 -0.05 0.11 
Total SFA (%kcal) -0.63 -0.48 -0.09 0.12 -0.43 0.81  0.67 0.16 0.38 -0.10 0.12 -0.21 -0.06 0.11 
Total MFA (%kcal) -0.76 -0.42 -0.04 0.13 -0.34 0.93 0.67  0.50 0.40 -0.08 0.17 -0.20 -0.06 0.11 
Total PFA (%kcal) -0.49 -0.15 -0.11 -0.09 -0.03 0.62 0.16 0.50  0.07 -0.07 0.11 -0.10 0.01 0.02 
Cholesterol (mg/1000 kcal) -0.50 -0.34 0.38 0.54 -0.36 0.40 0.38 0.40 0.07  -0.01 0.18 -0.13 -0.08 0.09 
Dietary alcohol (g/24 h) -0.25 -0.03 -0.06 -0.05 -0.04 -0.11 -0.10 -0.08 -0.07 -0.01  0.02 0.07 0.00 0.02 
Urinary sodium (mmol/24 h) -0.21 -0.04 0.17 0.15 0.03 0.18 0.12 0.17 0.11 0.18 0.02  0.32 0.30 0.32 
Urinary potassium (mmol/24 h) 0.07 0.42 0.25 0.11 0.27 -0.21 -0.21 -0.20 -0.10 -0.13 0.07 0.32  0.49 0.28 
Urinary magnesium (mmol/24 h) -0.01 0.28 0.13 0.00 0.25 -0.05 -0.06 -0.06 0.01 -0.08 0.00 0.30 0.49  0.45 
Urinary calcium (mmol/24 h) -0.15 0.02 0.13 0.11 0.04 0.11 0.11 0.11 0.02 0.09 0.02 0.32 0.28 0.45  
1 
Adjusted for age and population sample.                                                                                                                                                                                                                                                                                                               
2
 Correlation coefficients are statistically significant, except those ranging from -0.03 to 0.03. 
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Table A. 5. Estimated systolic and diastolic BP difference per 2SD higher differences of eating occasions, UK and USA men and women separately  
 
Systolic BP 
 
Diastolic BP  
 
Not adjusted for BMI Adjusted for BMI 
 
Not adjusted for BMI Adjusted for BMI  
Models n 
Difference, 
mm Hg 
95% CI p 
Difference, 
mm Hg 
95% CI p 
Difference, 
mm Hg 
95% CI p 
Difference, 
mm Hg 
95% CI p 
Model 4              
Men 
1
 1232 -1.9 -3.4, -0.5 0.01 -1.4 -2.9, -0.2 0.05 -0.7 -1.8, 0.5 0.27 -0.3 -1.5, 0.8 0.56 
Women 
2
 1153 -2.6 -4.4, -0.8 0.004 -1.7 -3.1, -0.3 0.04 -1.6 -2.8, -0.5 0.07×10
-01
 -1.2 -2.4,- 0.1 0.04 
Model 1a adjusted for total energy intake, age, and population sample. 
Model 2 Adjusted for variables in Model 1a plus adherence to a special diet, engagement in moderate and heavy physical activity (h/24 h), dietary supplement use, smoking, years of education (years 
completed), DM or CVD diagnosis, and family history of high BP. 
Model 3 adjusted for variables in model 2 plus 24-hour urinary excretion of sodium and potassium (mmol/24-hours). 
Model 3a adjusted for variables in model 3 plus total fibre intake (g/1000 kcal). 
Model 4 adjusted for variables in model 3 plus alcohol intake (g/24 h).                                                                                                                                                                                                                                                           
1
 2SD of eating occasions=2.6.                                                                                                                                                                                                                                                                                                                                                      
2
 2SD of eating occasions=2.5. 
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Table A. 6. Estimated BMI difference per 2SD higher differences of eating occasions, UK and USA men and women 
separately  
  
 
BMI  
Models n 
Difference, 
kg/m
2
 
95% CI p 
Model 3     
Men 
1
 1232 -0.7 -1.2, -0.2 0.02 
Women 
2
 1153 -1.7 -2.4, -1.0 4.81×10
-06
 
Model 1a adjusted for total energy intake, age, and population sample.  
Model 2 adjusted for variables in Model 1a plus adherence to a special diet, engagement in moderate and heavy physical activity (h/24 h), 
dietary supplement use, smoking, and years of education (years completed).  
Model 3 adjusted for variables in Model 2 plus alcohol intake (g/24 h).                                                                                                                                               
1
 2SD of eating occasions=2.6.                                                                                                                                                                                                                                          
2
 2SD of eating occasions=2.5. 
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Table A. 7. Estimated systolic and diastolic BP difference per 2SD higher differences of dietary energy density, UK and USA men and women separately 
 
Systolic BP 
 
Diastolic BP  
 
Not adjusted for BMI Adjusted for BMI 
 
Not adjusted for BMI Adjusted for BMI  
Models  n 
Difference, 
mm Hg 
95% CI p 
Difference, 
mm Hg 
95% CI p 
Difference, 
mm Hg 
95% CI p 
Difference, 
mm Hg 
95% CI p 
Model 4              
Men 
1
 1232 3.0 1.5, 4.5 9.05×10
-05
 2.5 0.6, 3.5 0.06×10
-01
 1.8 0.6, 2.9 0.003 1.1 -0.01, 2.2 0.05 
Women 
1
 1153 3.3 1.5, 5.1 0.004 2.1 0.4, 3.8 0.02 2.0 0.7, 3.2 0.002 1.4 0.2, 2.6 0.02 
Model 1 adjusted for age, and population sample.  
Model 2 Adjusted for variables in Model 1 plus adherence to a special diet, engagement in moderate and heavy physical activity (h/24 h), dietary supplement use, smoking, years of education (years 
completed), DM or CVD diagnosis, and family history of high BP. 
Model 3 adjusted for variables in model 2 plus 24-hour urinary excretion of sodium and potassium (mmol/24-hours).                                                                                                                                                                                                            
Model 4 adjusted for variables in Model 3 plus alcohol intake (g/24 h).                                                                                                                                                                                                                                                           
1
 2SD of dietary energy density (kcal/g)=0.8.                                                                                                                                                                                                                                                                                                          
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Table A. 8. Estimated BMI difference per 2SD higher differences of dietary energy density, UK and USA men and 
women separately 
   BMI  
Models n 
Difference, 
kg/m
2
 
95% CI p 
Model 3     
Men 
1
 1232 1.4 0.8, 1.9 1.29×10
-06
 
Women 
1
 1153 2.4 1.6, 3.1 1.18×10
-09
 
Model 1 adjusted for age, and population sample.  
Model 2 adjusted for variables in Model 1 plus adherence to a special diet, engagement in moderate and heavy physical activity (h/24 h), dietary 
supplement use, smoking, and years of education (years completed). 
Model 3 adjusted for variables in Model 2 plus alcohol intake (g/24 h). 
1
 2SD of dietary energy density (kcal/g)=0.8.                                                                                                                                                                                                               
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Table A. 9. Estimated BMI difference per 2SD higher differences of nutrient density, UK and USA men and women 
separately 
  
 
BMI  
Models n 
Difference, 
kg/m
2
 
95% CI p 
Model 3     
Men 
1
 1232 -1.3 -1.9, -0.7 3.30×10
-05
 
Women 
2
 1153 -1.6 -2.3, -0.9 4.72×10
-06
 
Model 1a adjusted for total energy intake, age, and population sample.  
Model 2 adjusted for variables in Model 1a plus adherence to a special diet, engagement in moderate and heavy physical activity (h/24 h), 
dietary supplement use, smoking, and years of education (years completed). 
Model 3 adjusted for variables in Model 2 plus alcohol intake (g/24 h).                                                                                                                                                                                            
1 
2SD of Nutrient Rich Food 9.3 index score=25.5.                                                                                                                                                                            
2 
2SD of Nutrient Rich Food 9.3 index score=30.4. 
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Table A. 10. Estimated systolic and diastolic BP difference per 2SD higher differences of the ratio of evening to morning energy intake, UK and USA men and 
women separately 
 
Systolic BP 
 
Diastolic BP  
 
Not adjusted for BMI Adjusted for BMI 
 
Not adjusted for BMI Adjusted for BMI  
Models n 
Difference, 
mm Hg 
95% CI p 
Difference, 
mm Hg 
95% CI p 
Difference, 
mm Hg 
95% CI p 
Difference, 
mm Hg 
95% CI p 
Model 4              
Men 
1
 1232 0.01 -0.2, 0.2 0.91 0.04 -0.2, 0.3 0.68 0.02 -0.2, 0.2 0.85 0.1 -0.2, 0.3 0.51 
Women 
2
 1153 0.1 -0.5, 0.2 0.11 0.04 -0.03, 0.1 0.32 0.1 0.01, 0.2 0.02 0.1 -0.01, 0.1 0.06 
Model 1 adjusted for age, and population sample.  
Model 2 Adjusted for variables in Model 1 plus adherence to a special diet, engagement in moderate and heavy physical activity (h/24 h), dietary supplement use, smoking, years of education (years 
completed), DM or CVD diagnosis, and family history of high BP. 
Model 3 adjusted for variables in model 2 plus 24-hour urinary excretion of sodium and potassium (mmol/24-hours).                                                                                                                                                                                                                        
Model 4 adjusted for variables in Model 3 plus alcohol intake (g/24 h).                                                                                                                                                                                                                                                          
1 
2SD of ratio of evening to morning energy intake=3.6                                                                                                                                                                                                                                                                                                
2 
2SD of ratio of evening to morning energy intake=3.4.                                                                                                                                                                                                                                                                                 
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Table A. 11. Estimated BMI difference per 2SD higher differences of the ratio of evening to morning energy intake, UK 
and USA men and women separately 
  
 
BMI  
Models n 
Difference, 
kg/m
2
 
95% CI p 
Model 3     
Men 
1
 1232 0.1 -0.03, 0.1 0.08 
Women 
2
 1153 0.1 0.03, 0.1 0.03 
Model 1 adjusted for age, and population sample.  
Model 2 adjusted for variables in Model 1 plus adherence to a special diet, engagement in moderate and heavy physical activity (h/24 h), dietary 
supplement use, smoking, and years of education (years completed). 
Model 3 adjusted for variables in Model 2 plus alcohol intake (g/24 h).                                                                                                                                                                
1 
2SD of ratio of evening to morning energy intake=3.6                                                                                                                                                                                                          
2 
2SD of ratio of evening to morning energy intake=3.4.                                                                                                                                                                                                                                                      
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Table A. 12. Partial Pearson correlation coefficients for dietary macro and micro nutrients of USA INTERMAP men participants, n=997 
1,2
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 c
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Total 
carbohydrate 
(%kcal) 
 0.32 0.79 0.56 0.14 0.56 0.08 0.19 0.55 0.09 0.46 0.27 0.30 0.28 -0.39 -0.49 0.29 -0.73 -0.59 -0.38 -0.69 -0.37 -0.15 0.01 -0.05 -0.11 
Starch                 
(%kcal) 
0.32  -0.33 -0.26 0.07 -0.28 -0.10 -0.01 -0.25 0.10 0.08 0.44 0.41 0.42 0.02 -0.29 0.64 -0.30 -0.39 -0.02 -0.31 -0.12 0.04 0.04 0.01 -0.07 
Total sugar                    
(%kcal) 
0.79 -0.33  0.73 0.10 0.74 0.15 0.19 0.71 0.03 0.41 -0.02 0.04 0.01 -0.40 -0.30 -0.13 -0.53 -0.33 -0.37 -0.48 -0.29 -0.18 -0.02 -0.06 -0.06 
Fructose          
(%kcal) 
0.56 -0.26 0.73  0.05 0.94 -0.10 0.11 0.12 -0.07 0.24 0.02 0.05 0.03 -0.31 -0.24 -0.07 -0.42 -0.34 -0.23 -0.37 -0.15 -0.16 -0.06 -0.08 -0.08 
Galactose    
(%kcal) 
0.14 0.07 0.10 0.05  0.05 0.06 0.12 0.02 -0.01 0.04 0.14 0.16 0.13 0.01 -0.04 0.13 -0.16 -0.12 -0.07 -0.17 -0.01 -0.07 0.08 0.05 -0.01 
Glucose         
(%kcal) 
0.56 -0.28 0.74 0.94 0.05  -0.10 0.20 0.14 -0.02 0.28 -0.05 -0.01 -0.04 -0.35 -0.26 -0.11 -0.42 -0.33 -0.24 -0.36 -0.12 -0.14 -0.07 -0.08 -0.08 
Lactose           
(%kcal) 
0.08 -0.10 0.15 -0.10 0.06 -0.10  0.03 -0.01 0.02 0.09 0.004 0.04 -0.03 0.23 0.25 -0.05 -0.09 0.07 -0.14 -0.14 -0.13 0.004 0.31 0.15 0.20 
Maltose         
(%kcal) 
0.19 -0.01 0.19 0.11 0.12 0.20 0.03  0.03 0.06 0.14 0.08 0.06 0.05 -0.15 -0.15 -0.01 -0.20 -0.10 -0.15 -0.19 0.06 -0.07 0.02 0.06 -0.02 
Sucrose         
(%kcal) 
0.55 -0.25 0.71 0.12 0.02 0.14 -0.01 0.03  0.08 0.33 -0.12 -0.07 -0.08 -0.36 -0.25 -0.18 -0.28 -0.12 -0.25 -0.25 -0.26 -0.11 -0.13 -0.09 -0.08 
Glycaemic 
index            
0.09 0.10 0.03 -0.07 -0.01 -0.02 0.02 0.06 0.08  0.45 -0.01 0.05 0.05 -0.02 -0.05 0.08 0.09 0.07 0.08 0.09 -0.25 0.06 0.04 0.04 0.02 
Glycaemic      
load 
0.46 0.08 0.41 0.24 0.04 0.28 0.09 0.14 0.33 0.45  -0.03 0.03 0.01 -0.31 -0.30 0.05 -0.21 -0.11 -0.15 -0.18 -0.20 0.16 0.17 0.10 0.12 
Total fibre 
(g/1000 kcal) 
0.27 0.44 -0.02 0.02 0.14 -0.05 0.004 0.08 -0.12 -0.01 -0.03  0.95 0.87 0.14 -0.24 0.76 -0.33 -0.47 -0.02 -0.33 -0.08 -0.04 0.29 0.18 -0.08 
Insoluble 
fibre 
(g/1000 
kcal) 
0.30 0.41 0.04 0.05 0.16 -0.01 0.04 0.06 -0.07 0.05 0.03 0.95  0.79 0.12 -0.25 0.76 -0.29 -0.44 0.02 -0.28 -0.16 -0.02 0.27 0.18 -0.07 
Soluble 
fibre 
(g/1000 
kcal) 
0.28 0.42 0.01 0.03 0.13 -0.04 -0.03 0.05 -0.08 0.05 0.01 0.87 0.79  0.17 -0.18 0.71 -0.30 -0.43 -0.03 -0.28 -0.14 -0.02 0.28 0.15 -0.07 
Total protein 
(%kcal) 
-0.39 0.02 -0.40 -0.31 0.01 -0.35 0.23 -0.15 -0.36 -0.02 -0.31 0.14 0.12 0.17  0.88 0.15 0.06 0.01 -0.05 0.05 -0.03 0.14 0.26 0.13 0.10 
Animal 
protein 
(%kcal) 
-0.49 -0.29 -0.30 -0.24 -0.04 -0.26 0.25 -0.15 -0.25 -0.05 -0.30 -0.24 -0.25 -0.18 0.88  -0.34 0.19 0.23 -0.07 0.18 0.03 0.13 0.17 0.06 0.13 
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Vegetable 
protein 
(%kcal) 
0.29 0.64 -0.13 -0.07 0.13 -0.11 -0.05 -0.01 -0.18 0.08 0.05 0.76 0.76 0.71 0.15 -0.34  -0.26 -0.43 0.07 -0.26 -0.18 0.005 0.17 0.13 -0.06 
Total fat              
(%kcal) 
-0.73 -0.30 -0.53 -0.42 -0.16 -0.42 -0.09 -0.20 -0.28 0.09 -0.21 -0.33 -0.29 -0.30 0.06 0.19 -0.26  0.82 0.61 0.93 -0.15 0.23 -0.09 0.02 0.11 
Total SFA            
(%kcal) 
-0.59 -0.39 -0.33 -0.34 -0.12 -0.33 0.07 -0.10 -0.12 0.07 -0.11 -0.47 -0.44 -0.43 0.01 0.23 -0.43 0.82  0.15 0.73 -0.12 0.19 -0.08 -0.01 0.17 
Total PFA         
(%kcal) 
-0.38 -0.02 -0.37 -0.23 -0.07 -0.24 -0.14 -0.15 -0.25 0.08 -0.15 -0.02 0.02 -0.03 -0.05 -0.07 0.07 0.61 0.15  0.44 -0.12 0.14 -0.06 0.04 0.002 
Total MFA           
(%kcal) 
-0.69 -0.31 -0.48 -0.37 -0.17 -0.36 -0.14 -0.19 -0.25 0.09 -0.18 -0.33 -0.28 -0.28 0.05 0.18 -0.26 0.93 0.73 0.44  -0.13 0.21 -0.10 0.02 0.07 
Dietary 
alcohol       
(g/24 h) 
-0.37 -0.12 -0.29 -0.15 -0.01 -0.12 -0.13 0.06 -0.26 -0.25 -0.20 -0.08 -0.16 -0.14 -0.03 0.03 -0.18 -0.15 -0.12 -0.12 -0.13  -0.07 -0.01 0.001 0.02 
Urinary 
sodium 
(mmol/24 h) 
-0.15 0.04 -0.18 -0.16 -0.07 -0.14 0.004 -0.07 -0.11 0.06 0.16 -0.04 -0.02 -0.02 0.14 0.13 0.005 0.23 0.19 0.14 0.21 -0.07  0.39 0.31 0.32 
Urinary 
potassium 
(mmol/24 h) 
0.01 0.04 -0.02 -0.06 0.08 -0.07 0.31 0.02 -0.13 0.04 0.17 0.29 0.27 0.28 0.26 0.17 0.17 -0.09 -0.08 -0.06 -0.10 -0.01 0.39  0.46 0.21 
Urinary 
magnesium 
(mmol/24 h) 
-0.05 0.01 -0.06 -0.08 0.05 -0.08 0.15 0.06 -0.09 0.04 0.10 0.18 0.18 0.15 0.13 0.06 0.13 0.02 -0.01 0.04 0.02 0.001 0.31 0.46  0.40 
Urinary 
calcium 
(mmol/24 h) 
-0.11 -0.07 -0.06 -0.08 -0.01 -0.08 0.20 -0.02 -0.08 0.02 0.12 -0.08 -0.07 -0.07 0.10 0.13 -0.06 0.11 0.17 0.002 0.07 0.02 0.32 0.21 0.40  
1
 Adjusted for age and population sample.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       
2
 Correlation coefficients are statistically significant, except those ranging from -0.03 to 0.03. 
  
 225
Table A. 13. Partial Pearson correlation coefficients for dietary macro and micro nutrients of USA INTERMAP women participants, n=944 
1,2
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Total 
carbohydrate 
(%kcal) 
 0.32 0.79 0.56 0.14 0.56 0.08 0.19 0.55 0.09 0.46 0.27 0.30 0.28 -0.39 -0.49 0.29 -0.73 -0.59 -0.38 -0.69 -0.37 -0.15 0.01 -0.05 -0.11 
Starch                 
(%kcal) 
0.40  -0.33 -0.26 0.07 -0.28 -0.10 -0.01 -0.25 0.10 0.08 0.44 0.41 0.42 0.02 -0.29 0.64 -0.30 -0.39 -0.02 -0.31 -0.12 0.04 0.04 0.01 -0.07 
Total sugar                    
(%kcal) 
0.76 -0.33  0.73 0.10 0.74 0.15 0.19 0.71 0.03 0.41 -0.02 0.04 0.01 -0.40 -0.30 -0.13 -0.53 -0.33 -0.37 -0.48 -0.29 -0.18 -0.02 -0.06 -0.06 
Fructose          
(%kcal) 
0.47 -0.26 0.73  0.05 0.94 -0.10 0.11 0.12 -0.07 0.24 0.02 0.05 0.03 -0.31 -0.24 -0.07 -0.42 -0.34 -0.23 -0.37 -0.15 -0.16 -0.06 -0.08 -0.08 
Galactose    
(%kcal) 
0.18 0.07 0.10 0.05  0.05 0.06 0.12 0.02 -0.01 0.04 0.14 0.16 0.13 0.01 -0.04 0.13 -0.16 -0.12 -0.07 -0.17 -0.01 -0.07 0.08 0.05 -0.01 
Glucose         
(%kcal) 
0.50 -0.28 0.74 0.94 0.05  -0.10 0.20 0.14 -0.02 0.28 -0.05 -0.01 -0.04 -0.35 -0.26 -0.11 -0.42 -0.33 -0.24 -0.36 -0.12 -0.14 -0.07 -0.08 -0.08 
Lactose           
(%kcal) 
0.10 -0.10 0.15 -0.10 0.06 -0.10  0.03 -0.01 0.02 0.09 0.004 0.04 -0.03 0.23 0.25 -0.05 -0.09 0.07 -0.14 -0.14 -0.13 0.004 0.31 0.15 0.20 
Maltose         
(%kcal) 
0.26 -0.01 0.19 0.11 0.12 0.20 0.03  0.03 0.06 0.14 0.08 0.06 0.05 -0.15 -0.15 -0.01 -0.20 -0.10 -0.15 -0.19 0.06 -0.07 0.02 0.06 -0.02 
Sucrose         
(%kcal) 
0.52 -0.25 0.71 0.12 0.02 0.14 -0.01 0.03  0.08 0.33 -0.12 -0.07 -0.08 -0.36 -0.25 -0.18 -0.28 -0.12 -0.25 -0.25 -0.26 -0.11 -0.13 -0.09 -0.08 
Glycaemic 
index            
0.05 0.10 0.03 -0.07 -0.01 -0.02 0.02 0.06 0.08  0.45 -0.01 0.05 0.05 -0.02 -0.05 0.08 0.09 0.07 0.08 0.09 -0.25 0.06 0.04 0.04 0.02 
Glycaemic      
load 
0.42 0.08 0.41 0.24 0.04 0.28 0.09 0.14 0.33 0.45  -0.03 0.03 0.01 -0.31 -0.30 0.05 -0.21 -0.11 -0.15 -0.18 -0.20 0.16 0.17 0.10 0.12 
Total fibre 
(g/1000 kcal) 
0.33 0.44 -0.02 0.02 0.14 -0.05 0.004 0.08 -0.12 -0.01 -0.03  0.95 0.87 0.14 -0.24 0.76 -0.33 -0.47 -0.02 -0.33 -0.08 -0.04 0.29 0.18 -0.08 
Insoluble 
fibre 
(g/1000 
kcal) 
0.31 0.41 0.04 0.05 0.16 -0.01 0.04 0.06 -0.07 0.05 0.03 0.95  0.79 0.12 -0.25 0.76 -0.29 -0.44 0.02 -0.28 -0.16 -0.02 0.27 0.18 -0.07 
Soluble 
fibre 
(g/1000 
kcal) 
0.34 0.42 0.01 0.03 0.13 -0.04 -0.03 0.05 -0.08 0.05 0.01 0.87 0.79  0.17 -0.18 0.71 -0.30 -0.43 -0.03 -0.28 -0.14 -0.02 0.28 0.15 -0.07 
Total protein 
(%kcal) 
-0.35 0.02 -0.40 -0.31 0.01 -0.35 0.23 -0.15 -0.36 -0.02 -0.31 0.14 0.12 0.17  0.88 0.15 0.06 0.01 -0.05 0.05 -0.03 0.14 0.26 0.13 0.10 
Animal 
protein 
(%kcal) 
-0.46 -0.29 -0.30 -0.24 -0.04 -0.26 0.25 -0.15 -0.25 -0.05 -0.30 -0.24 -0.25 -0.18 0.88  -0.34 0.19 0.23 -0.07 0.18 0.03 0.13 0.17 0.06 0.13 
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Vegetable 
protein 
(%kcal) 
0.27 0.64 -0.13 -0.07 0.13 -0.11 -0.05 -0.01 -0.18 0.08 0.05 0.76 0.76 0.71 0.15 -0.34  -0.26 -0.43 0.07 -0.26 -0.18 0.005 0.17 0.13 -0.06 
Total fat              
(%kcal) 
-0.83 -0.30 -0.53 -0.42 -0.16 -0.42 -0.09 -0.20 -0.28 0.09 -0.21 -0.33 -0.29 -0.30 0.06 0.19 -0.26  0.82 0.61 0.93 -0.15 0.23 -0.09 0.02 0.11 
Total SFA            
(%kcal) 
-0.65 -0.39 -0.33 -0.34 -0.12 -0.33 0.07 -0.10 -0.12 0.07 -0.11 -0.47 -0.44 -0.43 0.01 0.23 -0.43 0.82  0.15 0.73 -0.12 0.19 -0.08 -0.01 0.17 
Total PFA         
(%kcal) 
-0.52 -0.02 -0.37 -0.23 -0.07 -0.24 -0.14 -0.15 -0.25 0.08 -0.15 -0.02 0.02 -0.03 -0.05 -0.07 0.07 0.61 0.15  0.44 -0.12 0.14 -0.06 0.04 0.002 
Total MFA           
(%kcal) 
-0.78 -0.31 -0.48 -0.37 -0.17 -0.36 -0.14 -0.19 -0.25 0.09 -0.18 -0.33 -0.28 -0.28 0.05 0.18 -0.26 0.93 0.73 0.44  -0.13 0.21 -0.10 0.02 0.07 
Dietary 
alcohol       
(g/24 h) 
-0.20 -0.12 -0.29 -0.15 -0.01 -0.12 -0.13 0.06 -0.26 -0.25 -0.20 -0.08 -0.16 -0.14 -0.03 0.03 -0.18 -0.15 -0.12 -0.12 -0.13  -0.07 -0.01 0.001 0.02 
Urinary 
sodium 
(mmol/24 h) 
-0.23 0.04 -0.18 -0.16 -0.07 -0.14 0.004 -0.07 -0.11 0.06 0.16 -0.04 -0.02 -0.02 0.14 0.13 0.005 0.23 0.19 0.14 0.21 -0.07  0.39 0.31 0.32 
Urinary 
potassium 
(mmol/24 h) 
0.07 0.04 -0.02 -0.06 0.08 -0.07 0.31 0.02 -0.13 0.04 0.17 0.29 0.27 0.28 0.26 0.17 0.17 -0.09 -0.08 -0.06 -0.10 -0.01 0.39  0.46 0.21 
Urinary 
magnesium 
(mmol/24 h) 
-0.01 0.01 -0.06 -0.08 0.05 -0.08 0.15 0.06 -0.09 0.04 0.10 0.18 0.18 0.15 0.13 0.06 0.13 0.02 -0.01 0.04 0.02 0.001 0.31 0.46  0.40 
Urinary 
calcium 
(mmol/24 h) 
-0.16 -0.07 -0.06 -0.08 -0.01 -0.08 0.20 -0.02 -0.08 0.02 0.12 -0.08 -0.07 -0.07 0.10 0.13 -0.06 0.11 0.17 0.002 0.07 0.02 0.32 0.21 0.40  
1
 Adjusted for age and population sample.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       
2
 Correlation coefficients are statistically significant, except those ranging from -0.03 to 0.03. 
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Table A. 14. Estimated systolic and diastolic BP difference per 2SD higher differences of glycaemic index in UK and USA men and women separately 
 
Systolic BP 
 
Diastolic BP  
 
Not adjusted for BMI Adjusted for BMI 
 
Not adjusted for BMI Adjusted for BMI  
Models n 
Difference, 
mm Hg 
95% CI p 
Difference, 
mm Hg 
95% CI p 
Difference, 
mm Hg 
95% CI p 
Difference, 
mm Hg 
95% CI p 
Model 2              
Men 
1
 1232 0.3 -1.3, 1.9 0.71 0.4 -1.1, 1.9 0.62 0.6 -0.6, 1.7 0.35 0.5 -0.6, 1.6 0.39 
Women 
2
 1153 1.0 -0.5, 2.5 0.17 0.8 -0.6, 2.2 0.25 0.9 -0.1, 1.9 0.08 0.8 -0.2, 1.7 0.12 
Model 1 adjusted f for age, total energy intake (kcal/24-hours), total protein (%kcal), total fat (%kcal), and population sample.                                                                                                                                                                                              
Model 2 adjusted for variables in Model 2 plus adherence to a special diet, engagement in moderate and heavy physical activity (h/24 h), smoking, dietary supplement use, years of education (years 
completed), alcohol intake (g/24-hours), DM or CVD diagnosis, family history of high BP, 24-hour urinary excretion of sodium (mmol/24-hours).                                                                                                                      
1
 2SD of GI=15.7. 
2 
2SD of GI=19.64. 
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Table A. 15. Estimated systolic and diastolic BP difference per 2SD higher differences of glycaemic load in UK and USA men and women separately 
 
Systolic BP 
 
Diastolic BP  
 
Not adjusted for BMI Adjusted for BMI 
 
Not adjusted for BMI Adjusted for BMI  
Models n 
Difference, 
mm Hg 
95% CI p 
Difference, 
mm Hg 
95% CI p 
Difference, 
mm Hg 
95% CI p 
Difference, 
mm Hg 
95% CI p 
Model 2              
Men 
1
 1232 0.4 -2.5, 3.4 0.77 0.8 -2.0, 3.5 0.59 1.3 -0.9, 3.4 0.25 1.1 -1.0, 3.1 0.32 
Women 
2
 1153 3.2 -0.7, 7.1 0.11 3.0 -0.7, 6.8 0.11 2.5 -0.1, 5.1 0.06 2.4 -0.2, 4.9 0.07 
Model 1 adjusted f for age, total energy intake (kcal/24-hours), total protein (%kcal), total fat (%kcal), and population sample.                                                                                                                                                                                              
Model 2 adjusted for variables in Model 2 plus adherence to a special diet, engagement in moderate and heavy physical activity (h/24 h), smoking, dietary supplement use, years of education (years 
completed), alcohol intake (g/24-hours), DM or CVD diagnosis, family history of high BP, 24-hour urinary excretion of sodium (mmol/24-hours).  
1
 2SD of GL=124.6.  
2
 2SD of GL=91.9. 
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Table A. 16. Estimated BMI difference per 2SD higher differences of glycaemic index in UK and USA men and women 
separately 
  BMI 
 
Models n Difference, kg/m
2
 95% CI p 
Model 2  
   
Men 
1
 1232 0.03 -0.6, 0.6 0.92 
Women 
2
 1153 0.1 -0.5, 0.7 0.82 
Model 1 adjusted for age, total energy intake (kcal/24-hours), total protein (%kcal), total fat (%kcal), and population sample.                                                                                                                              
Model 2 adjusted for variables in Model 1 plus adherence to a special diet, engagement in moderate and heavy physical activity (h/24 h), smoking, 
dietary supplement use, years of education (years completed), and alcohol intake (g/24-hours).                                                                                                         
1
 2SD of GI=15.7.  
2 
2SD of GI=19.64. 
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Table A. 17. Estimated BMI difference per 2SD higher differences of glycaemic load in UK and USA men and women 
separately 
  BMI  
Models n Difference, kg/m
2
 95% CI p 
Model 2     
Men 
1
 1232 0.3 -0.7, 1.4 0.54 
Women 
2
 1153 0.01 -1.5, 1.7 0.89 
Model 1 adjusted for age, total energy intake (kcal/24-hours), total protein (%kcal), total fat (%kcal), and population sample.                                                                                                                              
Model 2 adjusted for variables in Model 1 plus adherence to a special diet, engagement in moderate and heavy physical activity (h/24 h), smoking, 
dietary supplement use, years of education (years completed), and alcohol intake (g/24-hours).                                                                                                    
1
 2SD of GL=124.6.  
2
 2SD of GL=91.9. 
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Table A. 18. Estimated systolic and diastolic BP difference per 2SD higher differences of total fibre in USA men and women separately 
 
Systolic BP 
 
Diastolic BP  
 
Not adjusted for BMI Adjusted for BMI 
 
Not adjusted for BMI Adjusted for BMI  
Models n 
Difference, 
mm Hg 
95% CI p 
Difference, 
mm Hg 
95% CI p 
Difference, 
mm Hg 
95% CI p 
Difference, 
mm Hg 
95% CI p 
Model 2 1              
Men 
2
 997 -2.5 -4.3, -0.6 0.08×10
-01
 -1.4 -3.2, -0.1 0.04 -1.3 -2.7, 0.1 0.07 -0.5 -1.9, 0.8 0.45 
Women 
3
 944 -3.6 -5.6, -1.5 0.001 -2.2 -4.2, -0.2 0.03 -1.6 -2.9, -0.2 0.02 -0.9 -2.2, 0.4 0.18 
Model 1 adjusted for age, total energy intake (kcal/24-hours), total protein (%kcal), total fat (%kcal), and population sample.                                                                                                                                                                                                       
Model 2 adjusted for variables in Model 2 plus adherence to a special diet, engagement in moderate and heavy physical activity (h/24 h), smoking, dietary supplement use, years of education (years 
completed), alcohol intake (g/24-hours), DM or CVD diagnosis, family history of high BP, 24-hour urinary excretion of sodium (mmol/24-hours).                                                                                                                     
1 
Additionally adjusted for total sugar (%).                                                                                                                                                                                                                                                                                                                  
2
 2SD fibres (g/1000 kcal) =6.3.                                                                                                                                                                                                                                                                                                                               
3 
2SD fibres (g/1000 kcal) =6.7.                                                                                                                                                                                                                                                                                                      
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Table A. 19. Estimated systolic and diastolic BP difference per 2SD higher differences of insoluble fibre in USA men and women separately 
 
Systolic BP 
 
Diastolic BP  
 
Not adjusted for BMI Adjusted for BMI 
 
Not adjusted for BMI Adjusted for BMI  
Models n 
Difference, 
mm Hg 
95% CI p 
Difference, 
mm Hg 
95% CI p 
Difference, 
mm Hg 
95% CI p 
Difference, 
mm Hg 
95% CI p 
Model 2 1              
Men 
2
 997 -2.3 -4.8, -0.2 0.04 -1.3 -3.7, -0.1 0.05 -1.2 -3.1, 0.7 0.20 -0.5 -2.3, 1.4 0.62 
Women 
3
 944 -3.8 -6.8, -0.8 0.01 -2.5 -5.5, -0.2 0.04 -2.3 -4.3, -0.4 0.02 -1.7 -3.6, 0.2 0.08 
Model 1 adjusted for age, total energy intake (kcal/24-hours), total protein (%kcal), total fat (%kcal), and population sample.                                                                                                                                                                                                       
Model 2 adjusted for variables in Model 2 plus adherence to a special diet, engagement in moderate and heavy physical activity (h/24 h), smoking, dietary supplement use, years of education (years 
completed), alcohol intake (g/24-hours), DM or CVD diagnosis, family history of high BP, 24-hour urinary excretion of sodium (mmol/24-hours).                                                                                                                   
1 
Additionally adjusted for total sugar (%) and soluble fibre (g/1000 kcal).                                                                                                                                                                                                                                              
2
 2SD insoluble fibres (g/1000 kcal)=4.4.                                                                                                                                                                                                                                                                                                             
3
 2SD insoluble fibres (g/1000 kcal)=4.5.                                                                                                                                                                                                                                                                                                                                                                                       
 
  
 233
Table A. 20. Estimated systolic and diastolic BP difference per 2SD higher differences of soluble fibre in USA men and women separately 
 
Systolic BP 
 
Diastolic BP  
 
Not adjusted for BMI Adjusted for BMI 
 
Not adjusted for BMI Adjusted for BMI  
Models n 
Difference, 
mm Hg 
95% CI p 
Difference, 
mm Hg 
95% CI p 
Difference, 
mm Hg 
95% CI p 
Difference, 
mm Hg 
95% CI p 
Model 2 1              
Men 
2
 997 -0.4 -3.2, 2.4 0.79 -0.5 -3.2, 2.2 0.72 -0.4 -2.5, 1.8 0.72 -0.5 -2.5, 1.6 0.65 
Women 
3
 944 0.2 -2.9, 3.4 0.88 0.2 -2.9, 3.2 0.92 0.3 -1.3, 2.8 0.50 0.7 -1.3, 2.7 0.52 
Model 1 adjusted for age, total energy intake (kcal/24-hours), total protein (%kcal), total fat (%kcal), and population sample.                                                                                                                                                                                                       
Model 2 adjusted for variables in Model 2 plus adherence to a special diet, engagement in moderate and heavy physical activity (h/24 h), smoking, dietary supplement use, years of education (years 
completed), alcohol intake (g/24-hours), DM or CVD diagnosis, family history of high BP, 24-hour urinary excretion of sodium (mmol/24-hours).                                                                                                                 
1
 Additionally adjusted for total sugar (%) and insoluble fibre (g/1000 kcal).                                                                                                                                                                                                                                                                                       
2
 2SD soluble fibres (g/1000 kcal)=2.0.                                                                                                                                                                                                                                                                                                                
3 
2SD soluble fibres (g/1000 kcal)=2.2. 
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Table A. 21. Estimated BMI difference per 2SD higher differences of total fibre in USA men and women separately 
  BMI  
Models n Difference, kg/m
2
 95% CI p 
Model 2 1     
Men 
2
 997 -1.3 -2.0, -0.6 0.0003 
Women 
3
 944 -2.0 -2.9, -1.2 5.34×10
-06
 
Model 1 adjusted for age, total energy intake (kcal/24-hours), total protein (%kcal), total fat (%kcal), and population sample.                                                                                                                              
Model 2 adjusted for variables in Model 1 plus adherence to a special diet, engagement in moderate and heavy physical activity (h/24 h), 
smoking, dietary supplement use, years of education (years completed), and alcohol intake (g/24-hours).                                                                        
1 
Additionally adjusted for total sugar (%).                                                                                                                                                                                                           
2 
2SD total fibre (g/1000 kcal)=6.3.                                                                                                                                                                                                      
3 
2SD total fibre (g/1000 kcal)=6.7.                                                                                                                                                                                                                                                                        
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Table A. 22. Estimated BMI difference per 2SD higher differences of insoluble fibre in USA men and women separately 
  BMI  
Models n Difference, kg/m
2
 95% CI p 
Model 2 1     
Men 
2
 997 -1.3 -2.3, -0.3 0.08×10
-01
 
Women 
3
 944 -1.9 -3.2, -0.7 0.003 
Model 1 adjusted for age, total energy intake (kcal/24-hours), total protein (%kcal), total fat (%kcal), and population sample.                                                                                                                              
Model 2 adjusted for variables in Model 1 plus adherence to a special diet, engagement in moderate and heavy physical activity (h/24 h), smoking, 
dietary supplement use, years of education (years completed), and alcohol intake (g/24-hours).                                                                                                  
1
 Additionally adjusted for total sugar (%) and soluble fibre (g/1000 kcal).                                                                                                                                           
2 
2SD insoluble fibre (g/1000 kcal)=4.4.                                                                                                                                                                                                      
3
 2SD insoluble fibre (g/1000 kcal)=4.5. 
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Table A. 23 Estimated BMI difference per 2SD higher differences of soluble fibre in USA men and women 
separately 
  BMI  
Models n Difference, kg/m
2
 95% CI p 
Model 2 1     
Men 
2
 997 0.1 -1.0, 1.2 0.85 
Women 
3
 944 0.1 -1.2, 1.4 0.87 
Model 1 adjusted for age, total energy intake (kcal/24-hours), total protein (%kcal), total fat (%kcal), and population sample.                                                                                                                              
Model 2 adjusted for variables in Model 1 plus adherence to a special diet, engagement in moderate and heavy physical activity (h/24 h), 
smoking, dietary supplement use, years of education (years completed), and alcohol intake (g/24-hours).                                                                           
1
 Additionally adjusted for total sugar (%) and insoluble fibre (g/1000 kcal).                                                                                                                                         
2
 2SD soluble fibre (g/1000 kcal)=2.0.                                                                                                                                                                                                                                    
3
 2SD soluble fibre (g/1000 kcal)=2.2. 
  
  
Figure A. 1. Glycaemic index and total fibre intake in relation to systolic 
participants, n=1232 
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Figure A. 2. Glycaemic index and total fibre intake in relation to systolic 
participants, n=1153 
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Figure A. 3. Glycaemic index and total fibre intake in relation to diastolic 
participants, n=1232 
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Figure A. 4. Glycaemic index and total fibre intake in relation to diastolic 
participants, n=1153 
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Figure A. 5. Glycaemic index and total fibre intake in relation to body mass index in UK and USA INTERMAP men 
participants, n=1232 
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Figure A. 6. Glycaemic index and total fibre intake in relation to body mass index in UK and USA INTERMAP women 
participants, n=1153 
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